How good are LLMs at doing real science?
Thatâs what weâre exploring with BenchBench. Our benchmarks test leading models on real scientific tasks, helping researchers find the right models for their work.
Check out the leaderboards: www.benchling.com/benchbench
Benchling
Benchling, Inc. is an American software company that develops electronic lab notebook, lab management, and cloud computing software for use in life sciences and biotechnology R&D. More on Wikipedia
-
Benchling
@benchling
-
Benchling reposted
Nicholas Larus-Stone
@nlarusstone
Getting data off an instrument in the lab and putting it into a structured database has historically been very difficult. Iâm here to tell you that writing manual parsers and setting up janky scripts is a thing of the past. Agents are extremely good at writing and understanding code, meaning they can build you a pipeline by just seeing a few example files. And if you already have a pipeline â even better! Agents are great at choosing the right pipeline to run based on the experiment. Stop bringing your USB drive into lab; set up an agent to do it right.
Sample prompt (feel free to tweak): Create an Instrument Parser Agent which looks at any new files and sees if there is an existing pipeline to parse the data. If there is, run that pipeline. If not, create a robust parsing pipeline that will work for future experiments that use this instrument and make sure the data ends up in a structured format. Save the new pipeline for future use with an informative name that helps future agents understand what itâs used for.
Day 25 of âAn agent a day keeps Phase 2 failures awayâ â instrument parser agentThis media couldn't be displayed. See it on the original post. -
Benchling reposted
Nicholas Larus-Stone
@nlarusstone
Every protein (yes, including your antibodies) should have a predicted structure associated with it. Seems simple enough, except thereâs a ton of different structure prediction models and they all have their own quirks. Luckily, we can build an agent which will do the comparison work for us and get smarter over time as we register more sequences.
Sample prompt (feel free to tweak): Create a Structure Prediction Agent that runs any time I create an amino acid sequence. It should decide which structure prediction model is likely to perform the best, then run that model. If unsure, it can run multiple models and compare the results. Initially, it should run multiple models to get a sense of which models perform well on our sequences and then remember that.
Day 24 of âAn agent a day keeps Phase 2 failures awayâ â structure prediction agentThis media couldn't be displayed. See it on the original post. -
Benchling reposted
GXL @gxl_ai
re:AGENT II is live, and applications are open!
Drug development moves through distinct phases of work: deciding what to investigate and how, designing and interpreting a trial, and carrying evidence through approval and launch. This January, scientists and builders will spend a weekend building agents and the tools they need for those jobs.
The three tracks follow that path:
AI Scientist â discovery through IND
AI Clinical Developer â the trial itself
AI Pharma Operator â approval, launch, and beyond
re:AGENT II is fully in person, January 9â10 in San Francisco, the weekend before JPM Healthcare Week.
No AI experience is required; apply on your own or with a team.
Applications close December 1. Application link in the comments.
Thank you to our sponsors @Benchling @AnthropicAI @modal @FenwickWest @benchflow_ai @StrandAI @biohub @arcinstitute and futurebio
#reagent #virtualbiotech #aiforscience #drugdevelopment #biotech #hackathon #jpm2027 -
Benchling
@benchling
How does Claude Mythos 5.2 stack up on real lab work?
It now leads BenchBench-Cloning, our benchmark testing how well AI models can design molecular cloning experiments, passing 40.7% of tasks. That's 10 points ahead of the next model.
See our updated BenchBench leaderboards: -
Benchling reposted
Nicholas Larus-Stone
@nlarusstone
Mythos 5.2 is the new king of cloning! Definitely a lot better than Mythos 5.1, though only marginal improvement over Astra. Making (slow) progress in biology, which is good to see.
Fable 5.2 not pictured because it refused all of the tasks :( -
Benchling reposted
Nicholas Larus-Stone
@nlarusstone
Nobody wants to think about compliance⌠until you need to think about compliance. Then you really regret not thinking about compliance. Regulated labs are often overrun by paperwork and reporting and have the most to benefit from effective use of AI. Luckily agents can help with the administrative burden and improve the quality of the underlying processes.
Sample prompt (feel free to tweak): Create a Deviation Triage Agent that runs whenever a new Deviation is registered. Pull in the related notebook entries, samples, equipment, and reagent lots. Search past deviations for similar events, and summarize their root causes, their CAPAs, and whether those CAPAs actually prevented recurrence. Draft an investigation outline and propose a severity, with your reasoning. Flag it if âhuman errorâ is being proposed as the root cause without supporting evidence. Assign the draft to the QA owner for review. Donât change the deviationâs status or close anything; a person signs off on every decision.
Day 23 of âAn agent a day keeps Phase 2 failures awayâ â deviation/CAPA triage agentThis media couldn't be displayed. See it on the original post. -
Benchling
@benchling
A research question can be completely safe, but mention a pathogen or certain lab techniques, and some AI models will refuse to answer.
Our latest benchmark, BenchBench-Refusals, tests how well leading AI models distinguish harmful from benign biology requests.
See the results: -
Benchling reposted
Nicholas Larus-Stone
@nlarusstone
Structured data is still king. Having a good scientific data model is even more important in the AI era. Luckily we can use AI to help us maintain and improve our data model. Letâs set up an agent that does exactly that.
Sample prompt (feel free to tweak): Create a Data Model Governance Agent that runs every month and takes a look at your data model and recommends suggestions. It should find areas where fields are not being used, schemas that are duplicative or overlapping, and recommend new places to start to structure the data capture process.
Day 22 of âAn agent a day keeps Phase 2 failures awayâ â data model governanceThis media couldn't be displayed. See it on the original post. -
Benchling reposted
Nicholas Larus-Stone
@nlarusstone
Drug discovery is an incredibly difficult multi-objective optimization problem. Thatâs why I know every biotech company is storing their objectives in a structured way so they can easily view their progress⌠right? Anyways, letâs create an agent that helps you keep track of progress against your TPP and make good decisions about what experiments to prioritize next.
Sample prompt (feel free to tweak): Create a TPP Monitor Agent that runs every time we get new data recorded against our TPP. Provide a molecular scorecard of our best molecule as a canvas. Give details on what attributes have been improving and which have been stagnant. Make sure to compare to publicly available data/comparisons
Day 21 of âAn agent a day keeps Phase 2 failures awayâ â TPP monitor -
Benchling reposted
Nicholas Larus-Stone
@nlarusstone
Day 20 of âAn agent a day keeps Phase 2 failures awayâ â workflow updater
Keeping track of work and project handoffs is very challenging. As my team has been doing more and more work with agents, Iâve found it challenging to keep track of everything thatâs going on â even with a dedicated workflow system. However, if you have a hammer, everything looks like a nail. So why not just build another agent to help you keep track of all the work (and more importantly update it in a durable way so others can see the status of work as well).
Sample prompt (feel free to tweak): Create a Workflow Updater Agent that runs every night and looks at work done in the past day. Look at any notebook entries or other work that me or my team has completed. Please group all updates by person. Make sure the person associated with the work is actually the right person. If there are workflows or workflow tasks related to the work done, update the workflow/task state appropriately. Keep track of any change you make. Separate from those changes, you should also review the workflows/tasks you did not change and see if any of their statuses were changed in the last 24 hours by a user. Summarizes both the changes you made as well as the status changes other users made. There should only be one status change summary for each piece of work. If you make a change to a workflow/task, share that status. If you do not make a change but a user has, share that status. If there is no status change, no need to mention the work. -
Benchling reposted
Nicholas Larus-Stone
@nlarusstone
Day 19 of âAn agent a day keeps Phase 2 failures awayâ â sequence QC
Sequencing is the backbone of molecular biology, but you need to make sure that your data is correct! I was just talking to a friend who got some data back from a CRO where their QC had put the number of sequences off by a factor of 20. Historically this required a bunch of manual work, a collection of brittle scripts, or a trusty bioinformatics colleague, but now you can set up an agent to do this for you.
Sample prompt (feel free to tweak): Create a Sequencing QC Agent that runs every night and looks at notebook entries updated in the past day. If an entry has new sequencing results attached (Sanger .ab1 files or whole-plasmid reads) that havenât been QCâd yet, align them to the intended sequence referenced in the entry. For nanopore or other high-error reads, call variants from the consensus across reads rather than from individual reads. Add a short summary to the entry saying which clones match and flagging any mismatches, indels, or low-quality regions. If you canât tell which sequence the reads should be compared against, note that in the entry instead of guessing.
S/o @NishantNeel for the video!This media couldn't be displayed. See it on the original post. -
Benchling reposted
Miles Grimshaw
@milesgrimshaw
AI for bio is already here ⌠see agent usage in @benchling
We can already speed up a lot! -
Benchling reposted
Nicholas Larus-Stone
@nlarusstone
New benchmark on biosecurity: BenchBench-Refusals. I like to call this one âshit every biologist knowsâ (but we put some numbers to it!).
Some models are refusing more than 50% of legitimate biology queries!
The most interesting thing to me is that refusal rate is not correlated to model quality â some of the strongest models are the best calibrated. -
Benchling
@benchling
Can LLMs distinguish harmful biology requests from legitimate research questions? Not always.
Our latest benchmark, BenchBench-Refusals, evaluated leading models on 160 prompts, ranging from benign to hazardous.
Get the results: www.benchling.com/blog/can-llms-identify-harmful-biology-⌠-
Benchling reposted
Nicholas Larus-Stone
@nlarusstone
Day 18 of âAn agent a day keeps Phase 2 failures awayâ â dataset builder
So you want to train (or finetune) a model to help your scientists. The first challenge most teams face is just finding the right data. Then thereâs knowing the experimental context the data was generated from. And finally keeping that dataset up to date as new data comes in. Luckily we can build an agent to help with all 3.
Sample prompt (feel free to tweak): Create a Dataset Builder Agent which builds datasets for training ML models every month. If thereâs an existing dataset its built, look for new data to add to the dataset. Also look for new data since the last run that could be used to build new datasets. Make sure to include any experimental caveats/notes alongside the data. -
Benchling reposted
Nicholas Larus-Stone
@nlarusstone
This might be my favorite agent yet⌠having spent years searching for random Excel files that scientists have tucked away, itâs nice to have an agent that just works in the background and cleans up data without me having to do anything.
Day 17 of âAn agent a day keeps Phase 2 failures awayâ â data structuring
While everyone knows you *should* have robust pipelines which automatically capture data from instruments and structure it, the real world is a lot messier. Scientists drop Excel files or PDFs in their notebooks as a ârecordâ of what happened. Letâs set up an agent to automatically clean up that data and make it ready for downstream analytics and ML use cases.
Sample prompt (feel free to tweak): Create a Data Structuring Agent which looks at any new notebook entries from the past day and if there are any attachments (e.g. Excel files, PDFs, etc) where the data hasnât been put into a structured table, add a structured table and fill out the data from the attachment.This media couldn't be displayed. See it on the original post. -
Benchling reposted
Nicholas Larus-Stone
@nlarusstone
Day 16 of âAn agent a day keeps Phase 2 failures awayâ â wiki builder
Tacit knowledge accumulates in every company, but itâs especially pernicious in biotechs. Which cell line should you use for this experiment? Does this machine have a technical artifact? This knowledge can be written down and made into a persistent, shareable record. But staying on top of all the science thatâs going on and converting it into digestible facts is too much for a person to do. Enter the Wiki creation agent.
Sample prompt (feel free to tweak): Create a Wiki agent that runs every evening. It should look at all the work that had been done during the day and record any meaningful result in a wiki file. If there was no meaningful progress to be recorded, say so. The wiki should be in the Open Knowledge Format and placed in the appropriate project/folder. Make sure every piece of information has a link back to the source information (ELN entry, registered entity, result, etc). Give me a summary of what was updated. -
Benchling reposted
Nicholas Larus-Stone
@nlarusstone
SLIDES! GANTT CHARTS! Every scientistâs (least) favorite topic
Keeping track of all the ongoing work in a program is extremely difficult. Especially if youâre asking everyone to take time out of their day to update a tracker. But if you want to scale to more programs without increasing headcount, youâll need some way of managing bottlenecks and staying on top of whatâs happening. Thatâs where an agent can come in handy.
Sample prompt (feel free to tweak): Create a Program Management Agent which gives me a status update on all of our ongoing programs and calls out any delays or blockers. Include a Gantt chart of our progress. Format the update as a slide deck.
Day 15 of âAn agent a day keeps Phase 2 failures awayâ â program managerThis media couldn't be displayed. See it on the original post. -
Benchling reposted
Nicholas Larus-Stone
@nlarusstone
Lots of discussion recently about target crowding. Some of that is intentional (derisked biology), but some of it comes out of ignorance of how many companies are going after the same indication. Staying up to date on the market has never been easier. Set up a competitive intelligence agent to make sure youâre informed about whatâs happening to your pipeline.
Sample prompt (feel free to tweak): Create a Competitive Intelligence Agent that runs every Sunday and gives me a full report on the last week. Focus on our lead programs. The first time you run, compile a list of relevant companies and labs and save it to your memory. Then, every report should give me an update on any progress or announcements (press releases, LinkedIn posts, conference presentations, etc). Make sure to also keep an eye out for any new entrants who werenât on the original list.
Day 14 of âAn agent a day keeps Phase 2 failures awayâ â competitive intelligenceThis media couldn't be displayed. See it on the original post. -
Benchling reposted
Nicholas Larus-Stone
@nlarusstone
Many people assuming that just because I posted this means I think LLMs will not get better at biology... not sure why, I agree this is a task with a nice verifiable reward that LLMs will certainly get better at.
However it shows how much tacit knowledge is in biology and how spiky the intelligence of these models is. Many tasks that are much harder to verify (e.g. program decisions, target ID)
Nicholas Larus-Stone
@nlarusstone
I hate to rain on everyone's parade, but unfortunately LLMs are still not that good at biology :(. Even basic molecular cloning tasks are beyond the reach of frontier models
-
Benchling reposted
Nicholas Larus-Stone
@nlarusstone
Yesterday we showed how to automatically import and structure CRO data. But what happens when those pipelines fail? Whether itâs getting data in a slightly different format, a firmware update to an instrument, or a new plate format â new data is constantly breaking deterministic pipelines. Luckily an agent can help you get the best of both worlds: use pipelines when you can, but automatically recover from errors as the science and data evolve.
Sample prompt (feel free to tweak): Create a Pipeline Agent that automatically monitors analysis pipelines that fail. When a pipeline fails, it should diagnose what happened (e.g. wrong file, data shape changed, transient issue, etc) and then perform the appropriate fix. If the fix involves changing the pipeline code, it should create a new draft of the pipeline but not publish it.
Day 13 of âAn agent a day keeps Phase 2 failures awayâ â automatically unblock pipelines
Nicholas Larus-Stone
@nlarusstone
Day 12 of âAn agent a day keeps Phase 2 failures awayâ â automate CRO data ingestion
Everyone is buzzing about one person biotechs who are heavily leveraging CROs. But basically every biotech and pharma company uses CROs. And scientists waste hours each week monitoring their email and reformatting data. What if the data just showed up how you needed it, when you needed it, in the place youâre already doing your daily work?
Sample prompt (feel free to tweak): Create a CRO Agent which takes any new files in our CRO project and automatically runs the correct pipeline to parse and structure the data. Then, take the outputs of the pipeline and create a notebook entry that includes all the structured data we extracted as well as a summary slide deck.
s/o Clare Young for the guest videoThis media couldn't be displayed. See it on the original post. -
Benchling reposted
Nicholas Larus-Stone
@nlarusstone
Day 12 of âAn agent a day keeps Phase 2 failures awayâ â automate CRO data ingestion
Everyone is buzzing about one person biotechs who are heavily leveraging CROs. But basically every biotech and pharma company uses CROs. And scientists waste hours each week monitoring their email and reformatting data. What if the data just showed up how you needed it, when you needed it, in the place youâre already doing your daily work?
Sample prompt (feel free to tweak): Create a CRO Agent which takes any new files in our CRO project and automatically runs the correct pipeline to parse and structure the data. Then, take the outputs of the pipeline and create a notebook entry that includes all the structured data we extracted as well as a summary slide deck.
s/o Clare Young for the guest videoThis media couldn't be displayed. See it on the original post. -
Benchling reposted
Ashu Singhal @daashu
We worked with scientific experts to build cloning tasks from real experiments and then tested leading models. GPT-6 Astra led at 30.6%, followed by GPT-6.1 Sol at 22.2% and Claude Opus 5.5 at 20.5%. Less recent models scored just 8-10%.
-
Benchling reposted
Ashu Singhal @daashu
How good is AI at molecular biology? Our newest benchmark, BenchBench-Cloning, shows recent models have gotten a lot better, but still have a ways to go.
-
Benchling reposted
Sajith Wickramasekara
@sajithw
How good is AI at molecular biology?
Cloning is foundational to molecular biology. I did plenty of it during my wet lab stints. We decided to set AI to the task. Introducing BenchBench-Cloning.
GPT-6 Astra led with a score of 30.6%, followed by GPT-6.1 Sol at 22.2% and Claude Opus 5.5 at 20.5%.
These tasks require long, multi-step reasoning. Models frequently make the right individual decisions but struggle to put them together.
Read more: www.benchling.com/blog/how-good-is-ai-at-molecular-biology -
Benchling reposted
Nicholas Larus-Stone
@nlarusstone
I hate to rain on everyone's parade, but unfortunately LLMs are still not that good at biology :(. Even basic molecular cloning tasks are beyond the reach of frontier models
-
Benchling
@benchling
AI can analyze DNA sequences. But can it design an entire molecular cloning experiment?
Introducing BenchBench-Cloning, our new benchmark that evaluates leading AI models on 65 real-world molecular cloning tasks.
Get the results and preprint: www.benchling.com/blog/how-good-is-ai-at-molecular-biology -
Benchling reposted
Nicholas Larus-Stone
@nlarusstone
I call this one the âdid youâ agent.
Day 11 of âAn agent a day keeps Phase 2 failures awayâ â data QC
Doing rigorous QC of your data requires answering a lot of questions. Did you check for transcription errors? Did you check if two samples got swapped? Did you check for outliers? Did you check for edge effects? Did you check for contamination? Did you check if a control is drifting? Did you check for batch effects? Did you check if different operators have different distributions of results? Letâs make an agent to help us automatically answer this question.
Sample prompt (feel free to tweak): Create a QC Agent which runs every day and looks at all of the new data for our program. It should do rigorous QC over the data and look for the following: transcription errors, sample swapping, outliers, edge effects, contamination, control drift, batch effects, operator effects, and any other potential data issues. Give me a full report on any issues and suggest next steps to remediate them or say that there are no issues.This media couldn't be displayed. See it on the original post. -
Benchling reposted
Nicholas Larus-Stone
@nlarusstone
Day 10 of âAn agent a day keeps Phase 2 failures awayâ â inventory
Thereâs no worse feeling than starting an experiment and realizing that youâve run out of a key reagent. Or that something is past its expiration date. But keeping track of every reagent or component of an experiment is a lot of work. So most of us donât bother to keep our digital inventory up to date. What if we had an agent that could keep it up to date without doing any additional work (other than keeping a good notebook entry)?
Sample prompt (feel free to tweak): Create an Inventory Agent which runs every day at all of the experiments which were run and updates our inventory (plates, reagents, stocks, etc) based on what was actually used. Also mention if anything is out of date or expired. If anything in our inventory seems to be running low, queue up an order for my approval.This media couldn't be displayed. See it on the original post. -
Benchling reposted
Sajith Wickramasekara
@sajithw
I tell everyone that @divergence_labs is one of the most impressive early stage biotech teams. Excited to see them start telling their story.
Bowen Jing
@bjing2016
Today, in collaboration with Anthropic, weâre excited to share rapid initial progress towards an antibody treatment for food allergy, which affects over 200 million people worldwide, discovered with the help of Claude.
At Divergence Labs, we believe that AI can unlock the next generation of antibody therapeutics with more effective mechanisms than before. Such mechanisms are urgently needed in food allergy, which involve overcoming one of the tightest affinity protein pairs in immunology, IgE and its receptor FcÎľRI, on mast cells.
Treatment with Xolairâthe only approved antibody for food allergyâsequesters circulating IgE, but mast cells remain sensitized for weeks to months due to the extraordinarily slow dissociation of IgE from FcÎľRI.
We envision a treatment that actively pulls IgE off of FcÎľRI, without waiting for natural dissociation. Like picking a lock, this requires the right combination of geometry and force.
Our research team, working with Claude, ideated on mechanisms to accomplish this disruption, and converged on an antibody format with two arms with different functions and epitopes. Within one month, we designed, synthesized, and experimentally confirmed the biophysical function of the two arms, which we are now assembling into full therapeutic formats. -
Benchling reposted
Nicholas Larus-Stone
@nlarusstone
Day 9 of âAn agent a day keeps Phase 2 failures awayâ â patents
IP is the lifeblood of biotech, but most data is hidden away and never examined after the initial experiment. However, Iâve been seeing more legal teams use our AI tools to look for novel research that can be patented. But many companies donât have dedicated patent attorneys or a large enough legal team to handle all of the research that is being produced. Luckily, you can just set up an agent to do that search on your behalf.
Sample prompt (feel free to tweak): Create a monthly Patentable Discoveries Agent which runs every month and looks at all of the research that has been done and identifies up to 3 pieces of work that could be patented. If there are no discoveries that rise to the level of a patentable piece of work, it says so and suggests how existing work would need to be extended to be a novel, patentable discovery. -
Benchling reposted
Nicholas Larus-Stone
@nlarusstone
Day 8 of âAn agent a day keeps Phase 2 failures awayâ â higher quality notebook entries
Notebook entries are the foundation of a biotechâs scientific record. If theyâre not accurate, high quality, and up to date, anything you try to do downstream will be more challenging. Most scientists I know see recording their work as a tax, not something they look forward to. But what if there was an agent that could help keep the quality of notebook entries high without requiring more work from already busy scientistsâŚ
Sample prompt (feel free to tweak): Create a Notebook Review Agent which runs when a notebook entry is sent for review. The agent should look over the entry and check for any data issues (e.g. transcription errors), the quality and clarity of the prose, as well as the overall completeness of the entry. If there are attached data files that havenât been put into a structured form, extract the data and put it into structured tables. After reviewing the full entry, the agent should make a few recommendations of what the author should do based on the entry.This media couldn't be displayed. See it on the original post. -
Benchling reposted
Nicholas Larus-Stone
@nlarusstone
This one is for all my LabOps folks!
Day 7 of âAn agent a day keeps Phase 2 failures awayâ â equipment
Most lab equipment costs hundreds of thousands (or sometimes millions) of dollars. So why wouldnât you have an agent making sure thereâs contamination or miscalibration on any of your machines? Maintaining a lot of equipment is challenging, but knowing when something needs your attention is half the battle: and an agent can help with that.
Sample prompt (feel free to tweak): Create an Equipment Monitor that runs every week and looks at all experiments run on a piece of equipment to determine if the machine might be miscalibrated, needs to be maintained, or is contaminated. Make sure it reports it as a full canvas depiction of the current state of our equipment. -
Benchling reposted
Nicholas Larus-Stone
@nlarusstone
Better science doesn't stop on the weekends! Day 6 of âAn agent a day keeps Phase 2 failures awayâ â save $10M
A biotech company once told me that they used Benchling AI to determine that 30% of their in vivo studies were redundant or wasteful. Thatâs millions of dollars and months of time down the drain. Every animal study should have an agent (or really a team of agents) making sure it is designed correctly and will provide useful results.
Sample prompt (feel free to tweak): Create an In Vivo Study Review agent that runs before an study moves to its execution stage. Analyze whether itâs a duplicate of an existing study and if it the readout will be statistically significant. If there are changes that should be made, provide concrete suggestions on how to update the study design. -
Benchling reposted
Nicholas Larus-Stone
@nlarusstone
Day 5 of âAn agent a day keeps Phase 2 failures awayâ â literature review
Literature Review is probably the most common way I see scientists use AI. AI tools have come a long way since the early days of ChatGPT when they used to hallucinate references, but most scientists are still not using AI to its full potential. If you set up a lit review agent that is *based on your actual experimental data* you will get much better results.
Sample prompt (feel free to tweak): Create a weekly Literature Review agent that runs every Friday morning and surveys the latest literature relevant to my work. In particular, look for papers that include new techniques that could accelerate my science or papers that contain data that might confirm or refute my current research direction. -
Benchling reposted
Feng Zhang
@zhangf
Thank you to Ed Pilkington and John Levy for making biology so exciting, and to the many teachers, students and colleagues I've learned from since. Grateful to @stephgreed and @NatRevChem for this birthday Q&A.
rdcu.be/1nwbXTvbRpWa -
Benchling reposted
Nicholas Larus-Stone
@nlarusstone
This is actually the path to having useful AI agents in GxP environments as well
Berci MeskĂł, MD, PhD
@Berci
An FDA official just said that generative AI tools in medicine might get evaluated more like a physician, rather than a device or software.
He explained the difficulty in regulating gen AI brilliantly:
âWeâve been looking at software as a medical device for 20 years. Weâre used to a paradigm where you have a piece of software â you can put in X, and it spits out Y â in a nutshell. ...Well, thatâs pretty straightforward from an evidentiary standpoint.â
âWe ended up putting out this idea that maybe these devices are starting to behave a little bit more like me as a physician than a heart valve or a defibrillator. I went through a system where, over time, I was evaluated on my knowledge and my clinical judgment and my communication ability and my ability to adhere to certain safety boundaries.â
Source: medcitynews.com/2026/10/fda-official-believes-genai-enabl⌠-
Benchling reposted
Nicholas Larus-Stone
@nlarusstone
Day 4 of âAn agent a day keeps Phase 2 failures awayâ â the little things
Sometimes itâs the little things that add up and cause delays. Like not knowing if a reagent is in stock or whether your sequencing core has finished with your samples. The last thing you want is to have to run around figuring something out in the middle of your experiment. So why not spend a few minutes up front planning to avoid hours of disruption later. Thatâs what our Daily Experiment Planner agent can help with.
Sample prompt (feel free to tweak): Create an Experiment Planner Agent which runs every weekday morning. It should look at what I did yesterday and my calendar today to determine what my schedule for today should be. Please prepare any notebook entries that I need to do my work today and call out any things I should be aware of (reagents running low, equipment I need to reserve, etc). -
Benchling reposted
Nicholas Larus-Stone
@nlarusstone
Day 3 of âAn agent a day keeps Phase 2 failures awayâ â data quality
Controls are only controls if they behave consistently between experiments. But are you really doing the work of comparing this experimentâs controls against all the previous times you ran the experiment? Or are you just eyeballing that they look okâŚ
Set up a Control Chart Agent to build and alert based on your control charts. Catch contamination or a bad batch of reagents before youâve spent months going down the wrong path.
Sample prompt (feel free to tweak): Create a Control Chart Agent which looks at my experiments from the week and creates or updates a control chart from the previous 5 experiments of the same type. Please alert me if anything falls outside of the UCL or LCL and investigate potential causes.This media couldn't be displayed. See it on the original post. -
Benchling
@benchling
New from Benchling and @NVIDIAAI:
Scientists and AI agents will be able to access RFD4-Proteina for generative protein design through Benchling Model Hub.
www.benchling.com/blog/building-agentic-lab-in-the-loop-f⌠-
Benchling
@benchling
Agentic lab-in-the-loop will only happen when dry lab computation and wet lab experimentation come together.
See what weâre building with @NVIDIAAI. www.benchling.com/blog/building-agentic-lab-in-the-loop-f⌠-
Benchling
@benchling
We teamed up with @NVIDIAAI to post-train Nemotron 3.5 Super VL on scientific protocol data.
It outperformed comparable closed models in troubleshooting and optimizing lab experiments, at a remarkably low cost, representing a promising path for R&D teams to build specialized intelligence they can customize and improve over time with their own data. www.benchling.com/blog/building-agentic-lab-in-the-loop-f⌠-
Benchling reposted
Nicholas Larus-Stone
@nlarusstone
Day 2 of âAn agent a day keeps Phase 2 failures awayâ -- AI for increasing creativity
Apparently yesterday was too tame, so letâs spice it up with a Hypothesis Dreamer Agent. When used appropriately, AI can actually be a great source of creativity.
No one (including AI) knows your science better than you do. But sometimes you need to integrate ideas from other people, other teams, or the broader literature. And thatâs exactly where an agent which is constantly synthesizing your research with broader context and dreaming up new hypotheses can help.
Sample prompt (feel free to tweak): Please create a Weekly Hypothesis Generation Agent that looks over my work, my teamâs work, and the published literature to suggest new hypotheses. These can include new research directions, ideas on why a particular experiment isnât working, or ways our work could be improved. Give a prioritized list of 3-5 actionable suggestions. Please present all of the sources you used to come to this conclusion. If itâs helpful, please use visual references to understand the reasoning behind the suggestions.This media couldn't be displayed. See it on the original post. -
Benchling reposted
Nicholas Larus-Stone
@nlarusstone
Day 1 of âAn agent a day keeps Phase 2 failures awayâ
We're going to start with something simple: a Weekly Report Agent.
Every scientist I know has to do some sort of communication about what theyâre working on. Whether itâs presenting at a lab meeting or discovery meeting, status updates for their boss, or preparing something for a partner. So why not automate the time consuming retrieval of data and creation of plots with an agent?
Sample prompt (feel free to tweak): Please create a Weekly Report Agent that summarizes all of the work that I've done over the past week in a slide deck. Make sure to check all of my notebook entries, any sequences or biological entities that I've created, and any other places I was mentioned. Add visualizations where appropriate and link back to the source data. -
Benchling reposted
Sajith Wickramasekara
@sajithw
30 days of agents that any scientist can instantly setup
Nicholas Larus-Stone
@nlarusstone
Day 1 of âAn agent a day keeps Phase 2 failures awayâ
We're going to start with something simple: a Weekly Report Agent.
Every scientist I know has to do some sort of communication about what theyâre working on. Whether itâs presenting at a lab meeting or discovery meeting, status updates for their boss, or preparing something for a partner. So why not automate the time consuming retrieval of data and creation of plots with an agent?
Sample prompt (feel free to tweak): Please create a Weekly Report Agent that summarizes all of the work that I've done over the past week in a slide deck. Make sure to check all of my notebook entries, any sequences or biological entities that I've created, and any other places I was mentioned. Add visualizations where appropriate and link back to the source data. -
Benchling reposted
Nicholas Larus-Stone
@nlarusstone
Launching what Iâm calling âan agent a day keeps Phase 2 failures awayâ
Itâs come to my attention that many people donât see how AI can be helpful for biotech. So, every day for the next 30 days, I will be posting an agent that can be helpful for biotech and pharma companies. The agents will span all departments and phases of R&D.
Hopefully this will inspire some folks to use AI in novel ways -
Benchling
@benchling
With Science Foundries, teams of agents handle routine work and surface insights, while scientists review, approve, and make the final calls.
See how it works in this Antibody Discovery Foundry walkthrough with Benchlingâs @nlarusstone.
www.benchling.com/blog/introducing-science-foundriesThis media couldn't be displayed. See it on the original post. -
Benchling
@benchling
Benchling Chemistry is officially GA.
Capture structured reaction data, calculate stoichiometry automatically, and run ADMET predictions to your heartâs content. www.benchling.com/blog/benchling-chemistry-building-the-d⌠-
Benchling
@benchling
Introducing Direct Data Share.
Keep your scientific data in sync between Benchling and @Snowflake, without building custom data pipelines.
Now available in beta: www.benchling.com/blog/direct-data-share-with-snowflake-a⌠-
Benchling reposted
Sajith Wickramasekara
@sajithw
Full house at Benchtalk Boston for @nlarusstone unveiling Science Foundries, a new way to run scientific processes end-to-end with agents and scientists working as a team.
www.benchling.com/blog/introducing-science-foundries -
Benchling reposted
BiopharmaTrend
@BiopharmaTrend
Breaking: @benchling just launched Science Foundries, moving from helping scientists with individual tasks to managing entire scientific processes with teams of AI agents.
www.biopharmatrend.com/news/benchlings-science-foundries-⌠-
Benchling reposted
Nicholas Larus-Stone
@nlarusstone
Multi-agent systems for science are finally here! Just launched Science Foundries with agent swarms, natively multiplayer agents, and more fun stuff
We wrote up some thoughts on how this will change scientific discovery as well: www.benchling.com/blog/introducing-science-foundriesThis media couldn't be displayed. See it on the original post. -
Benchling
@benchling
Just announced at Benchtalk: Science Foundries.
Foundries bring together specialized agents and models to run entire scientific processes, whether itâs protein production, assay development, or lead optimization.
A team of agents handles tasks and coordinates handoffs, while scientists still make the important decisions.
More from Benchlingâs @nlarusstone: www.benchling.com/blog/introducing-science-foundries -
Benchling
@benchling
Love a good Gantt chart? Use Benchling AI to vibe code your own lab project tracker.
-
Benchling
@benchling
Turn your in vivo data into a report draft in minutes with Benchling AI.
This media couldn't be displayed. See it on the original post. -
Benchling
@benchling
Automate your daily to-do list with Benchling AI.
Set up an agent to review your tasks, suggest priorities, and pull in updates from related work, all before you log in each morning. -
Benchling
@benchling
Build your own Western blot annotator with a single prompt.
-
Benchling reposted
Dr. Shelby
@shelbynewsad
last week, @CompoundVC, hosted the biggest data factory event ever.
@benchling hosted their amazing space and talked about the future of bio with AI Scientists
@scale_AI spoke about recent SOTA benchmarking judgement built around data sales
@FabioZB_I talked about the Polyphron tissue foundry
@contra showcased their work on creativity training
@TryBrickroad and @Freeman_Lewin are some of the most sophisticated data sellers
@QuickrBio wow'd us with their better, faster, cheaper platform
Dynamical Systems for materials science data factories and Ambitious for their healthy bill of materials.
So much happening here.
TY @shantenuagarwal for organizing and @nlarusstone for speaking!This media couldn't be displayed. See it on the original post. -
Benchling
@benchling
Plan it, run it, and record it â automatically.
Plates are now supported in Benchling Automation, so you can plan and execute plate transfers from your Notebook, pull instrument data back into Benchling, and record to your inventory. -
Benchling
@benchling
Build it with Benchling AI. Then share it with your team.
Now you can save dashboards and other artifacts directly to a project, so your team can use them too. -
Benchling
@benchling
Vibe coding for scientists is here.
Build your own interactive hit picking tool with a single prompt. -
Benchling
@benchling
How do you run over 600 AI-generated code executions a day, across hundreds of tenants a week, with zero security incidents?
Check out our technical deep dive with @AWS on securing multi-tenant code execution with account-level isolation, DNS exfiltration defenses, and per-job credential scoping. aws.amazon.com/blogs/machine-learning/how-benchling-secur⌠-
Benchling reposted
Ben Birnbaum
@benbirnbaum
One of the themes of my career has been deploying ML to to experts in complex domains, including to oncologists in 2017 and to medicinal chemists in 2022. Communicating about ML in a way that creates trust has been deeply important in both cases. It was fun to chat with @benchling about this after the launch of our models into their platform.
Benchling
@benchling
Get the stories behind the models.
@inductive_bio cofounder @benbirnbaum talks about ADMET modeling, the âwhack-a-moleâ of compound optimization, and why trust is earned through transparency. www.benchling.com/blog/how-inductives-ben-birnbaum-built-⌠-
Benchling
@benchling
Get the stories behind the models.
@inductive_bio cofounder @benbirnbaum talks about ADMET modeling, the âwhack-a-moleâ of compound optimization, and why trust is earned through transparency. www.benchling.com/blog/how-inductives-ben-birnbaum-built-⌠-
Benchling
@benchling
Ask Benchling AI to build a weekly update agent that runs every Monday. It can sum up what's done, what's in motion, and what needs your attention.
Save the agent once, share access with your team, and everyone benefits from the same automation. -
Benchling reposted
Pierce
@PierceOgdenJ
Today, weâre announcing mBER-2, our latest AI protein design system, and sharing a bit of how we use it to explore biology in vivo at scale.
For a long time, weâve been working on what I think of as âfrontier problemsâ in medicine and biology. We know a lot about the targets involved in disease, but there is still an enormous amount of biology we havenât explored, and potential uses for that biology we havenât discovered.
One of those problems is drug delivery. There are thousands of potential targets, and most receptors remain unexplored as routes for delivering medicines. We want to understand which ones we can use, where they can take a drug, and what kinds of molecules make that possible.
Ultimately, we need to test these molecules in vivo to understand what they actually do. Weâve spent the last six years building measurement technologies that let us generate millions of measurements in living systems.
mBER-2 is an AI protein design system built for that scale of in vivo measurement. Our goal is to generate binders across the full range of targets we care about, while systematically exploring the possible binding sites on each one. Itâs not just what you bind, but where and how you bind that determines whether a molecule performs it's function. mBER-2 lets us probe those differences at massive scale.
Weâre also sharing a look at some of our in vivo data. Weâve designed more than 50 million molecules across over 4,000 targets, and screened millions of molecules in living systems. By probing hundreds of receptors, weâve found new pathways for delivering genetic medicines into fat that outperform industry benchmarks by a large margin.
This is just the beginning. We call the space of all bindable sites across proteomes the EpiTome. As we explore it, weâre building the data to connect AI design, receptor binding, and what a molecule actually does in a living organism.
Much like the idea of a virtual cell, we envision a Virtual Organism that helps us design medicines with specific properties in mind. The foundation is our own in vivo data, connecting molecular design to outcomes measured in living systems.
The endgame is to use AI to explore more biology, measure what happens, and use what we learn to design better medicines. Every round should deepen our understanding of biology and improve our ability to build molecules that do what we need them to do. -
Benchling reposted
Gleb Kuznetsov
@glebkuz
Weâre hearing two kinds of voices on the potential of AI to cure all disease:
One says AI will cure everything, but without a concrete path to get there.
The other says biology is too complex to ever tame, but underestimates the power of the tools that will unlock the full potential of frontier intelligence.
At Manifold Bio, we see a path and weâre already building it: a high-throughput interface into living system biology. Millions of protein designs, measured directly in vivo, to learn how molecules behave in the body and ultimately predict what theyâll do before they reach a patient.
Today we share mBER-2, the latest iteration of our AI protein design model that is a core piece of this mission.
Pierce
@PierceOgdenJ
Today, weâre announcing mBER-2, our latest AI protein design system, and sharing a bit of how we use it to explore biology in vivo at scale.
For a long time, weâve been working on what I think of as âfrontier problemsâ in medicine and biology. We know a lot about the targets involved in disease, but there is still an enormous amount of biology we havenât explored, and potential uses for that biology we havenât discovered.
One of those problems is drug delivery. There are thousands of potential targets, and most receptors remain unexplored as routes for delivering medicines. We want to understand which ones we can use, where they can take a drug, and what kinds of molecules make that possible.
Ultimately, we need to test these molecules in vivo to understand what they actually do. Weâve spent the last six years building measurement technologies that let us generate millions of measurements in living systems.
mBER-2 is an AI protein design system built for that scale of in vivo measurement. Our goal is to generate binders across the full range of targets we care about, while systematically exploring the possible binding sites on each one. Itâs not just what you bind, but where and how you bind that determines whether a molecule performs it's function. mBER-2 lets us probe those differences at massive scale.
Weâre also sharing a look at some of our in vivo data. Weâve designed more than 50 million molecules across over 4,000 targets, and screened millions of molecules in living systems. By probing hundreds of receptors, weâve found new pathways for delivering genetic medicines into fat that outperform industry benchmarks by a large margin.
This is just the beginning. We call the space of all bindable sites across proteomes the EpiTome. As we explore it, weâre building the data to connect AI design, receptor binding, and what a molecule actually does in a living organism.
Much like the idea of a virtual cell, we envision a Virtual Organism that helps us design medicines with specific properties in mind. The foundation is our own in vivo data, connecting molecular design to outcomes measured in living systems.
The endgame is to use AI to explore more biology, measure what happens, and use what we learn to design better medicines. Every round should deepen our understanding of biology and improve our ability to build molecules that do what we need them to do. -
Benchling
@benchling
A lot of what makes someone good at benchwork isnât in a paper or protocol. It lives in their head. Thatâs one reason most LLMs still struggle with wet-lab reasoning.
Check out @nlarusstone on the Ion Genomics podcast to hear what we learned from putting leading models to the test. www.iongenomics.bio/p/how-well-do-ai-models-understand
Benchling
@benchling
Look out for more benchmarking research soon, and read the first preprint here! assets.ctfassets.net/kzeezny59h5p/1spGaR3QP9B9CBfuXHMrLl/âŚ
-
Benchling
@benchling
Hands-free data capture is here.
Now you can talk to Benchling AI instead of typing out every question or instruction. -
Benchling reposted
Nicholas Larus-Stone
@nlarusstone
@benchling Voice mode in Preview! Most scientific work still happens in the lab, so AI needs to be able to work in the lab
This media couldn't be displayed. See it on the original post. -
Benchling
@benchling
Build it once, then run it again and again.
Use Benchling AI to build a workflow that automatically turns raw instrument data into analyzed results. Save it as a template, then reuse it on your next dataset.This media couldn't be displayed. See it on the original post. -
Benchling
@benchling
Another job for Benchling Agents: inventory management.
Set up an Agent to automatically track reagent usage, flag trends, and forecast what youâll need next. -
Benchling reposted
Nicholas Larus-Stone
@nlarusstone
There's still a tremendous gap between what people believe models can do (design bioweapons) and what models can actually do (fail to optimize protocols more than half the time).
Even "bio-specific" models like GPT-Rosalind still struggle on real wet lab tasks. I spend a lot of time talking to scientists and this is one of the biggest reasons there's a huge gap between what the AI world thinks models can do and what scientists who use these models every day think they can do. -
Benchling
@benchling
Switch to âfull actionsâ mode to let Benchling AI take actions for you, whether thatâs creating notebook entries or registering samples.
See how it takes a shipment manifest and turns it into a set of prefilled receipt entries. -
Benchling reposted
Nicholas Larus-Stone
@nlarusstone
Narrative violation: Astra is better than Sol, but still not SOTA on hard wet lab biology tasks
Most biological reasoning is not captured in public data, so hard to train for this. Excited to see the progress though! -
Benchling
@benchling
From HPLC data to chromatograms, just like that.
Set up the workflow once, and Benchling automatically processes and analyzes your instrument data the same way every time. www.benchling.com/automation -
Benchling
@benchling
Vibe coding is changing who gets to build software. What does that mean for science?
Now scientists can build custom R&D apps in minutes, while agents take action across scientific workflows, and models keep getting better at reasoning through real lab problems.
Our Head of AI @nlarusstone spoke with @RandDWorld about the emerging AI stack for science and what comes next. www.rdworldonline.com/benchling-envisions-vibe-coding-cut⌠-
Benchling reposted
SynBioBeta
@SynBioBeta
@benchling now offers @EliLillyandCoâs TuneLab models for antibody developability and small-molecule ADME/Tox predictions. Participating biotechs can use the models through federated learning without directly exposing sensitive proprietary data.
www.benchling.com/blog/lilly-tunelab-pharma-powered-ai-moâŚ
Subscribe to our newsletter and get the biggest biotech news straight to your inbox đ§Ź
www.syntheticbiologysummit.com -
Benchling reposted
Chinmay Pala
@chinmay_pala
love @benchling đŞź
-
Benchling
@benchling
What if AI could check every new study against what your org already knows?
With Benchling Agents, it can.
Build an Agent, choose when it runs, and let it take action automatically. A Study Design Review Agent can compare new studies against past work and flag potential redundancy before work begins.
What will you build? www.benchling.com/blog/introducing-benchling-agents-your-⌠#aiforscientists -
Benchling reposted
Nicholas Larus-Stone
@nlarusstone
-
Benchling
@benchling
Introducing Benchling Agents, the next step toward giving every scientist an infinite program team.
Build an Agent in minutes to monitor your work and automatically take action, like a proactive lab partner.
That could mean:
âď¸ Checking study designs against past studies
âď¸ Monitoring and reorder inventory
âď¸ Processing CRO data as it arrives
What will your Agent do?
See how it works: www.benchling.com/blog/introducing-benchling-agents-your-⌠#aiforscientistsThis media couldn't be displayed. See it on the original post. -
Benchling reposted
SynBioBeta
@SynBioBeta
@benchling has released BenchBench-Protocol, testing whether LLMs can troubleshoot and optimize real wet-lab protocols. Opus 5 led at 59.2%, followed by GPT-5.6 Sol at 47.1% and Kimi K3 at 45.7%âshowing substantial room to improve practical biological reasoning.
www.benchling.com/blog/can-llms-work-in-the-wet-lab
Subscribe to our newsletter and get the biggest biotech news straight to your inbox đ§Ź
www.syntheticbiologysummit.com -
Benchling reposted
Sajith Wickramasekara
@sajithw
Congrats to @viswacolluru and @enveda for ENV-308 clearing its first human trial. ENV-308 mimics a molecule called Lac-Phe, a hormone the body releases during both intense exercise and after meals.
We've been working together for 6 years and can attest they're one of the most AI-pilled teams in biotech. Exciting to see a small fast team going after big indications.
www.statnews.com/2026/08/18/enveda-pill-mimics-exercise-p⌠-
Benchling
@benchling
Now chemists can sketch single-step reactions directly in Benchling, calculate stoichiometry, and capture resulting products, all while keeping molecules and their synthesis history connected to the broader scientific record. www.benchling.com/blog/benchling-now-brings-chemistry-andâŚ
See it in action next week at @AmerChemSociety. Or join the @cenmag webinar on Sept 1: www.acs.org/events/all-events/building-the-data-foundatio⌠-
Benchling reposted
Ben Birnbaum
@benbirnbaum
Excited to be part of this release by making our ADMET models available to Benchling users!
Benchling
@benchling
Weâre bringing chemistry and biology together in Benchling.
Now, chemists can model and capture single-step synthesis, automatically calculate stoichiometry, and account for salts and solvates, all on one unified R&D platform.
As R&D increasingly crosses the boundaries between biology and chemistry, teams need one connected, structured data foundation.
And weâre just getting started. www.benchling.com/blog/benchling-now-brings-chemistry-and⌠-
Benchling reposted
Sajith Wickramasekara
@sajithw
It is great for biotech when its stories captivate the tech zeitgeist. How can you not root for personalized cancer vaccines?
While it's having a moment, huge credit to the scientist who have been working on this for a decade, even while vaccines have taken an unnecessary beating in public conversation.
We're proud to work with both, including our public collaboration to support highly automated vaccine bioanalysis. If contributing to these efforts is motivating, we are hiring across many roles.
endpoints.news/merck-moderna-declare-phase-3-success-for-⌠-
Benchling
@benchling
Weâre bringing chemistry and biology together in Benchling.
Now, chemists can model and capture single-step synthesis, automatically calculate stoichiometry, and account for salts and solvates, all on one unified R&D platform.
As R&D increasingly crosses the boundaries between biology and chemistry, teams need one connected, structured data foundation.
And weâre just getting started. www.benchling.com/blog/benchling-now-brings-chemistry-and⌠-
Benchling
@benchling
Starting today, @EliLillyandCo's TuneLab models are available in Benchling.
Lilly turned decades of proprietary R&D data into models its own scientists use daily. Those models are now available in Benchling's Model Hub, including:
âď¸ AbLab: input antibody sequences, get developability predictions
âď¸ ChemLab: input a SMILES string, get ADMET predictions
With TuneLab, scientists are saving weeks by flagging candidates unlikely to perform well before they ever reach the lab.
Get access: www.benchling.com/blog/lilly-tunelab-pharma-powered-ai-mo⌠#benchlingai #aiforscientists -
Benchling
@benchling
Can LLMs work in the wet lab? We did the benchmarking to find out. www.benchling.com/blog/can-llms-work-in-the-wet-lab
Nicholas Larus-Stone
@nlarusstone
Frontier models are still not very good at real-world biological reasoning.
Today weâre releasing our work on BenchBench-Protocol, a benchmark built around real biological tasks. Opus 5 performs best, but we find that even frontier LLMs still make surprisingly simple reasoning errors on these tasks.
Unlike most benchmarks, we construct the tasks from actual work being done in the lab. We think this gives a better picture of how useful these models are in practiceâand may better reflect why LLMs still donât feel especially capable to many working biologists.
The tasks are still limited and donât capture the full complexity of how biologists work, but we think this is an important step toward evaluating models on the kinds of problems scientists actually encounter.
The most surprising result to me was that the performance of open-weight models was as good many closed-source frontier models. Distillation? Open-weight models are also training on biology tasks? I'm still not sure...
Read it yourself here: www.benchling.com/blog/can-llms-work-in-the-wet-lab -
Benchling
@benchling
Can LLMs work in the wet lab?
There werenât great benchmarks to answer that. So we did the research ourselves.
Today, we published results from BenchBench-Protocol, a benchmark built from thousands of real-world experiments, testing whether models can troubleshoot and optimize wet lab protocols like expert scientists.
Get the results and preprint: www.benchling.com/blog/can-llms-work-in-the-wet-lab -
Benchling reposted
Sajith Wickramasekara
@sajithw
Can LLMs do wet lab work? Seems important for AI drug discovery.
Weâre publishing a benchmark built from thousands of real-world experiments that tests whether models can troubleshoot and optimize wet lab protocols like expert scientists.
Opus 5 leads, followed by GPT 5.6 Sol, and Kimi K3. Thereâs still a lot of room to improve. Models give answers that sound sensible on paper but miss small changes that can ruin an experiment.
Protocols are the start. Weâre scaling this work to increasingly difficult problems, from sequence design and recommending the next experiment, to critical drug program decisions. -
Benchling reposted
Ashu Singhal @daashu
Been lurking here for a while, but this will be a good first one back.
Can LLMs actually do wet lab biology? We built BenchBench-Protocol to find out. đ§ľ -
Benchling
@benchling
Vibe coding has entered the lab.
Now available in Benchling, scientists can build and share applications across their R&D org. No need for IT, customizing software, or waiting.
It's speed and flexibility, without sacrificing the rigor and reproducibility that science demands. www.benchling.com/blog/vibe-coding-enters-the-lab -
Benchling
@benchling
đđ Analyze your in vivo data in minutes with #benchlingai.
Just ask: âSummarize tumor response across tissue types, after normalizing AUC distributions per tissue.â
Try it out today: www.benchling.com/ai/data-analysis
#aiforscientists ⨠-
Benchling reposted
Dr. Kaia Mattioli
@kaia_mattioli
i've been waiting for this! trying it out today. so far it seems pretty useful: it reminded me where I was on an experiment I paused 3 weeks ago and helped me draft a new entry based on an existing protocol. nice for everything to be contained in Benchling!
Benchling
@benchling
Science moves faster with AI built for scientists.
Benchling AI understands scientific context and helps you search the literature, import data, analyze experiments, create presentations, and more â all in the flow of your research.
Now available for academics.
Learn about our mission to bring AI to every scientist: www.benchling.com/blog/ai-for-every-scientist
#aiforscientists -
Benchling
@benchling
Science moves faster with AI built for scientists.
Benchling AI understands scientific context and helps you search the literature, import data, analyze experiments, create presentations, and more â all in the flow of your research.
Now available for academics.
Learn about our mission to bring AI to every scientist: www.benchling.com/blog/ai-for-every-scientist
#aiforscientists -
Benchling
@benchling
Too much compute might actually be slowing innovation down.
Lindsay Edwards, CTO of @RelationRx, argues that when companies have 10,000 GPUs to throw at a problem, they lose the discipline that drives real breakthroughs.
On #transcribed, he talks about building AI that actually works in biology: www.benchling.com/transcribed/lindsay-edwards-on-building⌠-
Benchling
@benchling
Your best AI workflows shouldn't live in one person's chat history.
Build Benchling AI Skills, share them with your team, and update once to apply everywhere. Standardize your teamâs processes, even as workflows evolve.
Try it out today: www.benchling.com/ai
#aiforscientists ⨠-
Benchling
@benchling
How do you get to $1.3B in business development deals? Kate Haviland, former CEO at @BlueprintMeds, explains why it all starts with relationship-building.
đď¸ Watch the conversation: www.benchling.com/transcribed/kate-haviland-turning-failu⌠-
Benchling
@benchling
In @Nature this week, our cofounder @daashu estimated that less than 20% of labs have fully embedded AI into their research. His advice: trial the tools yourself instead of trusting the headlines.
Most AI scientist tools reason over public literature and computational data. Benchling AI reasons over your own experimental history, molecules, and assays, the private data that's actually sitting in your lab.
Read Ashu's take in Nature. www.nature.com/articles/d41586-026-02091-6
Benchling
@benchling
See how Benchling AI works.
www.benchling.com/ai -
Benchling
@benchling
⥠Turn your process development data into actionable insights with #benchlingai.
Just ask: âWhich bioprocess parameter drives the biggest increase in titer?â
Try it out today: www.benchling.com/ai/data-analysis
#aiforscientists ⨠-
Benchling
@benchling
Pro tip: Turn your Python or SQL scripts into Benchling AI Skills. Upload a script once, then ask the agent to run it whenever you need it.
Less repetitive work, more time for science. Try it out! #aiforscientists -
Benchling
@benchling
Do you have a lab meeting coming up? Ask Benchling AI to generate a PowerPoint presentation to quickly summarize results and generate visualizations of your data.
Try it out today: www.benchling.com/ai #aiforscientists -
Benchling reposted
NVIDIA Healthcare
@NVIDIAHealth
â¨Your front-row seat to our #bio2026 special address
@kpowgerade introduced BioNeMo Agent Toolkit and sat down with @sajithw (@benchling), Josh (@chaidiscovery) , and @andrewwhite01 (@EdisonSci) on how AI agents are reshaping biotech R&D and lab workflows.
âśď¸ nvda.ws/3Tfc4l7 -
Benchling
@benchling
With Benchling, structure prediction is as simple as asking an AI agent.
Scientists can run predictions directly where they already work, including for complex multimers and proteinâligand folding. www.benchling.com/blog/benchling-structure-prediction #aiforscientists -
Benchling
@benchling
"Thatâs not gonna work." That's what experienced chemists said when AI kept ranking one motif at the top.
But they followed through anyway, and it became @Terray_Tx's leading program.
On #transcribed, Terrayâs CEO Jacob Berlin explains when to trust AI â and why human judgment still matters. www.benchling.com/transcribed/jacob-berlin-why-chemistry-⌠-
Benchling
@benchling
Structure prediction has been around for years. Why isnât everyone using it? Because it needs to be easy to run, scalable, and simple to interpret.
Today, Benchling AI changes that. Scientists can now use AI agents to run and analyze complex structure predictions with just a prompt. www.benchling.com/blog/benchling-structure-prediction -
Benchling
@benchling
How much time do you spend turning experimental data into presentation-ready charts?
Benchling AI can now generate visualizations directly in chat and save them to notebook entries for easier review and documentation. #aiforscientists -
Benchling
@benchling
đ Analyze your experimental data in minutes with #benchlingai.
Just ask: âCompare dose-response curves for these compounds. Show IC50s, means with error bars, and analyze variability.â
Try it out today: www.benchling.com/ai/data-analysis
#aiforscientists ⨠-
Benchling
@benchling
That massive data estate your company has been sitting on? It's probably not worth what you think, says Lindsay Edwards, CTO of @RelationRx.
On #transcribed, Lindsay makes the case that biology's measurement problem means most legacy data is effectively unusable for ML â and that the smarter bet is building a clean, consistent dataset from scratch starting today.
đď¸ Watch the interview: www.benchling.com/transcribed/lindsay-edwards-on-building⌠-
Benchling
@benchling
AI is breaking the assumptions traditional security was built on. Our new CISO & CIO Chad Kalmes argues that the future isn't about "containment."
Security in the age of AI agents looks radically different. It comes down to contextual authorization, behavioral provenance, and trust built into the data layer. www.benchling.com/blog/introducing-chief-information-secu⌠-
Benchling
@benchling
Need a faster way to visualize your experiments?
Benchling AI can generate diagrams of scientific workflows and experiments from a single prompt. #aiforscientists -
Benchling
@benchling
Scientists told us they were copying SQL queries out of Benchling AI responses to reuse them later. So we made it easier!
Now you can save AI-generated SQL queries directly to a new or existing dashboard. #aiforscientists -
Benchling reposted
SynBioBeta
@SynBioBeta
@boltz_bio has launched BoltzMol-1, BoltzProt-1 and the Boltz API for small-molecule hit discovery, protein design and biomolecular modeling.
With predictions from $0.025, the API will be accessible through partners including @benchling, @phylo_bio, @tamarindbio, @PaulingAi, @mirrorphysics and @CultivariumFRX.
boltz.bio/boltzmol-boltzprot-api
Subscribe to our newsletter and get the biggest biotech news straight to your inbox đ§Źwww.syntheticbiologysummit.com/2027/early-bird -
Benchling reposted
Nicholas Larus-Stone
@nlarusstone
We just launched Hypothesis Generation in Benchling AI.
This release is deeply personal to me.
It's a culmination of more than a decade spent building tools to help scientists -
Benchling
@benchling
Hot take: AI hypothesis generation isnât useful if it only reasons over published literature. Most of what a biotech company knows never gets published.
Thatâs why we built hypothesis generation differently.
Benchling AI now reasons over your institutional data and the published literature at the same time, so hypotheses are grounded in your actual science. Try it out! www.benchling.com/blog/ai-read-200-million-papers-but-sti⌠-
Benchling
@benchling
đ Import vendor CoAs in minutes with #benchlingai.
Just ask: âImport this CoA and register the lot with test name, specification, and result fields mapped to the Raw Material Lot schema.â
Try it out today: www.benchling.com/ai/data-import #aiforscientists ⨠-
Benchling reposted
LangChain
@LangChain
.@benchling Head of AI @nlarusstone on why understanding LLMs is closer to biology than software engineering.
-
Benchling
@benchling
Congrats @Terray_Tx!
Want to hear Terray's CEO Jacob Berlin talk about how they built EMMI? Listen on #transcribed: www.benchling.com/transcribed/jacob-berlin-why-chemistry-âŚTerray Therapeutics @Terray_Tx
We are thrilled to announce that Terrayâs drug discovery platform, EMMI (Experimentation Meets Machine Intelligence), has been recognized as a World Changing Idea by Fast Company!
EMMI seamlessly integrates AI and experimentation to explore the dark areas of chemical space to find and optimize novel small-molecule drugs for some of medicineâs toughest challenges. EMMI is transforming drug discovery and is changing the world!
Read about EMMI www.terraytx.ai/news-and-research/introducing-emmi-where-âŚ
#drugdiscovery #ai #fcworldchangingideas -
Benchling reposted
Gabriele Corso
@GabriCorso
Very excited to partner with the amazing Benchling team to bring state-of-the-art models to the fingertips of every scientist!
Benchling
@benchling
Benchling is a launch partner for the Boltz API!
Customers can access @boltz_bio's library of proprietary models for protein and small molecule workflows, directly from their existing Benchling tenant.
This is really exciting:
⥠Boltz has extended their open source models to include new functionality like protein library screening, protein-protein binding affinity predictions, and more
⥠Use your Benchling credits with the Boltz API. Itâs one payment channel between Benchling Models and the Boltz API
Get early access: airtable.com/appiZaByhWLvIVdKj/pagBuvYKCSSK8UEdK/form -
Benchling
@benchling
Benchling is a launch partner for the Boltz API!
Customers can access @boltz_bio's library of proprietary models for protein and small molecule workflows, directly from their existing Benchling tenant.
This is really exciting:
⥠Boltz has extended their open source models to include new functionality like protein library screening, protein-protein binding affinity predictions, and more
⥠Use your Benchling credits with the Boltz API. Itâs one payment channel between Benchling Models and the Boltz API
Get early access: airtable.com/appiZaByhWLvIVdKj/pagBuvYKCSSK8UEdK/form -
Benchling reposted
Gabriele Corso
@GabriCorso
Weâve partnered with @AnthropicAI, @benchling, @phylo_bio, @amazon Bio Discovery, Rowan, @tamarindbio, Kiin Bio, @PaulingAi, @mirrorphysics and @CultivariumFRX on first-party integrations so that our newest models and primitives are natively supported in your favorite tool.
-
Benchling reposted
Gabriele Corso
@GabriCorso
Big news from Boltz - our biggest update yet! đ
Today weâre releasing two new state-of-the-art models for protein and small molecule design with extensive wet lab validation and a new API to run all of our models on scalable GPUs wherever you (or your agents) work! đĽ -
Benchling reposted
Charlie Harris
@charlieharris01
Itâs been a busy time at Boltz already! Today, we are announcing:
- BoltzMol-1
- BoltzProt-1
- Boltz API
Delighted to have fantastic partners @benchling, @phylo_bio, @amazon Bio Discovery, @RowanSci , @tamarindbio, Kiin Bio, @PaulingAi, @mirrorphysics and @CultivariumFRX
Gabriele Corso
@GabriCorso
Big news from Boltz - our biggest update yet! đ
Today weâre releasing two new state-of-the-art models for protein and small molecule design with extensive wet lab validation and a new API to run all of our models on scalable GPUs wherever you (or your agents) work! đĽ -
Benchling reposted
LangChain
@LangChain
In the latest Max Agency, @hwchase17 asked @benchling Head of AI @nlarusstone about the biggest blockers in building agents for scientific work.
This media couldn't be displayed. See it on the original post. -
Benchling reposted
LangChain
@LangChain
Head of AI @nlarusstone on the patterns @benchling uses to look at production traces.
-
Benchling
@benchling
Plan the perfect next experiment, in minutes. With Benchling AI's new Experimental Design skill, scientists can now:
âď¸ Identify which variables actually drive results
âď¸ Optimize conditions with confidence
âď¸ Set up experiments with the right controls and metadata â generating AI-ready data from the start
âď¸ Get AI-powered recommendations for what to test next
Design the right experiment faster, right in your workspace. www.benchling.com/ai/experimental-design #aiforscientists -
Benchling
@benchling
What happens when AI can read, reason over, and write back to the scientific record?
On Decoding Bio, Benchling cofounder @daashu and Head of AI @nlarusstone talk about building an AI Scientist, closing the lab-in-the-loop, and why the future of discovery depends on more than just better models. decodingbio.substack.com/p/scaling-bio-009-benchlings-ash⌠-
Benchling reposted
LangChain
@LangChain
Watch the latest Max Agency with @hwchase17:
âŻď¸ YouTube: www.youtube.com/watch?v=RjpTrffSMjE
đ§ Apple Podcasts: podcasts.apple.com/us/podcast/the-tool-design-tricks-behiâŚ
đ§ Spotify: open.spotify.com/episode/2bFEj2W290bk2JW1zC6wyp -
Benchling reposted
LangChain
@LangChain
.@nlarusstone from @benchling on how they cross-check answers between models to get more out of each one.
-
Benchling
@benchling
Scientists shouldn't have to spend days turning data into decks.
With Benchling AI, you can generate analyses, visualizations, summaries, and even a presentation-ready PowerPoint from your data, in minutes. #aiforscientistsThis media couldn't be displayed. See it on the original post. -
Benchling reposted
Seqera
@SeqeraLabs
Scientists can now trigger actions on Seqera Platform directly from @Benchling: launch and track @nextflowio pipelines, investigate results, and spin up interactive environments.
đ Learn more: www.benchling.com/news/benchling-launches-ai-connectors-t⌠-
Benchling reposted
Seqera
@SeqeraLabs
From bench to computational analysis with @benchling.đ§Ź Bioinformatics is a critical piece of the R&D knowledge graph, but it has historically lived in a silo, disconnected from the lab data that gives it meaning.đ§ľ
This media couldn't be displayed. See it on the original post. -
Benchling reposted
LangChain
@LangChain
On the latest episode of Max Agency, @hwchase17
sat down with @nlarusstone, Head of AI at @benchling for a conversation on building agents for scientific work.
âŻď¸ YouTube: www.youtube.com/watch?v=RjpTrffSMjE
đ§ Apple Podcasts: podcasts.apple.com/us/podcast/the-tool-design-tricks-behiâŚ
đ§ Spotify: open.spotify.com/episode/2bFEj2W290bk2JW1zC6wypThis media couldn't be displayed. See it on the original post. -
Benchling
@benchling
Introducing the new Benchling AI, now built directly inside the notebook where scientists already work.
Now scientists can import data, run analyses, draft reports, build presentations, and more â all from within their notebook.
Try it out today, or read more: -
Benchling
@benchling
âI have a very strong belief that science has to happen in the physical world.â Benchling cofounder @daashu spoke with @RandDWorld about what makes a real AI Scientist.
Lab automation will be key. An AI scientist needs a connection into the physical world, a data model thatâs rich enough, and an interface that human scientists actually want to use. www.rdworldonline.com/benchling-bets-lab-automation-can-g⌠-
Benchling
@benchling
Benchling Automation is an open system for instrument, automation, and analysis â built on the Benchling Platform, unified with your science.
Plus, it works with the instruments and lab automation already in your lab, and the data platforms you use today, whether thatâs Benchling or not. www.benchling.com/blog/benchling-automation-closing-the-l⌠-
Benchling
@benchling
At the @ftlive Pharma Summit, Benchling CEO @sajithw predicted the rise of the âgeneralist scientistâ and what that means for the lab of the future.
Roles wonât disappear, but individual scientists will be able to go further and faster. -
Benchling
@benchling
Lab automation shouldnât stop when an instrument run ends.
Thatâs why we built Benchling Automation, a unified solution to automatically connect instrument data to scientific records.
Weâre launching with partners across the workcells and instruments scientists are using today: @HighResBio, @automata_tech, @Ginkgo, @CellTrio, @opentrons, and @HamiltonCompany. -
Benchling
@benchling
Today weâre launching Benchling Automation, a unified solution that connects lab instrument data directly to the scientific record.
Scientists can now:
âď¸ Pull data from 200+ instruments directly into Benchling
âď¸ Run analytics automatically, with results delivered to notebooks
âď¸ Automate workflows with flexible no-code and custom code options
Weâre building an open ecosystem and launching with partners powering modern labs: @HighResBio, @automata_tech, @Ginkgo, @CellTrio, @opentrons, and @HamiltonCompany.
Available now: www.benchling.com/blog/benchling-automation-closing-the-l⌠-
Benchling reposted
Sajith Wickramasekara
@sajithw
Congrats to the @biohub team! Excited to embed this in the workflow of scientists everywhere.
@salcandido was kind enough to sit down with us and take us behind the scenes building ESMFold2: www.benchling.com/blog/behind-the-model-with-sal-candido-âŚ
Alex Rives
@alexrives
Today we're announcing ESMFold2, an open scientific engine to power prediction, design, and discovery across protein biology.
The new model delivers state of the art performance on protein interactions, especially antibodies, a critical modality for therapeutics.
We have designed and validated miniprotein binders and single chain antibodies across five therapeutic targets that are important in cancer and immunology. We are seeing very high success rates, and affinities at levels consistent with therapeutic activity.
Weâre also releasing an atlas of 6.8 billion proteins, and 1.1 billion predicted structures.
ESMFold2 is built on a state of the art language model that has been trained on billions of protein sequences.
A world model of protein biology emerges through language modeling.
Weâve used the techniques of mechanistic interpretability developed to understand large language models to understand the concepts ESM uses to represent proteins.
The modelâs representation space has a compositional organization of features across scales, levels of complexity, and abstraction, that reflects and mirrors the understanding of protein biology developed through a century of empirical science.
This understanding emerges without prior knowledge, just from language modeling of protein sequences.
Language models are becoming a powerful substrate to understand and program biology.
The design of protein interactions is one of the most fundamental problems in biophysics, and has critical implications for the discovery of new medicines. A simple gradient based search with the model was able to discover high-affinity protein binders.
I'm excited by the potential this has to accelerate basic science and the understanding of proteins. And especially for the new avenues it opens up for therapeutic design and medicine. -
Benchling
@benchling
ESMFold2 will be available on Benchling's Model Hub soon!
Alex Rives
@alexrives
Today we're announcing ESMFold2, an open scientific engine to power prediction, design, and discovery across protein biology.
The new model delivers state of the art performance on protein interactions, especially antibodies, a critical modality for therapeutics.
We have designed and validated miniprotein binders and single chain antibodies across five therapeutic targets that are important in cancer and immunology. We are seeing very high success rates, and affinities at levels consistent with therapeutic activity.
Weâre also releasing an atlas of 6.8 billion proteins, and 1.1 billion predicted structures.
ESMFold2 is built on a state of the art language model that has been trained on billions of protein sequences.
A world model of protein biology emerges through language modeling.
Weâve used the techniques of mechanistic interpretability developed to understand large language models to understand the concepts ESM uses to represent proteins.
The modelâs representation space has a compositional organization of features across scales, levels of complexity, and abstraction, that reflects and mirrors the understanding of protein biology developed through a century of empirical science.
This understanding emerges without prior knowledge, just from language modeling of protein sequences.
Language models are becoming a powerful substrate to understand and program biology.
The design of protein interactions is one of the most fundamental problems in biophysics, and has critical implications for the discovery of new medicines. A simple gradient based search with the model was able to discover high-affinity protein binders.
I'm excited by the potential this has to accelerate basic science and the understanding of proteins. And especially for the new avenues it opens up for therapeutic design and medicine. -
Benchling
@benchling
The BioHub ESM ecosystem is live and we went behind the scenes with the team that built it.
We sat down with @biohub to talk about what it actually took to build a world model for protein biology: the decisions, the tradeoffs, and what the ESM Atlas might reveal that no one has found yet. www.benchling.com/blog/behind-the-model-with-sal-candido-âŚ
Benchling
@benchling
ESMFold2 will be available on Benchling's Model Hub soon!
-
Benchling
@benchling
AI-driven antibody design isnât going to work if your computational and ML teams donât have structured data.
Most platforms donât have a standard for capturing and storing antibody data across the growing number of formats. Benchling Biologics does.
Benchling is the only platform that connects the full DBTL loop for biologics, connecting your experimental data and assay results to every protein from the start.
đ Available now. www.benchling.com/blog/benchling-biologics-delivers-antib⌠-
Benchling
@benchling
âPipetting is not the problem.â At the @ftlive Pharma & Biotech Summit, Benchling CEO @sajithw talked about all the operational overhead that slows down R&D.
This knowledge work is where AI can really compress timelines at every step and handoff.
See how we're building the AI Scientist: www.benchling.com/blog/ai-scientist-that-deserves-the-name -
Benchling
@benchling
Scientists told us they wanted an easier way to copy tables from #benchlingai into their slides and reports. So we built it.
#aiforscientists -
Benchling
@benchling
âBiopharma wastes institutional knowledge at an industrial scale.â At last weekâs @ftlive Pharma & Biotech Summit, Benchling CEO @sajithw explained why â and how AI solves for that.
One example: a customer avoided repeating a yearâs worth of experiments after AI surfaced that one of their acquisitions had already done the work. -
Benchling reposted
Marylise Tauzia @marylise63530
How do you handle the massive infrastructure demands of modern AI biology models? You bring in the inference experts.
Check out this clip from @benchling 's Mihir Trivedi and @baseten 's Bola Malek on why they teamed up to build Benchling Inference.
Dive into the full launch blog post: www.benchling.com/blog/announcing-benchling-inference-powâŚThis media couldn't be displayed. See it on the original post. -
Benchling
@benchling
Not every partner can move 1.3 TB of data in under a minute across 85+ clusters.
Hear about the âinsane engineering challengesâ we had to solve with @baseten to make AI work at scale for scientific workloads.
Everything weâve learned about tailoring inference for biotech is built into Benchling Inference, powered by Baseten and available to Benchling customers.
Get the details: www.benchling.com/blog/announcing-benchling-inference-powâŚThis media couldn't be displayed. See it on the original post. -
Benchling
@benchling
Last week at #asgct2026, @PrimeMedicine shared how they used our AI Scientist to accelerate one of the hardest parts of taking an advanced modality to market: the final CMC push toward a BLA.
What normally takes months of manual curation and analysis was compressed into days â and it worked because Prime has been capturing every experiment in Benchling since 2022.
Details: www.benchling.com/blog/prime-medicine-used-benchlings-ai-âŚ
Benchling
@benchling
Interested in our AI Scientist? See what weâre building. www.benchling.com/blog/ai-scientist-that-deserves-the-name
-
Benchling reposted
Baseten
@baseten
Biotech R&D is generating more scientific AI models than ever, from protein structure prediction to molecular docking to sequence analysis. But the infrastructure to run them hasn't kept up.
Today we're announcing Benchling Inference, powered by Baseten. Together with @benchling, we're delivering on-demand GPU capacity built for the bursty, high-stakes demands of scientific workloads. With Benchling Inference, scientists can:
â Deploy models in seconds, not weeks
â Keep proprietary models inside their VPC if needed
â Benefit from economics that work even at small and mid-size biotech scale
Benchling and Baseten decided to team up because we believe that research teams shouldn't have to manage HPC queues, negotiate cloud contracts, or become GPU experts to run frontier models on their own data.
Six years of inference expertise are now available where science happens.
Read more here: www.benchling.com/blog/announcing-benchling-inference-pow⌠-
Benchling
@benchling
Today weâre announcing Benchling Inference, powered by @baseten! Together, weâre making scalable, cost-effective inference accessible for scientific AI.
Why? Scientific workloads are inherently bursty. Teams may need to run 100,000 predictions for a few hours, then go quiet for days. Most infrastructure wasnât built for that.
Now R&D teams can:
âď¸ Run scientific models without managing infrastructure
âď¸ Scale workloads up or down in seconds
âď¸ Access cost-effective compute through aggregated demand
Itâs an end-to-end solution for scalable inference, with all the configurations and defaults needed to make inference work out-of-the-box for biotech.
Get the details: www.benchling.com/blog/announcing-benchling-inference-pow⌠-
Benchling reposted
Sajith Wickramasekara
@sajithw
Weâre launching Benchling Inference, powered by @baseten
It is scalable GPU capacity across 15 clouds for our 1300+ customers, preloaded with today's top scientific models and the integrations to make in silico discovery work out-of-the-box for biopharma companies.
Startups get better economics and availability. Enterprises get best-in-class infrastructure that works alongside their cloud commits and data sovereignty requirements.
It's been a pleasure working with Baseten on this. They've spent six years building at the leading edge of inference and are the compute behind some of the most demanding AI in production.
www.benchling.com/blog/announcing-benchling-inference-pow⌠-
Benchling
@benchling
Everyone likes to think about partnerships as validation. But @janiceschen, cofounder and CSO at @mammothbiosci, thinks about them differently.
On #transcribed, Janice explains how early partnerships can shape a company for years, and shares lessons from Mammothâs deals with Regeneron and others.
www.benchling.com/transcribed/janice-chen-crispr-endgame-⌠-
Benchling
@benchling
Your lab meeting starts in an hour and somehow youâre still panic-searching how to make error bars in R. đŹđ
Instead, use #benchlingai to generate plots from a simple prompt. No last-minute scrambling required.
#aiforscientists ⨠-
Benchling
@benchling
Antibody formats have only gotten more complex â and your tools need to keep pace.
Thatâs why we built Benchling Biologics, an end-to-end platform for antibody discovery that tracks AI-ready candidates from day one.
Whether youâre working on bispecifics, multispecifics, TCRs, or fusion proteins, weâve got you covered.
đ Available now. www.benchling.com/blog/benchling-biologics-delivers-antib⌠-
Benchling
@benchling
đŠ Every scientist has had the âwhy does this diagram still look bad?â moment.
Instead, use #benchlingai to generate experimental workflow visuals from a single prompt. More science, less formatting. đŹâ
#aiforscientists ⨠-
Benchling
@benchling
Scientists are developing new antibody formats fast â faster than most tools can keep up with. With traditional systems, it could take weeks to add a new format.
Benchling Biologics changes that. You can define new formats in minutes and register proteins instantly, using an easy, no-code interface that ensures AI-ready data from day one.
This is what an end-to-end platform for antibody R&D looks like.
đ Available today. www.benchling.com/blog/benchling-biologics-delivers-antib⌠-
Benchling
@benchling
Now this is a message we can get behind: Let's build a many model future. #teamscience
Tuhin Srivastava
@tuhinone
-
Benchling
@benchling
Scientific AI models have made huge progress. Deploying them in real R&D workflows? Still slow, complex, and infrastructure-heavy.
Not anymore.
Model Hub brings model execution directly into Benchling.
Run models on your data and get structured, traceable results â no switching between tools, no manual work.
Get started: www.benchling.com/blog/introducing-benchling-model-hub -
Benchling
@benchling
đ§Ź Scientific AI models should be accessible to every scientist â not just teams with the infrastructure to run them.
Thatâs why we built Model Hub.
Run leading models like AlphaFold2, Chai-1, BoltzGen, Protenix, and OpenFold directly in Benchling, where your data lives and every output is captured as part of your experimental record.
More models across RNA, DNA, small molecules, and antibodies coming soon. www.benchling.com/blog/introducing-benchling-model-hub -
Benchling reposted
Sajith Wickramasekara
@sajithw
I'm excited to share our first AI Scientist collaboration: @PrimeMedicine using it to accelerate the path to approval for PM359, their prime-edited therapy for CGD.
They are presenting the work at ASGCT this week.This media couldn't be displayed. See it on the original post. -
Benchling
@benchling
đ Analyze your data in minutes. With #benchlingai, run stats, fit models, visualize results, and spot batch effects â without leaving your notebook.
Benchling AI understands your setup and picks the right methods automatically â from paired tests, to ANOVA and weighted dose-response.
Ask follow-up questions, re-run analyses instantly, and iterate fast without starting over.
Try it out: www.benchling.com/ai/data-analysis #aiforscientists ⨠-
Benchling reposted
Sid
@mosasaurus27
Super pumped to use this, benchling ftw
Benchling
@benchling
đ Introducing Benchling Biologics: an end-to-end platform for antibody R&D, built for the speed and complexity that scientists need.
âď¸ Antibody-aware data model
âď¸ No-code configuration for any format
âď¸ Automated registration linking proteins, chains, and domains
âď¸ Full experimental context across the DBTL cycle
The result? AI-ready data from the moment a sequence is created.
Available today. www.benchling.com/blog/benchling-biologics-delivers-antib⌠-
Benchling
@benchling
Our collaboration with @PrimeMedicine shows what an AI Scientist brings to one of the hardest phases of taking an advanced modality to market: the final CMC push toward a BLA.
What would traditionally require months of manual curation and analysis was compressed into days, with the AI Scientist amplifying the scientific judgement that only Primeâs team could provide.
Read more here: www.benchling.com/blog/prime-medicine-used-benchlings-ai-âŚ
Prime Medicine will be speaking about their collaboration with Benchling at the 2026 ASGCT Annual Meeting, today, May 11th, as part of the Automation in CGT Manufacturing workshop. -
Benchling
@benchling
đ Introducing Benchling Biologics: an end-to-end platform for antibody R&D, built for the speed and complexity that scientists need.
âď¸ Antibody-aware data model
âď¸ No-code configuration for any format
âď¸ Automated registration linking proteins, chains, and domains
âď¸ Full experimental context across the DBTL cycle
The result? AI-ready data from the moment a sequence is created.
Available today. www.benchling.com/blog/benchling-biologics-delivers-antib⌠-
Benchling reposted
Sajith Wickramasekara
@sajithw
Why does @RelationRx CTO Lindsay Edwards think that virtual cells are overrated? Lindsay shared his hot takes with me in front of a live audience, including why legacy data is worth less than you think, and why biologists need to be more like physicists.
On this episode of Transcribed, we also talked about his unconventional path. He started in music, producing hits with artists like Sting and Whitney Houston. Later, after becoming a scientist, he went on to build the first data science team at GSK. Today, heâs one of the industryâs clearest thinkers on what it takes to make machine learning work in drug discovery. -
Benchling
@benchling
Lindsay Edwards has spent his career at the intersection of machine learning and drug discovery â from building the first data science group at @GSK, to serving as @RelationRxâs CTO today. He's also one of the most direct voices in the industry on where AI is genuinely delivering and where it's mostly noise.
Lindsay joined Benchling CEO @sajithw on #transcribed to talk about why virtual cells are wildly overhyped, what companies get wrong about legacy data, and getting an ML-designed drug to patients.
đď¸ Watch the interview: www.benchling.com/transcribed/lindsay-edwards-on-building⌠-
Benchling
@benchling
đ§Ź Direct ordering is here!
Design sequences, run manufacturability checks, and order with @TwistBioscience â without leaving Benchling.
See how weâre accelerating the design-build-test-learn cycle with @TwistBioscience, @adaptyvbio, and @Ginkgo. www.benchling.com/blog/one-click-ordering-for-experiments⌠-
Benchling reposted
Tudor-Stefan Cotet @CotetTudor
I've been using @benchling ever since I first learned to hold a pipette. It has carried me through so many lab classes during uni...so working on this integration has been a full-circle moment
Adaptyv Bio
@adaptyv
Starting today, you can submit protein candidates from Benchling directly to the Adaptyv wet-lab.
We're launching as part of @benchling's Direct Ordering Partners, alongside @TwistBioscience for DNA synthesis and @Ginkgo for antibody developability. -
Benchling reposted
Adaptyv Bio
@adaptyv
Starting today, you can submit protein candidates from Benchling directly to the Adaptyv wet-lab.
We're launching as part of @benchling's Direct Ordering Partners, alongside @TwistBioscience for DNA synthesis and @Ginkgo for antibody developability. -
Benchling
@benchling
Weâre launching direct ordering with @TwistBioscience, @adaptyvbio, and @Ginkgo! đ
Now scientists can design candidates, place orders for synthesis and services, and receive structured results back without ever leaving Benchling. This closes the gap between in silico design and wet lab execution, with full experimental context.
In partnership with:
âď¸ @TwistBioscience for gene fragments, clonal genes, antibody production, and characterization
âď¸ @adaptyvbio for protein engineering services
âď¸ @Ginkgo for antibody developability
See how it works: www.benchling.com/blog/one-click-ordering-for-experiments⌠-
Benchling
@benchling
đ¤ What does an AI Scientist actually look like?
Benchling CEO Sajith Wickramasekara makes the case for an AI Scientist that runs the entire DBTL loop, from digital intelligence to physical lab execution.
All while keeping a human in the loop, because judgment still matters the most.
Thatâs what weâre building: www.benchling.com/blog/ai-scientist-that-deserves-the-name -
Benchling
@benchling
đŠ A super round for super poop. @kanvasbio is developing a microbiome-based therapy, which was reverse-engineered from a cancer survivorâs stool.
A clinical trial of the drug could begin as early as September.
Congratulations to the Kanvas team on their Series A! -
Benchling
@benchling
âď¸ Generate progress reports in minutes with #benchlingai.
Just ask: âTrack a screening campaign from library to lead including funnel metrics, timelines, and dose-response characterization of top candidates.â
Try it out today: www.benchling.com/ai/report-writing #aiforscientists ⨠-
Benchling reposted
Kevin Patrick Mahaffey
@dropalltables
@benchling is not so quietly building the foundation for AI to massively accelerate biotech. Nice job @sajithw @daashu and team!
Sajith Wickramasekara
@sajithw
In the AI era, the traditional biopharma industry is the underdog. Big tech and AI labs are building wet labs. China has overtaken Europe in molecules produced. But the tools available to the industry discuss science, not do it.
The hard problem in AI for science is at the interface between the physical and digital worlds.
We built an AI Scientist at that seam. It wires together the digital and physical worlds of R&D. Predictive models, data infrastructure, wet lab execution feed into a single loop that reasons, acts, and improves with every experiment. Our ambition: get molecules to the clinic twice as fast.
Last fall I wrote about why biotech needs to be rebuilt for the AI era. Today I'm sharing the next chapter: what the AI Scientist is, a blueprint for how it works, and why even Richard Feynman couldn't hack it in a wet lab.This media couldn't be displayed. See it on the original post. -
Benchling
@benchling
When @janiceschen started as a grad student in Jennifer Doudnaâs lab, she wasnât looking to start a company.
Over 10 years later, CRISPR gene editing has moved beyond breakthrough science to its first FDA-approved therapy â and more are on the way.
Today, Janice is cofounder and CSO at @mammothbiosci, where theyâre building a discovery platform to expand the CRISPR toolbox and advance new gene therapies.
đď¸ Hear her reflect on the Doudna Lab and why curative treatments are no longer far-fetched: www.benchling.com/transcribed/janice-chen-crispr-endgame-⌠-
Benchling
@benchling
âď¸ Generate process development reports in minutes with #benchlingai.
Just ask: âSummarize bioreactor performance and product quality across DoE conditions, and identify recommended operating ranges.â
Try it out today: www.benchling.com/ai/report-writing #aiforscientists ⨠-
Benchling
@benchling
Itâs going to take more than any single model or tool to unlock AI in R&D.
A true AI scientist has to run the full DBTL loop.
Today, that loop is fragmented by siloed data, disconnected tools, and missing context.
Thatâs why weâre building an AI scientist that connects the ecosystem across the entire R&D process. www.benchling.com/blog/ai-scientist-that-deserves-the-name -
Benchling
@benchling
Upload CRO reports, CDMO batch records, and CoAs â then watch #benchlingai route every data point to the right tables, in the right format, automatically.
âď¸ Structured data in minutes
âď¸ Outputs verified across models
âď¸ Context-aware mapping to your internal IDs (not vendor terminology)
Clean, connected data from the start.
Try it out: www.benchling.com/ai/data-import #aiforscientists ⨠-
Benchling
@benchling
âItâs been no surprise that while coding agents have taken over, scientific agents havenât taken off,â says Benchling CEO @sajithw. âThatâs because AI for science has a big wet lab problem.â
To work, AI has to close the loop between the digital layer and the messy physical world where experiments happen.
Thatâs the gap.
đ Read Sajithâs essay on what an AI Scientist actually looks like: www.benchling.com/blog/ai-scientist-that-deserves-the-name -
Benchling
@benchling
Weâre building a true AI Scientist that reasons, acts, and improves with every experiment, accelerating the entire design-build-test-learn loop.
An AI Scientist that deserves the name.
See what weâre building: www.benchling.com/blog/ai-scientist-that-deserves-the-name -
Benchling
@benchling
Weâre building an AI Scientist with the ambition to get molecules to the clinic twice as fast.
The challenge is that AI thrives on fast iteration â something science lacks. Unlike software, science runs in the physical world, where experiments are slow and messy. Thatâs why coding agents took off, and AI scientists havenât (yet).
Our CEO @sajithw argues that the breakthrough will come from closing the loop between the digital and physical worlds of R&D.
An AI scientist that lives up to the name has to:
âď¸ Use the best predictive models and LLMs for each task
âď¸ Execute both automated and manual wet lab work
âď¸ Turn every result into reusable knowledge
âď¸ Act without prompting to keep experiments moving
Scientists still set the direction. AI removes the waiting and the busywork, connecting scattered tools and steps into one loop where knowledge compounds.
Thatâs the AI Scientist weâre building at Benchling.
đ Read Sajithâs essay: www.benchling.com/blog/ai-scientist-that-deserves-the-name
Benchling
@benchling
Want early access to our AI Scientist? Sign up for the waitlist. www.benchling.com/ai-scientist-waitlist
-
Benchling reposted
Sumon Sadhu đ đŻ
@sharpshoot
The foundation of building AI scientists is great data and connecting the digital and physical world. Exciting for @benchling to be paving the path here.
Sajith Wickramasekara
@sajithw
In the AI era, the traditional biopharma industry is the underdog. Big tech and AI labs are building wet labs. China has overtaken Europe in molecules produced. But the tools available to the industry discuss science, not do it.
The hard problem in AI for science is at the interface between the physical and digital worlds.
We built an AI Scientist at that seam. It wires together the digital and physical worlds of R&D. Predictive models, data infrastructure, wet lab execution feed into a single loop that reasons, acts, and improves with every experiment. Our ambition: get molecules to the clinic twice as fast.
Last fall I wrote about why biotech needs to be rebuilt for the AI era. Today I'm sharing the next chapter: what the AI Scientist is, a blueprint for how it works, and why even Richard Feynman couldn't hack it in a wet lab.This media couldn't be displayed. See it on the original post. -
Benchling reposted
Nicholas Larus-Stone
@nlarusstone
Lot of talk on here about building an "AI Scientist", but not a lot of discussion about what an AI Scientist actually does.
So we wrote the guide: www.benchling.com/blog/ai-scientist-that-deserves-the-name -
Benchling reposted
Sajith Wickramasekara
@sajithw
Read the full essay: www.benchling.com/blog/ai-scientist-that-deserves-the-name
-
Benchling reposted
Sajith Wickramasekara
@sajithw
In the AI era, the traditional biopharma industry is the underdog. Big tech and AI labs are building wet labs. China has overtaken Europe in molecules produced. But the tools available to the industry discuss science, not do it.
The hard problem in AI for science is at the interface between the physical and digital worlds.
We built an AI Scientist at that seam. It wires together the digital and physical worlds of R&D. Predictive models, data infrastructure, wet lab execution feed into a single loop that reasons, acts, and improves with every experiment. Our ambition: get molecules to the clinic twice as fast.
Last fall I wrote about why biotech needs to be rebuilt for the AI era. Today I'm sharing the next chapter: what the AI Scientist is, a blueprint for how it works, and why even Richard Feynman couldn't hack it in a wet lab.This media couldn't be displayed. See it on the original post. -
Benchling
@benchling
đĄ Tip: The more context your AI agent has, the better it performs.
#benchlingai now makes it easy to share that context with a simple onboarding flow that builds your "About You" profile automatically.
Tell it who you are and what you work on. Get back insights that actually match your role and how you think.
#aiforscientists ⨠-
Benchling
@benchling
âď¸ Generate preclinical reports in minutes with #benchlingai.
Just ask: âGenerate a complete nonclinical study report with dose-group findings, toxicokinetic parameters, and target organ identification structured for IND-enabling packages.â
Try it out today: www.benchling.com/ai/report-writing #aiforscientists ⨠-
Benchling
@benchling
đŻ Whatever you start working on is your actual business.
Jacob Berlin's sharpest piece of advice for biotech founders: don't plan to prove the platform on one target and then pivot to the "real" work. @sajithw agrees: A then B doesn't exist. It's just A.
đ Watch the full interview with @Terray_Txâs CEO. www.benchling.com/transcribed/jacob-berlin-why-chemistry-⌠#transcribed -
Benchling reposted
No Priors
@NoPriorsPod
This is the best 60-second breakdown of how a medicine is made.
Sajith Wickramasekara (@sajithw), CEO of @benchling:This media couldn't be displayed. See it on the original post.
Sajith Wickramasekara
@sajithw
Listen here: youtu.be/JwyX7fDERBc
-
Benchling
@benchling
Today, weâre launching AI Connectors, new MCP-based capabilities that connect scientific data across AI tools in R&D.
Teams can now use data from common enterprise applications like Notion, SharePoint, and Snowflake directly in #benchlingai.
Pre-built connectors for life science applications like @elicitorg, @gxl_ai, @quiltdata, @SeqeraLabs also bring relevant scientific context together with your experimental records.
AI in science only works when you can connect your data to the right tools.
Learn more: www.benchling.com/news/benchling-launches-ai-connectors-t⌠-
Benchling reposted
Terray Therapeutics @Terray_Tx
Benchling's latest Transcribed episode dives deep into how Terray is wiring hardware, data, and AI into a single engine for small-molecule drug discovery. Our CEO and founder, Jacob Berlin, sat down with Benchlingâs founder, @sajithw, to discuss the importance of pairing precise, proprietary data at scale with industry-leading AI models â and most importantly, having it all deeply integrated with workflows in the lab. EMMI takes these elements and turns them into agentic, end to end workflows.
They cover why models alone arenât a moat, how EMMI Select tackles âAI abundanceâ, and why synthetically constrained generative models are the only practical future. If you care about building real medicines at the intersection of experimentation and machine intelligence, please listen and subscribe!
Thanks to the @benchling team!
Available on all podcast platforms and YouTube!
www.benchling.com/transcribed/jacob-berlin-why-chemistry-⌠-
Benchling
@benchling
What if you could write your first report draft in minutes, not hours?
Today we launched Report Writing in #benchlingai. It generates structured, cited drafts in minutes, using your data, historical records, and public sources.
âď¸ Built-in templates
âď¸ Fully traceable citations
âď¸ Consistent formatting
Try it out today: www.benchling.com/ai/report-writing #aiforscientists ⨠-
Benchling
@benchling
Automate lab documentation with #benchlingai.
Got a new assay kit with a 15-page protocol? Normally thatâs hours of manual typing into your notebook.
With Benchling AI, just upload the PDF. In minutes, youâll get a structured template with materials, procedures, and results tables.
Learn more: www.benchling.com/blog/4-ways-to-automate-documentation-wâŚ
#aiforscientists ⨠-
Benchling
@benchling
âď¸ The "war of models" framing in #ai drug discovery is missing the point.
Jacob Berlin, cofounder and CEO of @Terray_Tx, makes the case that best-in-class models arenât enough. The real edge is at the intersection of experimentation and AI â powered by large, precise, and iterative data.
Thatâs exactly what Terray has spent years building.
đ Watch Jacob and @sajithw talk about why small molecules are AI's last frontier, what "AI abundance" means for medicinal chemists, and why weâll always need humans in the loop.
www.benchling.com/transcribed/jacob-berlin-why-chemistry-⌠#transcribed -
Benchling reposted
Sajith Wickramasekara
@sajithw
What's the real moat in AI drug discovery? Not the models.
Jacob Berlin, cofounder and CEO of @Terray_Tx, and his team built a microarray chip the size of a fingernail that can measure billions of small molecule interactions. Their chemistry data set is now 40x larger than whatâs publicly available. For small molecules, where the search space is essentially infinite, that scale makes all the difference.
His take:Â "You can't learn fast enough if you're only distributing your models to others."
On this episode of Transcribed, Jacob and I talk about why chemistry is harder than biologics for AI, what "AI abundance" means when your models give you 10,000 molecules and your chemists can only make 50, and why whatever you pick to start on is your actual business. -
Benchling
@benchling
At @BlueprintMeds, former CEO Kate Haviland brought in over $1.3B in business development transactions. Sheâs been called Blueprintâs âdeals mastermind.â
Whatâs her secret? On #transcribed, Kate shares how to strategize beyond price and structure partnerships that last. -
Benchling
@benchling
Everyone's talking about #ai. But real, practical guidance on how to use it in the lab is still hard to find. Thatâs why we started #aiforscientists.
Weâre bringing together real examples, practical prompts, and honest stories from scientists using AI for R&D, whether theyâre using Benchling or not.
⨠See how scientists are actually using AI: www.benchling.com/ai/ai-for-science -
Benchling
@benchling
#benchling AI now writes and runs Python in your research workflow.
Our Deep Research Agent handles statistical analysis, data transformations, and complex calculations automatically, returns results for review, and logs them to your scientific record.
Just describe the chart or analysis you need. Benchling AI does the rest.
#aiforscientists ⨠-
Benchling
@benchling
đ¤đŹ Lab automation just got easier. Benchling + HighRes now work together to:
â Design experiments
â Trigger robotic runs
â Return analyzed results automatically
See how it works: www.benchling.com/blog/benchling-and-highres-lab-automation -
Benchling
@benchling
How do you turn a failed phase 3 into a blockbuster drug? Kate Haviland, former CEO at @BlueprintMeds, did it with Ayvakit.
Instead of abandoning the program, Blueprint went back to the data and bet on a patient population that no one had treated before.
On #transcribed, Kate talks to Benchling CEO @sajithw about navigating clinical setbacks and the strategy that led to a multi-billion dollar Sanofi acquisition. -
Benchling reposted
Sajith Wickramasekara
@sajithw
Kate Haviland, former CEO of @BlueprintMeds, and her team turned an expensive Phase 3 failure into Ayvakit, a first-in-class therapy for systemic mastocytosis.
On this episode of Transcribed, Kate takes us inside the company-defining pivot from oncology to immunology that ultimately led to Ayvakit and a $9.5B acquisition by @sanofi.
I hope you enjoy this episode of Transcribed, which was recorded live in front of 500 scientists.This media couldn't be displayed. See it on the original post. -
Benchling
@benchling
Still spending too much time on lab documentation? Hereâs how #ai can help:
âď¸ Transcribe kit protocols into Benchling templates
âď¸ Turn whiteboard sketches into structured experiment entries
âď¸ Clone past experiments and modify sample counts/controls
âď¸ Import CRO data and notes into entries simultaneously
Learn how: www.benchling.com/blog/4-ways-to-automate-documentation-w⌠#aiforscientists ⨠-
Benchling reposted
Sajith Wickramasekara
@sajithw
There has been no shortage of excitement about CRISPR, but turning it into medicines has been slower and harder than many expected. @janiceschen, cofounder & CSO at @mammothbiosci, isnât fazed.
As a grad student in Jennifer Doudnaâs lab, Janice helped shape early conversations around CRISPR. Eight years in, she sees a path to eradicating certain genetic diseases.
On Transcribed, Janice and I talk about expanding the CRISPR toolkit, proving real-world utility, and building when science outpaces the system. Plus, the story of how Jennifer challenged her to aim higher and start her own company. -
Benchling
@benchling
đ§Ź What if we could eradicate certain rare genetic diseases, like we did for infectious diseases such as smallpox? @janiceschen, cofounder and CSO at @mammothbiosci, thinks #crispr could do it in the next 10 years.
On #transcribed, Janice talks to Benchling CEO @sajithw about founding Mammoth straight out of the Doudna Lab, why the biggest barriers to gene editing aren't scientific, and how they developed a COVID test in days.
Benchling
@benchling
đď¸ Watch the full conversation. www.benchling.com/transcribed/janice-chen-crispr-endgame-âŚ
-
Benchling
@benchling
Your lab meeting just ended and your PIâs whiteboard sketch needs to become a proper notebook entry.
You could transcribe it from photos and scattered notes... or just let #ai handle it.
We show exactly how, with copy-paste prompts: www.benchling.com/blog/4-ways-to-automate-documentation-w⌠#aiforscientists ⨠-
Benchling
@benchling
Tired of re-explaining context to #ai agents?
With Custom Instructions in #benchlingai, set your preferences once â and get responses tailored to your workflows and requirements every time.
Try it out and see the difference personalized context makes. #aiforscientists -
Benchling reposted
Dr. Nicole Paulk
@Nicole_Paulk
When people ask "How can we make #aav #genetherapy accessible and affordable" --> this is how đ
Benchling
@benchling
đ âWhat if you could make a gene therapy that could treat 2 or 200 diseases with the exact same drug product. Could that be possible?â
Congrats @Nicole_Paulk on @SirenBioâs second IND clearance!! đThis media couldn't be displayed. See it on the original post. -
Benchling
@benchling
đ âWhat if you could make a gene therapy that could treat 2 or 200 diseases with the exact same drug product. Could that be possible?â
Congrats @Nicole_Paulk on @SirenBioâs second IND clearance!! đThis media couldn't be displayed. See it on the original post.
Benchling
@benchling
đď¸ Watch @Nicole_Paulk explain universal gene therapy (and much more) on #transcribed. www.benchling.com/transcribed/nicole-paulk-quest-for-univâŚ
-
Benchling
@benchling
⨠@mammothbiosci cut hours of preclinical data entry down to minutes with #benchlingai.
What used to require writing custom Jupyter notebooks to ingest Excel files from CROs now takes 10 minutes and natural language prompts â no code needed.
#builtonbenchling #aiforscientists -
Benchling
@benchling
At @enveda, non-clinical reports used to take weeks.
With #benchlingai, teams can now generate draft reports in a day â directly from experimental records.
âď¸ Drafts 400% faster
âď¸ One reporting workflow across US + India teams
âď¸ Data stays secure (no exporting)
How they did it đ www.benchling.com/blog/enveda-reinventing-non-clinical-re⌠#builtonbenchling #aiforscientists -
Benchling
@benchling
Which lab superstitions are you guilty of? đťđ§Ş
#fridaythe13th #lablife
Benchling
@benchling
"The centrifuge was run at 5000 rpm for five minutes, with a stuffed cow placed on top to keep it happy." đŽ
Donât worry, youâre not the only one who does it. www.reddit.com/r/labrats/comments/1bin75p/does_your_lab_hâŚ
Happy #fridaythe13th to the most logical yet superstitious people we know: scientists! -
Benchling
@benchling
How do you attract top #ai talent to biotech?
@ManifoldBio CEO @glebkuz says itâs simple: work on problems that matter.
Few domains let you generate hypotheses computationally, test them at scale, and ultimately impact human health.
On #transcribed, Gleb explains why biology is uniquely compelling for serious AI builders. -
Benchling
@benchling
How does a biotech reach the clinic with just six people?
@SirenBio founder @Nicole_Paulk is doing it â and argues this isnât an edge case, but the direction the entire industry needs to move.
On #transcribed, Nicole talks about brutal capital efficiency, outsourcing everything non-essential, and why every biotech startup should be writing grants.
Benchling
@benchling
đď¸ Watch the full conversation. www.benchling.com/transcribed/nicole-paulk-quest-for-univâŚ
-
Benchling
@benchling
âąď¸ From two years to four months.
That's how much @IFF compressed their protein redesign and manufacturing scale-up timeline, enabled by #ai-ready data and infrastructure.
R&D leaders from @IFF and @moderna_tx shared what it actually takes to scale AI-ready data across global R&D organizations.
Their honest take: We're not planning ten years out. We're just trying to do the right thing now. www.benchling.com/blog/moderna-and-iff-on-the-reality-of-⌠-
Benchling
@benchling
#ai can generate millions of drug candidates. But if you can only test a handful in vivo, youâd still hit a bottleneck.
@ManifoldBio CEO @glebkuz explains how screening hundreds of thousands of antibody designs per animal (including 587,000 in a single non-human primate) changes whatâs possible in drug discovery.
On #transcribed, he talks about the âdark art of multiplexing,â AI, and how the intersection of these technologies is redefining what âscaleâ means in biology.
Benchling
@benchling
đď¸ Watch the full conversation. www.benchling.com/transcribed/gleb-kuznetsov-building-a-pâŚ
-
Benchling
@benchling
Biotechâs first #ai wins came from copilots â the next wave is semi-autonomous, closed loop R&D. đ
See what AI leaders are investing in to speed up design-build-test cycles. www.benchling.com/biotech-ai-report-2026 #biotechaireport -
Benchling
@benchling
Congratulations @Nicole_Paulk and the entire @SirenBio team! đ
đď¸ Get the story behind Siren's start: www.benchling.com/transcribed/nicole-paulk-quest-for-univ⌠#transcribed
Dr. Nicole Paulk
@Nicole_Paulk
More big news from @SirenBio today! #fasttrack designation â¨
This post is unavailable. See it on X. -
Benchling
@benchling
â@SirenBio wouldnât have been here if not for COVID.â
When @Nicole_Paulkâs lab couldnât work in person during the pandemic, she didnât let that stop her. She left academia and founded a company in a matter of weeks: raising $6M, moving into an incubator, and keeping the science alive.
On #transcribed, Nicole shares how she turned frustration into momentum, and why we need to move fast in todayâs market.
Benchling
@benchling
đď¸ Watch the full conversation. www.benchling.com/transcribed/nicole-paulk-quest-for-univâŚ
-
Benchling
@benchling
𤯠Plotting is here in #benchlingai!
No more custom scripts or manual formatting. Just tell our Deep Research agent what you need, and get a publication-ready graph, directly in Benchling.
Watch Benchling engineer @nlarusstone demo how to generate plots from your data in minutes. #aiforscientistsThis media couldn't be displayed. See it on the original post. -
Benchling reposted
Eli Levine @teleturn
As an enterprise company grows so does it product surface area and customers' expectations of its developer platform. Learn how @benchling approached this pivot by rearchitecting how its application features and platform capabilities relate.
Benchling
@benchling
As a platform grows, a familiar problem emerges: every new data type has to be manually integrated with every platform capability, and vice versa. Cost, gaps, and drift are real problems that only deepen as the product surface area expands.
How did we solve for this? Benchling engineer @teleturn shares how we re-architected the platform so new capabilities like APIs just work automatically across objects.
đ Get the details: benchling.engineering/fragmentation-to-framework-spec-fir⌠-
Benchling
@benchling
As a platform grows, a familiar problem emerges: every new data type has to be manually integrated with every platform capability, and vice versa. Cost, gaps, and drift are real problems that only deepen as the product surface area expands.
How did we solve for this? Benchling engineer @teleturn shares how we re-architected the platform so new capabilities like APIs just work automatically across objects.
đ Get the details: benchling.engineering/fragmentation-to-framework-spec-fir⌠-
Benchling reposted
Dr. Nicole Paulk
@Nicole_Paulk
Does your Thursday need some #biotech and #genetherapy hot takes? Of course it does. Enjoy! đĽ
Benchling
@benchling
What if gene therapy didnât have to be bespoke?
@Nicole_Paulk, founder and CEO of @SirenBio, is challenging the status quo with a radical idea: universal gene therapies.
On #transcribed with @sajithw, she talks unpopular ideas, launching a company in weeks, and why biotechâs speed + cost structure must change by whole-digit orders of magnitude. -
Benchling
@benchling
What if gene therapy didnât have to be bespoke?
@Nicole_Paulk, founder and CEO of @SirenBio, is challenging the status quo with a radical idea: universal gene therapies.
On #transcribed with @sajithw, she talks unpopular ideas, launching a company in weeks, and why biotechâs speed + cost structure must change by whole-digit orders of magnitude.
Benchling
@benchling
đď¸ Watch the full conversation. www.benchling.com/transcribed/nicole-paulk-quest-for-univâŚ
-
Benchling reposted
Sajith Wickramasekara
@sajithw
For a master class in speed and cost, look to @Nicole_Paulk.
She shut down her UCSF lab, raised $6M, and launched @SirenBio in weeks.
Now sheâs headed to the clinic with a team of only six. All while pursuing a radical idea: universal gene therapy.
In this Transcribed episode, Nicole and I talk about what capital efficiency looks like in practice, the power of grants and crowdfunding, and how biotech has to evolve to survive.This media couldn't be displayed. See it on the original post. -
Benchling
@benchling
đ With #benchlingai, teams can turn thousands of unstructured files into validated Benchling entries â no manual transcription, no migration chaos, just clean data captured at scale. #aiforscientists
-
Benchling
@benchling
đ Huge win for computational drug discovery! @Terray_Tx's new binding-affinity model is 20% more accurate than leading models. It also delivers predictions in 1.04s (that's 26x faster).
How? Rethinking the paradigm:
âď¸ Shifting to non-diffusion-based architecture
âď¸ No structural visualizations
This is potency prediction at real-world scale.
Read it in @endpts:
endpoints.news/terray-says-its-ai-model-beats-boltz-2-at-âŚ
Proud to support the team at Terray. #builtonbenchlingTerray Therapeutics @Terray_Tx
Today we announced EMMI Predict: TerraBind, our universal potency model that dramatically expands Terrayâs ability to move molecules to the clinic faster. Far outpacing publicly available models, TerraBind is a cornerstone of Terrayâs end-to-end workflow for small molecule discovery and development.
Read our blog: www.terraytx.com/insights/emmi-predict-terrabind -
Benchling
@benchling
Itâs no secret that @geochurch's lab has spawned dozens of biotech startups. The more interesting question is: what creates that level of momentum?
@glebkuz left Google to join the Church Lab. Today, heâs CEO at @ManifoldBio. He and his labmates started the first wave of #ai-native biotechs, including two other companies from his lab bay alone: @Dyno_Tx and @nablabio.
On #transcribed, Gleb reflects on career pivots, why the Church Lab was so special, and the unexpected moments (like giving George a ride from San Francisco to Mountain View) that changed his entire trajectory.
Benchling
@benchling
đď¸ Watch the full conversation. www.benchling.com/transcribed/gleb-kuznetsov-building-a-p⌠#transcribed
-
Benchling
@benchling
With #benchlingai, teams can run AlphaFold 2, Chai-1, and Boltz-2 directly in Benchling â no scripts, no handoffs, just results captured automatically.
#aiforscientists -
Benchling
@benchling
Nothing says âproduct launchâ like branded cupcakes. đ§đ
#benchlingai. Itâs here. www.benchling.com/ai -
Benchling
@benchling
âWithin days, scientists were talking about it in meetings and the break room.â
Thatâs what an SVP told Benchling cofounder @daashu after their company turned on #benchlingai. Within weeks, hundreds of scientists were using it daily to unlock years of data.
This story is one of many. Over the past year, 500 biotech companies have put Benchling AI to work.
See the use cases driving adoption today: www.benchling.com/blog/benchling-ai-now-generally-available -
Benchling
@benchling
When Roche published breakthrough brain shuttle data, it reshaped biologics targeting the brain. @ManifoldBio CEO @glebkuz saw the signal and pivoted.
Today, Manifold is partnering with Roche in a deal valued at over $2B to develop next-gen brain shuttles.
On #transcribed, Gleb talks about âbet the companyâ decisions and strategic timing. www.benchling.com/transcribed/gleb-kuznetsov-building-a-p⌠-
Benchling
@benchling
Youâve seen the billboard. Now meet the product.
500 biotech companies helped us test it. Now itâs GA.
#benchlingai is designed for how R&D actually works. Itâs #ai that understands your data, workflows, and scientific context â because it's built directly into the platform where all of that already exists.
www.benchling.com/ai -
Benchling reposted
Sajith Wickramasekara
@sajithw
In one large organization that turned Benchling AI on in December, an SVP told us that within days, he was hearing scientists talk about it in the break room and within weeks, hundreds were using it in their daily work.
Turn it on, sit back, and let the agents get to work.
Benchling
@benchling
#benchlingai is now generally available! đ
Over the past year, itâs been put to use across 500 biotech companies, from #ai-native startups to top 20 biopharma, and itâs already delivering real value across R&D.
Teams are using it to:
⨠Structure messy data automatically
⨠Generate study reports in minutes
⨠Run models like AlphaFold 2, Chai-1, and Boltz-2 directly inside Benchling
Benchling cofounder @daashu shares the âkiller AI appsâ making the biggest impact today: www.benchling.com/blog/benchling-ai-now-generally-available -
Benchling
@benchling
⥠What used to take days of searching, comparing, and formatting can now be done in less than an hour.
With #benchlingai, now GA, scientists can:
âď¸ Synthesize months of experiments and publications
âď¸ Get instant answers about their own data
âď¸ Generate lab-ready protocols in minutes
This is Benchling AI in action. www.benchling.com/ai -
Benchling
@benchling
#benchlingai is now generally available! đ
Over the past year, itâs been put to use across 500 biotech companies, from #ai-native startups to top 20 biopharma, and itâs already delivering real value across R&D.
Teams are using it to:
⨠Structure messy data automatically
⨠Generate study reports in minutes
⨠Run models like AlphaFold 2, Chai-1, and Boltz-2 directly inside Benchling
Benchling cofounder @daashu shares the âkiller AI appsâ making the biggest impact today: www.benchling.com/blog/benchling-ai-now-generally-available -
Benchling reposted
Gleb Kuznetsov
@glebkuz
Fun podcast with @sajithw where I share the story of @ManifoldBio and my own journey as an engineer into the world of biophysics and now drug design.
Sajith Wickramasekara
@sajithw
One of the biggest unsolved problems in making medicines is what comes after AI design. @glebkuz, cofounder and CEO of @ManifoldBio, is tackling the in vivo bottleneck. Screening hundreds of thousands of antibody designs in a single animal changes whatâs possible in drug discovery.
Iâve known Gleb since he was my TA at MIT, so it was really fun to have him on Transcribed.
We talked about:
- Why he left Google to start over in biology (literally showing up at @geochurchâs lab and asking how he could be useful)
- How 3 companies came out of his grad school lab bay
- What it takes to build a true platform company
- Where AI-driven drug discovery is actually headed -
Benchling
@benchling
What if you could test hundreds of thousands of drug candidates in a single animal? @ManifoldBio is already doing that.
Manifold CEO @glebkuz is redefining how in vivo data gets generated, and what happens when scale meets #ai.
On #transcribed, Gleb joined Benchling CEO @sajithw to talk about platform strategy, AI-guided discovery, and why zero-shot clinical design is closer than you think. -
Benchling reposted
Sajith Wickramasekara
@sajithw
One of the biggest unsolved problems in making medicines is what comes after AI design. @glebkuz, cofounder and CEO of @ManifoldBio, is tackling the in vivo bottleneck. Screening hundreds of thousands of antibody designs in a single animal changes whatâs possible in drug discovery.
Iâve known Gleb since he was my TA at MIT, so it was really fun to have him on Transcribed.
We talked about:
- Why he left Google to start over in biology (literally showing up at @geochurchâs lab and asking how he could be useful)
- How 3 companies came out of his grad school lab bay
- What it takes to build a true platform company
- Where AI-driven drug discovery is actually headed -
Benchling
@benchling
âAI feels very much like cloud did about 10 years ago, where there's this opportunity to democratize access to cutting-edge agents and models and to bring them to scientists everywhere.â
#ai adoption is moving faster this time, and it should.
Benchling CEO @sajithw joined @FlagshipPioneer to talk about bringing AI to R&D, and why it wonât take a decade to go mainstream, even in biopharma. -
Benchling
@benchling
𤊠Image generation is here in #benchlingai! Generate diagrams of your experimental flow in minutes, directly from your Benchling data.
Watch Benchling cofounder @daashu demo how Deep Research turns real experiments into clear, publication-ready visuals. #aiforscientists -
Benchling
@benchling
đ Move over, PubMed. #ai is now the fastest-growing way scientists find, filter, and summarize data.
What used to be a manual search through hundreds of papers is now a quick chat with AI.
đ See all the trends: www.benchling.com/biotech-ai-report-2026 #biotechaireport -
Benchling
@benchling
At @moderna_tx, the mission is clear: deliver the greatest possible impact to patients through mRNA medicines. What makes that possible is being AI-ready.
See how structured data, scalable infrastructure, and unified tools help Moderna drive innovation: www.benchling.com/customer-stories/moderna-building-ai-dr⌠#builtonbenchlingThis media couldn't be displayed. See it on the original post. -
Benchling
@benchling
âIf I watch JPM presentations from a couple of years ago, no one was saying AI in their presentation. Now everyone's an AI company to some extent.â
Thereâs huge energy in early drug discovery, but discovery is just step one. Some of the hardest problems still lie downstream in regulatory, CMC, and development.
Benchling CEO @sajithw joined @FlagshipPioneer at #jpm26 to talk about what it really means to build in the #ai era.
Benchling
@benchling
đş Watch the full @FlagshipPioneer panel: youtu.be/9ObdF-WY8ZU
-
Benchling
@benchling
âThereâs a lot of excitement about these models that help you create a new hypothesis. And thatâs really important, but drug discovery is 9,999 steps after that.â
Benchling CEO @sajithw joined @tbpn to talk about the big opportunity with #ai in R&D, especially further downstream, including CMC and regulatory workflows.
Benchling
@benchling
Watch the full @tbpn segment. www.youtube.com/live/_MvQoZ7b-pU?t=10419
-
Benchling
@benchling
đŠ Why do #ai pilots fail? Biotech leaders weighed in: itâs becoming clear that AI is hitting the limits of data and biotech infrastructure.
Making the leap from AI copilots to co-scientists means AI needs to collaborate across teams, systems, and stages of R&D.
Explore the data: www.benchling.com/biotech-ai-report-2026 #biotechaireport -
Benchling
@benchling
âA scientist was about to run some studies that would have taken about eight months, and they realized that someone else had already done the work many years ago.â
The data already existed. #ai just helped pull it out of old spreadsheets and PDFs.
Benchling CEO @sajithw joined @tbpn to share real-world examples of how AI is already compressing the timeline for drug discovery.
Benchling
@benchling
Watch the full @tbpn segment. www.youtube.com/live/_MvQoZ7b-pU?t=10419
-
Benchling reposted
Sajith Wickramasekara
@sajithw
2026 feels like the year for a JPM tech + bio crossover!
Thanks for having me @tbpnThis media couldn't be displayed. See it on the original post. -
Benchling
@benchling
This year already feels different. And the data proves it: #ai in biotech has moved from theoretical to practical, with real impact across R&D.
Our #biotechaireport shows whatâs next: scale AI and make it foundational to scientific work.
Itâs how we build the future of discovery: AI for every scientist, breakthroughs for all.
đ Get the data: www.benchling.com/biotech-ai-report-2026 -
Benchling reposted
Ryan Flinn
@RS_Flinn
Lots of interesting insights from @benchlingâs AI report - check out my @BiotechTV interview with Sandy Li.
BiotechTV
@BiotechTV
đđ đ˘đ§ đđ˘đ¨đđđđĄ: @benchling's Sandy Li breaks down new survey data showing biotechâs first AI âkiller appsâ (literature review, knowledge extraction) are already mainstream.
Full video: www.biotechtv.com/post/sandy-li-benchling-ai-killer-appsThis media couldn't be displayed. See it on the original post. -
Benchling reposted
BiotechTV
@BiotechTV
đđ đ˘đ§ đđ˘đ¨đđđđĄ: @benchling's Sandy Li breaks down new survey data showing biotechâs first AI âkiller appsâ (literature review, knowledge extraction) are already mainstream.
Full video: www.biotechtv.com/post/sandy-li-benchling-ai-killer-appsThis media couldn't be displayed. See it on the original post. -
Benchling
@benchling
âIf there's any industry that doesn't like uncertainty, it's biotech. You're underwriting something that's going to take 10 years to see the results of.â
Benchling CEO @sajithw joined @tbpn to talk about biotechâs âdot comâ moment and why the speed and cost of making new drugs needs to radically change.This media couldn't be displayed. See it on the original post. -
Benchling
@benchling
âAI in bio is like GPT without the chat. GPT came out but it didn't explode until someone put the right interface on it.â
Benchling CEO @sajithw joined @tbpn to talk about why usability, and the right interface, is what will bring #ai into everyday scientific workflows. -
Benchling
@benchling
Biotechâs #ai leaders are rolling out copilots and agents across everyday R&D â but the depth of adoption is just beginning.
Use of scientific models is growing, and we see deeper scientific adoption on the horizon. Get the data: www.benchling.com/biotech-ai-report-2026 #biotechaireport -
Benchling
@benchling
đ§ŹđĽď¸ Biotechâs #ai future depends on scientists who upskill, not tech hires. Teams want domain experts who speak both biology and ML.
See how a new generation of hybrid scientists is emerging: www.benchling.com/biotech-ai-report-2026 #biotechaireport -
Benchling reposted
Profluent
@ProfluentBio
Great event at @benchling! We're excited to be among so many great teams creating more and better medicines with AI.
Thanks for having us, @sajithw
Benchling
@benchling
𤊠It was a full house at Benchling last night! Over 200 biotech and biopharma leaders joined to hear how scientific models are driving real impact today â and what it means for the future of R&D.
What stood out?
- Scientific models are here, but the real challenge is adoption
- Protein design isnât solved yet. But thereâs a huge opportunity space with dynamics
- Federated learning is how we democratize models and unlock ecosystem-wide efficiency
- Whatâs next? AI across the full R&D stack
Thanks to @IsomorphicLabsâs @maxjaderberg, @ProfluentBioâs @thisismadani, @EliLillyandCoâs Aliza Apple, and @AnthropicAIâs Eric Kauderer-Abrams for joining the panel with @sajithw! -
Benchling reposted
BiotechTV
@BiotechTV
đđ đđđđĽđđĄđđđŤđ đđđđ¤: Meet some of the incredible Female Biotech CEO leaders of the Biotech CEO Sisterhood!
This media couldn't be displayed. See it on the original post. -
Benchling
@benchling
𤊠It was a full house at Benchling last night! Over 200 biotech and biopharma leaders joined to hear how scientific models are driving real impact today â and what it means for the future of R&D.
What stood out?
- Scientific models are here, but the real challenge is adoption
- Protein design isnât solved yet. But thereâs a huge opportunity space with dynamics
- Federated learning is how we democratize models and unlock ecosystem-wide efficiency
- Whatâs next? AI across the full R&D stack
Thanks to @IsomorphicLabsâs @maxjaderberg, @ProfluentBioâs @thisismadani, @EliLillyandCoâs Aliza Apple, and @AnthropicAIâs Eric Kauderer-Abrams for joining the panel with @sajithw! -
Benchling
@benchling
đş Catch Benchling CEO @sajithw live on @tbpn today!
Tune in to hear about the state of biopharma today, the biggest trends coming out of #jpm26, and more.
TBPN
@tbpn
Gm. On today's show:
- @ScottNolan (General Matter)
- @shervin (Sofreh Capital)
- @justindross (WithCoverage)
- @RobCSlaughter (Defense Unicorns)
- @sajithw (Benchling)
- Horacio Rozanski (Booz Allen Hamilton)
- Glenn Fogel (BKNG)
- Nick Fleisher (Sandstone)
See you there.
TBPN
@tbpn
Siri Needs an App, Who is John Ternus, Shervin Pishevar's Iran Deep Dive, Scott Nolan Truth Nuke x.com/i/broadcasts/1djxXWqZWOEJZ
-
Benchling reposted
TBPN
@tbpn
Gm. On today's show:
- @ScottNolan (General Matter)
- @shervin (Sofreh Capital)
- @justindross (WithCoverage)
- @RobCSlaughter (Defense Unicorns)
- @sajithw (Benchling)
- Horacio Rozanski (Booz Allen Hamilton)
- Glenn Fogel (BKNG)
- Nick Fleisher (Sandstone)
See you there.
TBPN
@tbpn
Siri Needs an App, Who is John Ternus, Shervin Pishevar's Iran Deep Dive, Scott Nolan Truth Nuke x.com/i/broadcasts/1djxXWqZWOEJZ
-
Benchling reposted
Isomorphic Labs
@IsomorphicLabs
Itâs @JPM Healthcare Week and today @IsomorphicLabs' President @maxjaderberg will join a panel hosted by @Benchling, on how scientific models are reshaping biotech R&D. If youâre in town, come along to hear Max share how Isoâs unified drug design engine could help accelerate treatments across many diseases. Head to the comments for the link. #jpmhc26
-
Benchling
@benchling
#jpm26 is in full swing! Swing by Union Square to find #jeffyp serving up two of our favorite things: coffee and data. âđ
Jeffyâs coffee cart will be parked in front of 366 Geary St until 4pm today. Come say hi and get a copy of the #biotechaireport! đ
Benchling
@benchling
Not in SF? No worries, read the full #biotechaireport here. www.benchling.com/biotech-ai-report-2026
-
Benchling
@benchling
đĽ #ai is officially out of pilot mode in biotech. The first âkiller appsâ are here: lit review, scientific reporting, and protein structure prediction.
Why these? Itâs where the data is local, clean, and easily validated.
Get the data: www.benchling.com/biotech-ai-report-2026 #biotechaireport -
Benchling reposted
David K. Yang
@davidkmyang
Join us for breakfast this morning with our friends at @benchling !
Sajith Wickramasekara
@sajithw
Congrats to the Lux team. Great news for ambitious founders working on scientific progress.
Come meet @davidkmyang at our JPM breakfast on Monday morning. I am bringing coffee and he will have term sheets.
Lux Capital
@Lux_Capital
We started Lux in 2000 with a simple conviction: the biggest opportunities lie at the frontier of science and technology that others find too hard, too early, or too confusing. Twenty-five years later, that conviction hasn't changed. What has changed is that the world has caught on.
Now compute, automation, and biology have matured into scalable engineering disciplines, and what was once fringe "deep tech" has become essential infrastructure. New talent, new tools, and new industrial capacity now exist to turn the most cutting-edge technology across the physical, computational, and life sciences into enduring businesses.
For these businesses and founders to become category-defining winners, they need meaningful capital and conviction. That is why we are especially excited to announce our largest fund to date, Lux Ventures IX, a $1.5B commitment to investing in the people turning sci-fi into sci-fact.
Today entire sectors of aerospace, biotech, defense, industrials, transportation and beyond are being reinvented by a new generation of brilliantly ambitious, often irreverent, scientists and engineers. And while markets have changed and capital reshapes around fewer companies and larger checks, our focus on the craft remains constant.
That focus matters because science doesnât scale itself. The path from a result in the lab, only known to a few, to something durable the entire world will use requires a different kind of partnership. One that deploys the first $100K and the last $100M, that stays through the full arc of company-building, that mobilizes a powerful network of kinetic like-minded founders, and that treats capital as a tool rather than the product.
Forty-four people at Lux now manage $7B, still operating with the same discipline and purpose we had on day one. We find and fund founders others have overlooked, back conviction over consensus, and build alongside these rebels of science and tech at every stage.
Weâre grateful to our valued LPs who've partnered with us through multiple cycles, and to the founders who trust us with their life's work. The mission continues, with even greater intensity and momentum.
www.luxcapital.com/news/announcing-lux-ventures-ix -
Benchling
@benchling
Weâre proud to partner with @AnthropicAI as part of the launch of its Healthcare & Life Sciences ecosystem today at JPM.
With Benchling's Model Context Protocol (MCP) integration, researchers can ask Claude questions directly about their data in Benchling.
MCPs are the safe and flexible way to adopt and scale AI. This is going to be big in the year ahead.
What's new today:
âď¸ Benchling's MCP now authenticates via SSO (no API keys), making it easy for entire teams to use securely
âď¸Available on web and desktop
âď¸One-click traceability back to underlying scientific data
âď¸Existing permissions and audit logs carry over automatically
This is how AI should work in life sciences: powerful, context-aware, and built on systems scientists already trust. Excited to see what teams build on this foundation.
anthropic.com/news/healthcare-life-sciencesThis media couldn't be displayed. See it on the original post.
Benchling
@benchling
Learn more about our partnership with @AnthropicAI. www.benchling.com/partnerships/anthropic
-
Benchling reposted
Andrew Dunn
@AndrewE_Dunn
Lilly TuneLab deals (announced in Sept) â offering AI model access in exchange for biotechs sharing data
+ Schrodinger (in LiveDesign)
+ Revvity (in Xynthetica)
+ Benchling (in platform)
+ BigHat (antibody developability datasets)
+ Insitro (small mol property prediction models) -
Benchling reposted
Flagship Pioneering
@FlagshipPioneer
Tech and biotech are convergingâbut key differences remain.
Join Andrew Clare (@elroyair), Margo Georgiadis (Montai Therapeutics), Armen Mkrtchyan, and @SajithW (@benchling) next week during #jpm26 for a candid conversation on how companies are being built in the AI era.
đ Jan 12 | 7:45am PT
đ Register: events.flagshippioneering.com/blurringlinesvir -
Benchling reposted
Kyle Tretina, Ph.D.
@AllThingsApx
The @benchling 2026 Biotech AI Report is out!
đ -
Benchling reposted
Menlo Ventures
@MenloVentures
@benchling just released their 2026 Biotech AI Report and it captures where biotech AI is actually delivering value today vs. where it's still hitting barriers.
Read more here: www.benchling.com/biotech-ai-report-2026
Benchling
@benchling
đ The data is in â and the #biotechaireport is massive. Get the most detailed look yet at how biotechâs #ai frontrunners are turning AI into real scientific impact.
Read it: www.benchling.com/biotech-ai-report-2026 -
Benchling reposted
Sajith Wickramasekara
@sajithw
Excited for this! @EliLillyandCo has invested >$1B on scientific AI models. We both share a belief in the democratization of tools for scientific progress and through this TuneLab collaboration, we hope the entire industry can benefit.
Benchling
@benchling
Big news: Weâre teaming up with @EliLillyandCo to bring Lilly TuneLab models directly into Benchling.
Scientists will be able to access prediction models for antibodies and small molecules â which have been trained on decades of Lillyâs research. www.benchling.com/news/benchling-and-lilly-tunelab-partne⌠-
Benchling reposted
Vega Shah
@dr_alphalyrae
Benchling remains in an incredibly powerful position to have an eagleâs eye view of AI adoption, especially around lab data management and regulatory submissions in the life sciences industry. Check out their annual AI report showing some interesting trends
Sajith Wickramasekara
@sajithw
Our 2026 Biotech AI Report is out, based on insights from 100+ biotech and pharma leaders, plus unique perspectives from BMS, Xaira, Takeda, Eli Lilly, NVIDIA, Anthropic, and others.
-
Benchling
@benchling
#ai is supposed to make R&D faster. But when? 52% of biotech AI leaders are already seeing the impact, whether itâs faster decisions or reduced time-to-target.
And the other projections arenât too far off.
Take a look: www.benchling.com/biotech-ai-report-2026 -
Benchling
@benchling
đ Huge congrats to the Boltz team! Can't wait to see what they build next.
Want an inside look at how they built BoltzGen? Check out our interview with model co-creator @HannesStaerk: www.benchling.com/blog/behind-the-model-building-boltzgenâŚ
Gabriele Corso
@GabriCorso
Big news from Boltz today: weâre launching Boltz Lab, a new platform with new small-molecule + protein design agents, announcing Boltz PBC and a $28M seed round, and sharing a multi-year partnership with Pfizer. More below! đ
-
Benchling
@benchling
Big news: Weâre teaming up with @EliLillyandCo to bring Lilly TuneLab models directly into Benchling.
Scientists will be able to access prediction models for antibodies and small molecules â which have been trained on decades of Lillyâs research. www.benchling.com/news/benchling-and-lilly-tunelab-partne⌠-
Benchling reposted
Gleb Kuznetsov
@glebkuz
Nice report on the momentum of AI adoption in biotech from the @benchling team. Echoing my quote from the report that AI is now table stakes in discovery, but not sufficient. Highly differentiated data gen is the moat. We're blasting off on the AI tailwinds. What an epic next few years it'll be for us at @ManifoldBio and the industry.
Sajith Wickramasekara
@sajithw
Our 2026 Biotech AI Report is out, based on insights from 100+ biotech and pharma leaders, plus unique perspectives from BMS, Xaira, Takeda, Eli Lilly, NVIDIA, Anthropic, and others.
-
Benchling
@benchling
đ Biotech teams that use scientific models are already seeing the payoff: 42% report better hit rates and prediction accuracy and 50% already see faster R&D.
#biotechaireport
Benchling
@benchling
When will we see #ai-designed molecules? Most experts project a 3-5 year horizon. Only 20% are seeing new revenue or IP gains from scientific models today.
#biotechaireport
Benchling
@benchling
Read the full report: www.benchling.com/biotech-ai-report-2026 #biotechaireport
-
Benchling
@benchling
đ The data is in â and the #biotechaireport is massive. Get the most detailed look yet at how biotechâs #ai frontrunners are turning AI into real scientific impact.
Read it: www.benchling.com/biotech-ai-report-2026 -
Benchling reposted
Sajith Wickramasekara
@sajithw
Our 2026 Biotech AI Report is out, based on insights from 100+ biotech and pharma leaders, plus unique perspectives from BMS, Xaira, Takeda, Eli Lilly, NVIDIA, Anthropic, and others.
-
Benchling
@benchling
#ai is already changing biotech. Scaling it is the hard part.
On Jan 13, Benchling is co-hosting a special event with @Anthropic and @MenloVentures. Weâre bringing together experts across the scientific model ecosystem to discuss what itâll take to cross the adoption chasm and make models a part of everyday R&D.
đ Register: events.benchling.com/aipanelandhappyhourwbenchling -
Benchling
@benchling
đ§Ş Drug development isnât magic. Itâs bold ideas, crushing setbacks, and the people who keep going anyway. But most never see that part of the journey.
Thatâs why we started #transcribed: to share real stories from the people driving biotech forward.
Thank you to @DrSynbio, to every guest who opened up this year, and to all of you who listened. Hereâs to telling those stories even better in 2026. đĽThis media couldn't be displayed. See it on the original post.
Benchling
@benchling
đď¸ Watch Jake Becraftâs full interview: www.benchling.com/transcribed/jake-becraft-mrna-proving-sâŚ
-
Benchling
@benchling
Whatâs @ekelsicâs advice for the next generation of #biotech founders?
đ The best ideas often start weird
đ Tackle problems youâre uniquely built for
đ Trust your judgement â even when itâs unpopular
He joined @sajithw to share his journey from Caltech physics to @geochurchâs lab, and now using #ai to reinvent AAVs at @Dyno_Tx.
đ Read the interview: www.benchling.com/transcribed/eric-kelsic-on-breaking-con⌠#transcribed -
Benchling
@benchling
đ Bio x AI isnât new⌠but 10 years ago, it was. @ekelsic saw the wave coming, and co-founded @Dyno_Tx. Now, heâs using #ai to solve in vivo gene delivery â and challenging the way biotech is built.
đ Read his #transcribed interview with @sajithw. www.benchling.com/transcribed/eric-kelsic-on-breaking-con⌠-
Benchling
@benchling
âMost people arenât really using that much #ai in R&D â yet.â On @NoPriorsPod, @sajithw talks about the concerns holding the industry back, and why the priority has to be building something that scientists trust and will actually use.
-
Benchling
@benchling
đ¤ Do you think most people could name five biotech CEOs? @sajithw and @saranormous talk about why we need to tell scientistsâ stories better.
There are so many heroes behind each new drug, and we need to celebrate that more. đ -
Benchling
@benchling
⥠Try it out today â an early preview of BoltzGen in Benchling!
Using any amino acid sequence as a target, use BoltzGen to design binders of customizable length, and visualize the outputs directly in Benchling. #featurefriday #benchlingaiThis media couldn't be displayed. See it on the original post.
Benchling
@benchling
đ Stay tuned: support for additional target modalities coming soon!
-
Benchling reposted
Sajith Wickramasekara
@sajithw
The last few years have been bleak in biotech. Yet, there's never been more excitement (and capital) around AI for scientific progress. How do you reconcile that?
I recently sat down with @saranormous on @NoPriorsPod for a vibe check on biotech and how AI can help us get more medicines faster.
We talked about the macro climate, what it actually takes to make a medicine, and why this is the moment for biotech to rebuild for the AI era. Plus some reflections as we build a culture at the intersection of science and technology.
No Priors
@NoPriorsPod
Sajith Wickramasekara, CEO of @benchling, argues that scienceâs complexity and specialization make it ideal for LLMs. AI can absorb the massive scientific corpus, provide expert level guidance, and remove the artisanal, inefficient parts of research that hold teams back.
@sajithw -
Benchling reposted
No Priors
@NoPriorsPod
Sajith Wickramasekara, CEO of @benchling, argues that scienceâs complexity and specialization make it ideal for LLMs. AI can absorb the massive scientific corpus, provide expert level guidance, and remove the artisanal, inefficient parts of research that hold teams back.
@sajithw -
Benchling
@benchling
đď¸ Benchling CEO @sajithw joins @saranormous on @NoPriorsPod to discuss biotechâs âdot comâ moment, why R&D remains slow and expensive, and how AI agents could finally speed up discovery and development.
Full episode: youtu.be/JwyX7fDERBcThis media couldn't be displayed. See it on the original post. -
Benchling
@benchling
đĽ Incredible turnout for our event with Boltz! Over 100 scientists and R&D leaders came to meet BoltzGen co-creator @HannesStaerk and hear how the model was built.
Missed it? Read our interview with Hannes: www.benchling.com/blog/behind-the-model-building-boltzgen⌠-
Benchling
@benchling
đ TOMORROW: Join us for a live chat with @HannesStaerk, co-creator of BoltzGen â one of the most exciting breakthroughs in generative protein design.
Come to the Benchling office to meet Hannes, and see why the model is such a game changer.
đ Save your spot: -
Benchling
@benchling
đ This week: @HannesStaerk shares how BoltzGen, the latest breakthrough generative protein design model, was built and validated.
Join us at the Benchling office to discuss what this means for the future of biomolecular design!
đ Donât miss it: luma.com/h2hod0uy -
Benchling reposted
Hannes Stark
@HannesStaerk
We would be happy to have you at our BoltzGen launch event with Benchling in San Francisco with a presentation + discussion session!
Thursday November 6th at 5pm:
680 Folsom St floor 10, San Francisco
luma.com/h2hod0uy -
Benchling
@benchling
đ You know whatâs scary? Spending hours manually copy-pasting data from PDFs (or even handwritten notes đą).
Thatâs why we built our Data Entry Agent, so you can turn messy files into clean, usable data in minutes. #benchlingai -
Benchling
@benchling
đ¤ Every biotech startup faces a key choice: build a platform or focus on a product. Over time, the industry has swung between the two.
On #transcribed, @ambellinger shares why Verveâs product-first focus brought in vivo editing to the clinic faster. www.benchling.com/transcribed/andrew-bellinger-pioneering⌠-
Benchling reposted
Sajith Wickramasekara
@sajithw
BoltzGen is coming to @benchling. We had a chance to sit down with the model co-creator @HannesStaerk to hear how BoltzGen was built, why transparent validation matters, and what sets this model apart.
www.benchling.com/blog/behind-the-model-building-boltzgenâŚ
Hannes Stark
@HannesStaerk
Excited to release BoltzGen which brings SOTA folding performance to binder design! The best part of this project has been collaborating with many leading biologists who tested BoltzGen at an unprecedented scale, showing success on many novel targets and pushing its limits! đ§ľ..
-
Benchling
@benchling
đ Congrats @HannesStaerk @GabriCorso and the entire team! Weâre excited to partner with the Boltz team to bring BoltzGen, one of the worldâs most advanced generative protein design models, into Benchling.
⥠Design custom protein binders from any target with unprecedented speed and control.
Read our conversation with @HannesStaerk: www.benchling.com/blog/behind-the-model-building-boltzgenâŚ
Hannes Stark
@HannesStaerk
Excited to release BoltzGen which brings SOTA folding performance to binder design! The best part of this project has been collaborating with many leading biologists who tested BoltzGen at an unprecedented scale, showing success on many novel targets and pushing its limits! đ§ľ..
-
Benchling reposted
Andrew Bellinger @ambellinger
Thanks for having me on @sajithw ! Super fun conversation about one of my favorite topics
Benchling
@benchling
đ Bold science starts with bold bets. @ambellinger, former CSO at @VerveTx, joins @sajithw on #transcribed to talk focus, hiring, and building new drug modalities from scratch.
đď¸ Watch the full conversation. www.benchling.com/transcribed/andrew-bellinger-pioneering⌠-
Benchling reposted
Sajith Wickramasekara
@sajithw
Many scientists have told me @VerveTx is the best-run biotech they have ever worked at. I wanted to find out why.
Very grateful to my friend @ambellinger for sitting down and sharing what made Verve special and lessons he learned as CSO.
We covered:
- Paying the pioneer's tax with a new modality
- The contrarian decision to build a product (not platform) company in 2018
- Operational and cultural decisions that helped Verve move fast
- The gift of mentorship and high standards
I hope you enjoy as much as I did!This media couldn't be displayed. See it on the original post. -
Benchling
@benchling
đ Bold science starts with bold bets. @ambellinger, former CSO at @VerveTx, joins @sajithw on #transcribed to talk focus, hiring, and building new drug modalities from scratch.
đď¸ Watch the full conversation. www.benchling.com/transcribed/andrew-bellinger-pioneering⌠-
Benchling reposted
Menlo Ventures
@MenloVentures
This is the breakthrough biotech needs.
@benchling and @AnthropicAI are tackling the real bottleneck in drug discovery, not by layering AI on broken systems, but by rebuilding the foundation. Scientists can now ask @claudeai questions about their Benchling data and get traceable insights instantly.
Nothing better than seeing our portfolio companies join forces to accelerate breakthroughs that matter. This is the kind of powerful pairing that transforms health outcomes. đ
Mike Krieger
@mikeyk
Weâre launching our Claude for Life Sciences initiative today, including new bioinformatics Skills, and new MCPs from @benchling, @BioRender, PubMed, @WileyGlobal, @Sagebio, @10xGenomics and more:
www.anthropic.com/news/claude-for-life-sciences -
Benchling
@benchling
đ How do we get groundbreaking medicines to patients faster? @StrandTx CEO @DrSynbio unpacks what it really takes, why medicine is the best investment, and how policy needs to reflect that.
đď¸ Watch his conversation with @sajithw: www.benchling.com/transcribed/jake-becraft-mrna-proving-s⌠#transcribed -
Benchling
@benchling
We're proud to partner with @AnthropicAI!
Now researchers can ask @claudeai questions about their data in Benchling â accelerating how scientists design, run, interpret, and report on experiments. www.cnbc.com/2025/10/20/anthropic-claude-life-sciences-re⌠#benchlingai -
Benchling
@benchling
⨠Now, scientists can ask Claude questions about their Benchling data â and get source-linked answers, analyses, and insights in minutes.
Weâre excited to partner with @AnthropicAI!
Read the news in @endpts. endpoints.news/interview-with-anthropics-life-sciences-he⌠-
Benchling reposted
Mike Krieger
@mikeyk
Weâre launching our Claude for Life Sciences initiative today, including new bioinformatics Skills, and new MCPs from @benchling, @BioRender, PubMed, @WileyGlobal, @Sagebio, @10xGenomics and more:
www.anthropic.com/news/claude-for-life-sciences -
Benchling reposted
Anthropic
@AnthropicAI
Claude can now connect to @benchling, PubMed, and synapse.org, among other platforms. And our new Agent Skills can help Claude follow scientific protocols and procedures consistently.
-
Benchling reposted
Will Reed
@willreed
iconic collab @claudeai x @benchling
CNBC
@CNBC
Anthropic launches Claude Life Sciences to give researchers an AI efficiency boost www.cnbc.com/2025/10/20/anthropic-claude-life-sciences-reâŚ
-
Benchling
@benchling
⨠Now scientists can ask @claudeai questions about their Benchling data â and get source-linked answers in minutes.
We're proud to partner with @AnthropicAI, bringing @claudeaiâs reasoning and Benchlingâs data platform together to accelerate scientific discovery. www.benchling.com/news/benchling-partners-with-anthropic-⌠#benchlingai -
Benchling
@benchling
Big reveals from #benchtalk!
⥠#benchlingai now open for any scientist to try at benchling.ai
⥠New collabs with @NVIDIAHealth & GXL
⥠Major advances in antibody discovery, automation, and development
Thanks to all who joined us â your breakthroughs inspire us! -
Benchling reposted
Tim Draper
@TimDraper
Scientists have historically operated in silos.
@Benchling changed that.
When founder @sajithw walked into my office, he caught my attention.
He didn't pitch me on some amazing future. He just laid out how he was going to make it easier for scientists to store, share, and work with their data.
Scientists kept experiments to themselves. Their data got stuck in separate workflows. They rarely connected with other researchers.
The solution was a platform that allows scientists to easily organize and share data.
So far over 200,000+ scientists are working and innovating on the platform.
I invested in Benchling because Sajith had such a clear understanding of his customers and what they neededâŚ
He could improve science through networking.
The greatest companies are founded on the premise that there are simple solutions to complex problems. -
Benchling
@benchling
"Of course, we're talking about #ai," says Benchling CPO @shawnawol. "We're talking about AI across everything we do â but our investments in driving efficiency go well beyond our investments in AI."
BiotechTV
@BiotechTV
đđđ§đđĄđđđĽđ¤ đđđđ: @benchlingâs Chief Product Officer Shawna Wolverton describes whatâs new at Benchling, including empowering users with an antibody discovery solution, automation design, bringing code directly into Benchling, and more. #sponsored
This media couldn't be displayed. See it on the original post. -
Benchling reposted
BiotechTV
@BiotechTV
đđđ§đđĄđđđĽđ¤ đđđđ: @benchlingâs Head of Product - Applications Derek Halliday describes how technology is changing the âDevelopmentâ side of R&D, and how Benchling has helped Merck modernize its bioanalytical systems in this regard. #sponsored
This media couldn't be displayed. See it on the original post. -
Benchling reposted
BiotechTV
@BiotechTV
đđđ§đđĄđđđĽđ¤ đđđđ: Software Engineer Alan Pierce describes @benchlingâs vision of the future of the lab, which includes automatically capturing information while you work. #sponsored
This media couldn't be displayed. See it on the original post. -
Benchling
@benchling
"There's so much opportunity to automate tedious work that gets in the way of doing science," says Benchling CEO @sajithw.
"These #ai agents automate all kinds of busywork, from analyzing data to writing reports. We've released them to customers and seen success already." #benchtalk
BiotechTV
@BiotechTV
đđđ§đđĄđđđĽđ¤ đđđđ: @benchling Co-Founder & CEO @sajithw describes why he believes science and Benchling are entering a new era of speed and cost of R&D.#sponsored
Full video: www.biotechtv.com/post/benchling-benchtalk-2025This media couldn't be displayed. See it on the original post. -
Benchling reposted
BiotechTV
@BiotechTV
đđđ§đđĄđđđĽđ¤ đđđđ: @Dyne_tx's CSO Ron Batra describes the company's FORCE platform, and previews big trial readouts scheduled in DMD and DM1 over the next year. $DYN
Full video: www.biotechtv.com/post/dyne-therapeutics-october-14-2025This media couldn't be displayed. See it on the original post. -
Benchling reposted
BiotechTV
@BiotechTV
đđđ§đđĄđđđĽđ¤ đđđđ: BiotechTV is broadcasting from @benchling's annual Benchtalk event in Boston today. Check out company interviews and product updates throughout the day. #sponsored
This media couldn't be displayed. See it on the original post. -
Benchling
@benchling
⨠Starting today, anyone can explore #benchlingai! Go to benchling.ai to play around with example queries and interactive previews.
See what else we announced at #benchtalk đ www.benchling.com/news/benchling-reveals-the-next-chapter⌠-
Benchling reposted
Vega Shah
@dr_alphalyrae
when two awesome companies join forces
Benchling
@benchling
đ§Ź Weâre teaming up with @NVIDIAHealth to bring #bionemo models directly into #benchlingai.
Scientists will be able to access leading models like OpenFold2 for protein structure prediction â right inside their workflows. www.benchling.com/news/benchling-powers-ai-model-access-f⌠-
Benchling
@benchling
đ§Ź Weâre teaming up with @NVIDIAHealth to bring #bionemo models directly into #benchlingai.
Scientists will be able to access leading models like OpenFold2 for protein structure prediction â right inside their workflows. www.benchling.com/news/benchling-powers-ai-model-access-f⌠-
Benchling
@benchling
With #benchlingai, the latest AI models are right where you work â in the same place youâre designing molecules.
Now with access to:
⨠AlphaFold
⨠Chai-1
⨠Boltz-2
Wanna try it? Itâs free for academics. www.benchling.com/try-ai -
Benchling
@benchling
⨠Turn scattered files, protocols, and handwritten notes into polished notebook entries â all with the Compose Agent in #benchlingai.
Wanna try it? Itâs free for academics. www.benchling.com/try-ai -
Benchling
@benchling
Now with #benchlingai, use our Deep Research Agent to
⨠Analyze internal experimental data and public literature
⨠Get answers to complex scientific questions
⨠Generate detailed reports â in minutes
Wanna try it? Itâs free for academics. www.benchling.com/try-ai -
Benchling reposted
Menlo Ventures
@MenloVentures
Exciting news from @benchling today.
Benchling sees an opportunity to transform biotech by compressing timelines, reducing costs, and helping scientists make better medicines faster. How will this happen? Starting with AI-powered molecular design and AI agents for automation.
Check out this essay from @sajithw to learn more: www.benchling.com/blog/rebuild-biotech-for-the-ai-era
Benchling
@benchling
⨠Introducing Benchling AI â the first command center for scientific #ai. Built-for-science agents, models, and your R&D data, all in one trusted place, so itâs right in your daily workflow.
#benchlingai is available today for all customers and free for academics! www.benchling.com/news/introducing-benchling-ai -
Benchling
@benchling
#ai wonât change science until itâs useful and accessible to scientists in their daily work. Thatâs why we built #benchlingai.
⨠See why weâre making it free for academics. www.benchling.com/blog/ai-for-every-scientist -
Benchling
@benchling
⨠Introducing Benchling AI â the first command center for scientific #ai. Built-for-science agents, models, and your R&D data, all in one trusted place, so itâs right in your daily workflow.
#benchlingai is available today for all customers and free for academics! www.benchling.com/news/introducing-benchling-ai -
Benchling
@benchling
đ§ł Pack your bags. Itâs time for #benchtalk.
Last chance to register: www.benchtalk.benchling.com/boston2025 -
Benchling
@benchling
A milestone for patients and families living with Huntingtonâs disease. Congrats to our longtime customer @uniQure on data bringing real hope â proud to have supported them since the early days.
uniQure
@uniQure_NV
We announced positive topline data from the pivotal study of our #genetherapy AMT-130 for #huntingtonsdisease, which met its primary endpoint, demonstrating a 75 percent slowing of disease progression as measured by cUHDRS compared to an external control. uniqure.gcs-web.com/news-releases/news-release-details/unâŚ
-
Benchling
@benchling
What does it take to turn a PhD thesis into clinical-stage biotech? @DrSynbio sat down with Benchling CEO @sajithw on #transcribed to talk @StrandTx's journey, early trial results, and staying laser-focused on patients.
đď¸ Listen to their conversation: www.benchling.com/transcribed/jake-becraft-mrna-proving-s⌠-
Benchling reposted
Sajith Wickramasekara
@sajithw
Come for @DrSynbio's inspirational journey building @StrandTx. Stay for the fun: sneaking posters into conferences and getting stumped by @geochurch during his thesis defense.
Benchling
@benchling
đď¸@DrSynbio shares the story of @StrandTx's first clinical trial patient â and the moment he heard the initial results.
On #transcribed, he and @sajithw talk about betting early on mRNA, why medicine is the best investment, and what biotech needs to deliver breakthroughs faster.This media couldn't be displayed. See it on the original post. -
Benchling reposted
Jake Becraft
@DrSynbio
Biotech moves too slowly. Patients cannot wait.
On this new podcast, I share how we can speed up discovery and development so cures reach people faster.
Thanks to @sajithw and @benchling for having me on. Listen here.
#biotech #patientsfirst #innovation
Benchling
@benchling
đď¸@DrSynbio shares the story of @StrandTx's first clinical trial patient â and the moment he heard the initial results.
On #transcribed, he and @sajithw talk about betting early on mRNA, why medicine is the best investment, and what biotech needs to deliver breakthroughs faster.This media couldn't be displayed. See it on the original post. -
Benchling
@benchling
⨠Introducing: Compose, our newest #ai agent!
Turn files or notes into experiment entries in seconds. Whether itâs a protocol PDF, a rough outline from a team meeting, or even handwritten notes â Compose drafts it, you review and save.This media couldn't be displayed. See it on the original post. -
Benchling
@benchling
đď¸@DrSynbio shares the story of @StrandTx's first clinical trial patient â and the moment he heard the initial results.
On #transcribed, he and @sajithw talk about betting early on mRNA, why medicine is the best investment, and what biotech needs to deliver breakthroughs faster.This media couldn't be displayed. See it on the original post.
Benchling
@benchling
Watch the full interview: www.benchling.com/transcribed/jake-becraft-mrna-proving-sâŚ
-
Benchling reposted
Josh Wolfe
@wolfejosh
Lux family co @benchling founder CEOđĽ
Sajith Wickramasekara
@sajithw
Long time lurker, breaking a decade of silence to share an essay on what I've learned from scientists about making medicines (spoiler: it's hard) and why the future looks bright (also spoiler: AI) đ§ľ
-
Benchling reposted
Patrick Hsu
@pdhsu
@benchling CEO on rebuilding biotech in the AI era. Worth a read!
Sajith Wickramasekara
@sajithw
Long time lurker, breaking a decade of silence to share an essay on what I've learned from scientists about making medicines (spoiler: it's hard) and why the future looks bright (also spoiler: AI) đ§ľ
-
Benchling reposted
Ravi Gupta
@GuptaRK22
This is Sajiâs first tweet in fifteen years. I think you should read it.
Sajith Wickramasekara
@sajithw
Long time lurker, breaking a decade of silence to share an essay on what I've learned from scientists about making medicines (spoiler: it's hard) and why the future looks bright (also spoiler: AI) đ§ľ
-
Benchling reposted
Sajith Wickramasekara
@sajithw
Long time lurker, breaking a decade of silence to share an essay on what I've learned from scientists about making medicines (spoiler: it's hard) and why the future looks bright (also spoiler: AI) đ§ľ
-
Benchling
@benchling
đ Medicines are humanityâs greatest invention, yet the system for making them is broken. It still takes $2B and 10 yrs to get a drug to market.
Itâs time to rebuild biotech. #ai with the right data infrastructure is how we get there.
www.benchling.com/blog/rebuild-biotech-for-the-ai-era -
Benchling
@benchling
âď¸ Cloud made modern biotech possible â and it's the foundation for what's next. If cloud was the first technological wave for biotech, then #ai is next. We canât wait to help build it. đ
Proud to be on the @Forbes #cloud100. Thanks @NasdaqExchange for helping us celebrate! -
Benchling
@benchling
âď¸ Benchling is on the @Forbes #cloud100 for the 6th year in a row!
Cloud transformed biotech and powered the rise of biologics. Now itâs the foundation for #ai-native science â the future of discovery. We canât wait to help build it. www.forbes.com/lists/cloud100/ -
Benchling
@benchling
đŹReal labs, real results. Find out how scientists at @CortevaUS and @mammothbiosci are already using #benchlingai to cut hours of work down to minutes â getting more time back for science. www.benchling.com/blog/how-benchling-ai-saves-scientists-âŚ
-
Benchling
@benchling
đ What if you could just type: âWrite a report for how we engineered viral vector X, including the objective, methods, and results.â
Get a detailed report tracing experimental lineage â in minutes.
⨠Benchlingâs Deep Research Agent is here. #featurefriday #benchlingai -
Benchling reposted
Harrison Chase
@hwchase17
Deep research for scientists!
Benchling
@benchling
⨠Benchlingâs Deep Research Agent is here!
Find out how scientists are already using it to:
âď¸ Answer complex questions by retrieving and analyzing your data in Benchling
âď¸ Produce comprehensive reports with links to your data
#benchlingaiThis media couldn't be displayed. See it on the original post. -
Benchling reposted
Ari Wagen
@AriWagen
Cool work from @nlarusstone at @benchling!
Benchling
@benchling
⨠Benchlingâs Deep Research Agent is here!
Find out how scientists are already using it to:
âď¸ Answer complex questions by retrieving and analyzing your data in Benchling
âď¸ Produce comprehensive reports with links to your data
#benchlingaiThis media couldn't be displayed. See it on the original post. -
Benchling reposted
Jake Becraft
@DrSynbio
This was an awesome convo with Saji! Covered a lot of ground from early research, to founding stories, and even some bigger picture issues facing research and biomedicine. Canât wait to see the final product out!
Benchling
@benchling
đ Last week, @StrandTx announced a $153M Series B. But back in 2017, @DrSynbio was a young, unconventional founder pitching mRNA tech â years before COVID would make it mainstream.
đď¸ Jake recently joined us on #transcribed. Stay tuned for his episode: www.benchling.com/transcribed -
Benchling reposted
Nicholas Larus-Stone
@nlarusstone
Been working on some fun stuff
Benchling
@benchling
⨠Benchlingâs Deep Research Agent is here!
Find out how scientists are already using it to:
âď¸ Answer complex questions by retrieving and analyzing your data in Benchling
âď¸ Produce comprehensive reports with links to your data
#benchlingaiThis media couldn't be displayed. See it on the original post. -
Benchling
@benchling
⨠Benchlingâs Deep Research Agent is here!
Find out how scientists are already using it to:
âď¸ Answer complex questions by retrieving and analyzing your data in Benchling
âď¸ Produce comprehensive reports with links to your data
#benchlingaiThis media couldn't be displayed. See it on the original post.
Benchling
@benchling
Try it out. www.benchling.com/blog/complex-questions-fast-answers-ben⌠#benchlingai
-
Benchling reposted
Aaron Edwards
@aedwards02
@DrSynbio this resonates. Just a year ago, we were laughed out of rooms for leading with GBM. Now the tide is turning â the field is seeing why itâs the BEST place to showcase our approach at @KiraGenBio and change lives for the better.
Benchling
@benchling
đ Last week, @StrandTx announced a $153M Series B. But back in 2017, @DrSynbio was a young, unconventional founder pitching mRNA tech â years before COVID would make it mainstream.
đď¸ Jake recently joined us on #transcribed. Stay tuned for his episode: www.benchling.com/transcribed -
Benchling reposted
Eric Newcomer
@EricNewcomer
stacked speaker lineup at Deus Ex Medicina.
just announced @munjalshah (@hippocraticai), @DrSynbio (@StrandTx), Sajith Wickramasekara (@benchling), @danielreidcahn (@slingshotai_inc), @pssamant (@akidolabs), @hon_pak (@Samsung), and @RobertCGreen (@Genomes2People)
thrilled to co-host with @nayeema -
Benchling
@benchling
đ Last week, @StrandTx announced a $153M Series B. But back in 2017, @DrSynbio was a young, unconventional founder pitching mRNA tech â years before COVID would make it mainstream.
đď¸ Jake recently joined us on #transcribed. Stay tuned for his episode: www.benchling.com/transcribed -
Benchling
@benchling
đ Say goodbye to copy & paste! Instantly fill table columns by automatically pulling data from other tables â now available in sub-templates, so you can work faster with more consistency.
đ See how this started as a user request in #benchlingcommunity: www.benchling.com/blog/launching-table-mapping-in-sub-tem⌠-
Benchling
@benchling
đ Huge congrats to our friends at @StrandTx! We were thrilled to have cofounder and CEO @DrSynbio join us on #transcribed, to talk about building Strand from the ground up â and the power of founder-led #biotech.
đď¸ A sneak peek drops next week... stay tuned!
Strand Therapeutics
@StrandTx
We just raised $153M Series B to advance the future of programmable mRNA medicinesđˇ
Thank you to our investors fueling the next generation of cell-targeted genetic medicines.
#biotech #mrna #seriesb #synbio #strandtherapeutics
www.forbes.com/sites/amyfeldman/2025/08/07/mit-spinout-st⌠-
Benchling
@benchling
đ ď¸ âYou cannot develop technology in a vacuum.â Karen Akinsanya shares how SchrĂśdinger turned skepticism into billion-dollar partnerships â and how theyâre rewriting the rules of drug discovery.
đ Watch Karenâs conversation with @sajithw: www.benchling.com/transcribed/karen-akinsanya-on-drug-dis⌠#transcribed -
Benchling
@benchling
đ§âđť Less time writing SQL = more time for science.
With our #ai assistant, just use natural language prompts â it generates SQL code to help you create custom dashboards in Benchling.
⨠See what else we're building: www.benchling.com/ai #benchlingassistants #featurefriday -
Benchling
@benchling
đ Our Data Entry Assistant just got two major upgrades.
See how customers like @mammothbiosci are cutting data entry down from hours to just 10 minutes. www.benchling.com/ai #benchlingassistants -
Benchling
@benchling
âď¸đŤ Stop digging through lab notebooks, PDFs, and papers. Benchlingâs Deep Research extracts insights by reasoning across your own experimental data and public literature.
⨠Check out our #ai assistants: www.benchling.com/ai #featurefriday #benchlingassistants -
Benchling
@benchling
đľâđŤ From chaos to clarity â in seconds. Let our #ai assistant convert your messy PDFs, docs, and spreadsheets into clean, structured, analysis-ready data in Benchling.
⨠See what else weâre building: www.benchling.com/ai #featurefriday #benchlingassistants -
Benchling
@benchling
đ From Lipitor to the first FDA-approved CAR T, John Tsai is behind some of the biggest R&D efforts of our time, including as former CMO at Novartis.
On #transcribed, he and @sajithw talk high-stakes trials, bold bets, and the road to blockbuster drugs. www.benchling.com/transcribed/john-tsai-clinical-developm⌠-
Benchling
@benchling
đ¨ Manual errors slow science down. Benchlingâs Notebook Check is here to help:
â Catch typos, like copy-paste errors
â Flag missing samples
â Customize checks for formatting and naming conventions
Check out our #ai assistants: www.benchling.com/ai #featurefriday -
Benchling
@benchling
From being told to âbe more aggressiveâ, to leading R&D at @AlectorTx, @skenkaremitra shares what it was like to rise in #biotech, sometimes as the only woman in the room. Her advice? Authenticity always wins.
đď¸ Watch the full interview: www.benchling.com/transcribed/sara-kenkare-mitra-saving-d⌠#transcribed -
Benchling
@benchling
đď¸ âThis is an industry of guts. You have to take risks with the conviction that even if you fail, you'll get up and find a way forward,â says @skenkaremitra.
After bringing 15 drugs to market, Sara reflects on what it takes to keep moving: www.benchling.com/transcribed/sara-kenkare-mitra-saving-d⌠#transcribed -
Benchling
@benchling
⨠Bring joy back to science with #ai. See what weâre building to automate busywork and deliver in silico insights to every scientist:
đŞ Data entry assistant
đŞ Deep research
đŞ Notebook check
đŞ SQL assistant
đŞ Guided search & more
www.benchling.com/ai -
Benchling
@benchling
𤚠Juggling a lot these days? Custom Studies help you connect the dots:
đ Auto-link notebook entries, containers, entities & more
đ See all related data in one place
đ Control access with project-level permissions
See what else is new: www.benchling.com/whats-new #featurefriday -
Benchling
@benchling
đ Our Data Entry Assistant just leveled up. Now itâs faster, smarter, and easier to use. Watch your messy CRO files and spreadsheets turn into clean structured data â now in seconds. www.benchling.com/ai #benchlingassistants #poweredbyai
-
Benchling
@benchling
đ Orderâs up! Now admins can enable a request portal where your users submit requests, track status, and access outputs.
đ Find out how to manage requests for Workflows users at scale â and what else is new: www.benchling.com/whats-new #featurefriday -
Benchling
@benchling
Meet @skenkaremitra: She rescued Genentechâs first antibody-drug conjugate. Management nearly shut the program down, but Sara asked for 6 months more â and made it count. Today, it's a blockbuster drug. đ
đď¸ Watch #transcribed for her chat with @sajithw: www.benchling.com/transcribed/sara-kenkare-mitra-saving-d⌠-
Benchling
@benchling
đ Get ready for #benchtalk 2025 â where our global community of R&D scientists and technology leaders come together for:
đď¸ 30+ expert-led sessions
đť Hands-on workshops
đ¤ Hundreds of Benchling users â all in one place
Register now: www.benchtalk.benchling.com/event/boston2025/home -
Benchling
@benchling
đ Process development â faster. Whether youâre running 12 or 24 bioreactors in parallel, you deserve software thatâs built for the way you work.
Run your multi-condition experiments together, and capture all the data in a single worksheet. đ www.benchling.com/whats-new #featurefriday -
Benchling
@benchling
What does it take to speed up vaccine development in todayâs world? đâĄď¸
For @Merck and Benchling, it meant rethinking one of the most critical but overlooked parts of R&D: bioanalysis. www.benchling.com/news/benchling-collaboration-with-merck⌠#builtonbenchling -
Benchling
@benchling
In #biotech, your data is your competitive edge â but what if that mentality is holding everyone back? @pdhsu argues that the future of #ai in biology will require a culture shift from competition to collaboration.
đ Watch the interview: www.benchling.com/transcribed/patrick-hsu-on-crispr-ai-op⌠#transcribed -
Benchling
@benchling
Templates should bring clarity â not confusion. Thatâs why weâre excited to share template versioning!
Now you can:
â¨Work privately on template drafts
⨠Add context with version descriptions
⨠Clearly mark status: Draft, Effective, Superseded, Withdrawn
#featurefriday -
Benchling
@benchling
đ§âđŹ At age 14, @pdhsu cold-emailed 50 professors asking to join a lab. One said yes. Now heâs a #crispr pioneer, cofounder of @arcinstitute, and builder of large-scale #ai models for biology.
His story is a reminder: follow the fun, bet on impact, and share what you learn. www.benchling.com/transcribed/patrick-hsu-on-crispr-ai-op⌠#transcribed -
Benchling reposted
Neville Sanjana
@nevillesanjana
"The lab was a team [...] it was pretty special"
Great interview with @pdhsu where he shares the gems on science and leadership that we were lucky to learn in @zhangf lab. And insights into AI and its current + future impact in bio.
đŻ% recommend this interview.
Benchling
@benchling
đĽ When @pdhsu first spoke about #crispr at Harvard, the room was so packed they called the fire marshal. He knew then: this was big. Now, he's betting big on #ai and open science at @arcinstitute.
đď¸ Watch #transcribed for his chat with @sajithw: www.benchling.com/transcribed/patrick-hsu-on-crispr-ai-op⌠-
Benchling
@benchling
đĽ When @pdhsu first spoke about #crispr at Harvard, the room was so packed they called the fire marshal. He knew then: this was big. Now, he's betting big on #ai and open science at @arcinstitute.
đď¸ Watch #transcribed for his chat with @sajithw: www.benchling.com/transcribed/patrick-hsu-on-crispr-ai-op⌠-
Benchling
@benchling
At Benchling, weâve spent 13 years building software to support the scientists behind biotechâs biggest breakthroughs. Now, weâre telling their stories.
đď¸Today, weâre launching #transcribed, a new series from Benchling CEO @sajithw featuring biotechâs boldest thinkers. -
Benchling
@benchling
đŠ Got a lot on your plate⌠literally?
Donât worry, weâve got you covered with a new feature: plate designs! Create reusable plate designs to stay organized and design your experiments in a snap. www.benchling.com/whats-new #featurefriday #dadjokes -
Benchling
@benchling
đĽ Go big or go home â 1000-row tables are here! Add rows with one click and stay organized with sticky headers and footers that scroll with you.
Big ideas deserve bigger tables. #featurefriday -
Benchling
@benchling
âWe work hard to make sure weâre applying #ai in situations where itâs truly useful, not just building AI for the sake of it being AI.â
đ Get an inside look at how @alangpierce and team are building #ai agents for scientists. builtin.com/articles/benchling-ai-powered-solutions-drive⌠#teamscience -
Benchling
@benchling
.@MacroGenics is speeding up development of #antibody-based cancer therapeutics.
Their strategy? A unified digital platform that standardizes data capture, delivers faster insights, and supports complex process development workflows. www.benchling.com/customer-stories/macrogenics-macrogenic⌠#builtonbenchling -
Benchling
@benchling
⨠Itâs easy as 1-2-3! Automatically capture instrument data and analyze it in just 3 clicks.
1ď¸âŁ Retrieve data from connected instruments
2ď¸âŁ Choose output files for processing
3ď¸âŁ Process data using an analysis template
And thatâs it! Scroll down to see all the charts appear in your notebook. đŞ #featurefriday -
Benchling
@benchling
đĄ What does it take to raise early-stage capital in todayâs cautious market? #biotech founders @tombergk @Menon_Ashwin lay it out.
Spoiler: Itâs not just about great science â itâs about simplicity, resilience, and #ai strategy. www.benchling.com/blog/5-fundraising-tips-for-biotech #buildyourbench -
Benchling
@benchling
#biopharma is facing a major AI talent shortage, with just 17% of small companies ready to attract skilled professionals. What else is holding the industry back?
đ Get the report: www.benchling.com/state-of-tech -
Benchling
@benchling
.@moderna_tx is setting the new standard for #ai-driven research, as they ready their scientists with a unified R&D digital platform powered by Benchling.
Today we announce our collaboration with Moderna. www.benchling.com/news/benchling-and-moderna-collaborate-⌠#builtonbenchling -
Benchling
@benchling
"All these companies are building agents on AWS â like Benchling."
Excited to be spotlighted by @awscloud, among companies using #ai to transform the pharmaceutical value chain. See how weâre building our AI agents with @Anthropic in Amazon Bedrock: www.anthropic.com/customers/benchling -
Benchling
@benchling
See how weâre building with @AnthropicAI's Claude to set the new standard of #ai in science: www.anthropic.com/customers/benchling
Weâve launched three AI assistants so far â each tackling a key challenge in R&D. And weâre just getting started. -
Benchling
@benchling
"AI will transform the biotech industry. But today, only a handful of R&D teams are at the frontier,â says Benchling cofounder @daashu. That's why we're proud to be building with @AnthropicAI, bringing #ai to more scientists. www.fastcompany.com/91328039/anthropic-hires-a-top-biden-âŚ
-
Benchling
@benchling
.@orchard_tx is redefining whatâs possible in HSC gene therapy â starting with how they manage their data.
See how theyâve transitioned from paper-based workflows to a unified, automated platform. The result? Improved data access, fewer errors, and faster breakthroughs. www.benchling.com/customer-stories/orchard-therapeutics-m⌠#builtonbenchling -
Benchling
@benchling
What if you could use all your experimental data AND the world's scientific literature to answer questions in seconds?
Here's an early look at our Deep Research agent â an #ai agent that searches and reasons across both your private data and public data sources. www.benchling.com/blog/deep-research
đ Join the waitlist to become an early tester: www.benchling.com/deep-research-waitlist -
Benchling
@benchling
Heartfelt words from Nobel laureate Ardem Patapoutian: www.cnn.com/2025/04/09/health/nobel-laureate-research-funâŚ
Benchling will always be on #teamscience. đ -
Benchling
@benchling
At @DTUBiosustain, sustainability isnât just a buzzword â itâs a mission. For #earthday, see how theyâre using #ai to power protein engineering, and produce biochemicals, natural products & microbial foods in a more sustainable way. đđ§Ş www.benchling.com/customer-stories/dtu-biosustain-how-dtu⌠#builtonbenchling
-
Benchling
@benchling
𼲠You know what makes us teary-eyed? Really pretty, intuitive UIs. (Also sports movies.)
Compose complex polymer structures more accurately, using our interactive drag-and-drop canvas for oligo duplexes and conjugates. #featurefriday -
Benchling
@benchling
đŤ Weâve all been there. No one likes manually entering data from PDFs and spreadsheets. Thatâs why we built an #ai-powered tool to do it for you.
Just upload the file and get your data in Benchling. That's it.
đ Sign up for the waitlist: www.benchling.com/data-entry-assistant-waitlist #featurefriday -
Benchling
@benchling
đĄ You know what makes us happy? Bringing Benchling usersâ feature requests to life!
Check out three new Notebook features â including ones that started as product ideas from our online #community. www.benchling.com/blog/3-new-benchling-notebook-features-⌠-
Benchling
@benchling
đĽ Drop it like itâs hot. Drag and drop columns in the Benchling Notebook to reorder them in a snap!
And... did you know this fan favorite originated as a Benchling #community feature request? www.benchling.com/blog/3-new-benchling-notebook-features-⌠#featurefriday -
Benchling
@benchling
đĄ Most execs talk about #ai. Our co-founder dropped everything to build it. Since January, @daashu has been back to building full-time, focused on one mission: bringing practical AI to the lab.
Today, weâre launching our Data Entry Assistant, now in beta! Our latest #ai-powered tool captures data from messy formats (like PDFs or spreadsheets), and converts it into structured data in Benchling. www.benchling.com/blog/ai-agents-for-scientists -
Benchling
@benchling
We get it. It's not uncommon for R&D teams to use dozens of software apps â but that doesnât mean it has to be difficult to build a connected R&D ecosystem.
Check out some of our integrations for 3rd party apps, so you can easily move your data back and forth. #featurefriday -
Benchling
@benchling
Mark your calendars â #benchtalk is back! Join our global community of R&D scientists and leaders for two non-stop days of learning and fun:
đ Boston: October 14-15
đ London: October 22-23
Save your spot: benchling.com/benchtalk -
Benchling
@benchling
đ Nothing makes us happier than shouting about the amazing work our customers are doing. #teamscience
đş Watch the full @BBCNews interview: www.benchling.com/news/opportunity-with-science-and-softw⌠-
Benchling
@benchling
Did you know that you can create custom interactive user interfaces within Benchling? đ
Hereâs an example of a custom UI that helps the user search for chemicals in PubChem, and then allows them to view and register in Benchling. #featurefriday -
Benchling
@benchling
đŽ 2025 is going to be a big year for #biotech. On @BBCNews, our CEO @sajithw explains why the industry is on the cusp of a faster, more automated, and #ai-driven future.
đş Watch the full interview: www.benchling.com/news/opportunity-with-science-and-softw⌠-
Benchling
@benchling
âThanks to #ai-ready data and integrated systems, we can apply machine learning techniques to our work today.â See how adopting a centralized, unified system sets @novonesis up to work at speed and scale: www.benchling.com/customer-stories/novonesis-how-1-500-no⌠#builtonbenchling
-
Benchling
@benchling
What core capabilities do you need to successfully use #ai â and how do you stack up against the industry?
đ Get the report: www.benchling.com/state-of-tech -
Benchling
@benchling
đ¤ @BBCNews wants to know: How will #ai transform biopharma? Our CEO @sajithw separates the hype from the reality.
đş Watch the full interview: www.benchling.com/news/opportunity-with-science-and-softw⌠-
Benchling reposted
Jonathan Sebat
@sebatlab
Thank you for coming to my poster #standupforscience
-
Benchling reposted
Dr. Bri is on Bluesky đŠđžâđŹđ§
@BrielleRyan
Great turnout in Boston, come join us!!!
#standupforscience #standupforscienceboston -
Benchling reposted
Margot Brunet
@Margot_Brunet_
A Jussieu, des centaines de scientifiques manifestent pour #standupforscience
VidĂŠo Ă voir bientĂ´t sur @grand_labo -
Benchling reposted
Dr. Theresa Desrochers
@DesrochersLab
Stand Up For Science DC #standupforscience
Science will not be silenced -
Benchling
@benchling
đ§Ş Science. Like magic. But real.
âď¸ Just one of our favorite slogans seen at today's rallies. From DC to NYC, Boston, Philly, and even in Paris, it's been heartwarming to see the photos and support streaming in. www.nature.com/articles/d41586-025-00704-0
Let's #standupforscience. #teamscience -
Benchling
@benchling
You asked, we delivered. Now you can annotate images to your heartâs content. đ
Add text, arrows, and circles to your images in Benchling, using a simple drag-and-drop tool. Mark it up! #featurefriday -
Benchling
@benchling
đŹđ§ Seen on @BBCNews! Benchling CEO @sajithw talks through global competition, the rise of Chinese R&D, and what that means for #biopharma.
đş Watch the full interview: www.benchling.com/news/opportunity-with-science-and-softw⌠-
Benchling
@benchling
"If #ai is not applied at all stages of the drug development cycle, many promising treatments are at high risk of never reaching patients.â Benchling CEO @sajithw explains why AI-driven drug discovery won't be enough â we need to ramp up the entire R&D system.
Forbes France
@forbes_fr
Lâintelligence artificielle (IA) est en train de rĂŠvolutionner la dĂŠcouverte de mĂŠdicaments, attirant des milliards de dollars dâinvestissements.
đ www.forbes.fr/science/biopharmas-biotechs-des-milliards-d⌠-
Benchling
@benchling
See how 1,500 @novonesis employees around the world are using Benchling to power discovery, development, and testing for its R&D operations. www.benchling.com/customer-stories/novonesis-how-1-500-no⌠#builtonbenchling
This media couldn't be displayed. See it on the original post. -
Benchling
@benchling
Managing over 165k cloud resources across hundreds of workspaces could seem daunting. But for us, itâs just another day at Benchling. Hereâs how we do it.
benchling.engineering/how-we-run-terraform-at-scale-da7bb⌠-
Benchling
@benchling
⨠Sometimes itâs the simple pleasures. â¨
Turn your table columns into single input fields â so you can automatically apply the same value across all your rows. #featurefriday -
Benchling
@benchling
âI think there's huge opportunity, not just to 10x the number of medicines that we get to market," said @sajithw on @BBCNews, "but to make every step of getting them through the process of drug research and development way faster, way more automated, and take fewer people."
Benchling
@benchling
On @BBCNews, Benchling CEO @sajithw talks about #biotechâs productivity challenges, the industryâs changing global landscape, and how technology like #ai will fuel innovation.
This media couldn't be displayed. See it on the original post. -
Benchling
@benchling
On @BBCNews, Benchling CEO @sajithw talks about #biotechâs productivity challenges, the industryâs changing global landscape, and how technology like #ai will fuel innovation.
This media couldn't be displayed. See it on the original post. -
Benchling
@benchling
Your notebook just got prettier.
Annotate your images with text, arrows, and circles â using a simple drag-and-drop tool. Ready, get set, annotate! âď¸
#featurefriday -
Benchling
@benchling
âA lot of the current problems with viral vectors used in gene therapy can be traced back to manufacturing problems.â
See how Fuse Vectors is revolutionizing gene therapy with their cell-free viral vector technology. www.benchling.com/customer-stories/fuse-vectors-revolutio⌠#builtonbenchling -
Benchling
@benchling
đŠđżâđŹđŠđťâđŹđŠđ˝âđŹđŠđźâđŹ Happy International Day of Women & Girls in Science! We're celebrating by elevating the voices of #womeninscience â find out how to win a 1-year Audible subscription, or a #benchlingbookclub pick. đđ§
đ Enter now: www.benchling.com/subscribe #womeninstem -
Benchling
@benchling
Only 23% of small #biopharma have adopted #ai. Why is that? While some companies started with an AI-driven strategy, many more would need significant retooling â and they're uncertain about ROI.
đ See what theyâre prioritizing instead. Get the report: www.benchling.com/state-of-tech -
Benchling reposted
Jahnavi Krishnan @JahnaviK07
live editing on @benchling is honestly the best feature I've come across in a while
-
Benchling
@benchling
How are the most cutting-edge #immunotherapy companies using Benchling to scale up?
đ See how @UmojaBiopharma sped up IND filings and audits, with a centralized system of record for their R&D data: www.benchling.com/customer-stories/umoja-biopharma-transf⌠#builtonbenchling -
Benchling
@benchling
đ New year, new features! Check out our latest product capabilities:
⨠Create dashboards using an #ai-powered assistant to generate, modify, or debug #sql queries
⨠Publish templates for your users, with full version history
⨠Save time with enhanced table features
⨠And more!
See what else is new: www.benchling.com/whats-new -
Benchling
@benchling
What's the secret to achieving end-to-end #automation? Get tips from an engineer at @CellinoBio, where theyâre building a scalable biomanufacturing platform for personalized cell therapies. www.benchling.com/blog/cellino-how-to-achieve-lab-automation
Want to chat more? If youâre at #slas2025, drop by booth #1243! -
Benchling
@benchling
Why this new wave of #ai in drug development different from before? Itâs not just about moving faster â itâs about using AI/ML to develop drugs that are inaccessible to older technologies, or address unmet needs in new ways.
Thanks @MarkDePristo @TClozel @hardsphere @ThomasFuchsAI Karen Akinsanya, Felix Wong, and Robert Marino for your insights! -
Benchling
@benchling
It's been a busy year! In 2024, we launched hundreds of new capabilities:
⨠Benchling Analysis, a no-code solution that can automate data insights
⨠#ai-powered productivity tools
⨠Specialized capabilities for scientists across discovery, in vivo, and development
⨠And much more...
www.benchling.com/blog/2024-year-in-review -
Benchling
@benchling
đŞ Introducing our new Insights SQL assistant! This #ai-powered tool generates SQL code to help you create custom Insights dashboards in Benchling.
Simply use natural language prompts to:
âď¸ Create new SQL queries
âď¸ Modify existing SQL queries
âď¸ Debug and fix errors
Get the details: www.benchling.com/blog/boost-dashboard-creation-with-insi⌠-
Benchling
@benchling
Whatâs our biggest prediction for 2025? Itâs about #ai readiness, not hype. In @pharmaphorum, see why we think it going to be a pivotal year for scaling AI across #biopharma. pharmaphorum.com/digital/biopharmas-ai-rally-readiness-noâŚ
-
Benchling
@benchling
Spotted in SF for #jpm25! Find our billboard on your way to and from the airport.
Weâre proud to support the companies making breakthroughs â and building their next blockbusters â on Benchling. #builtonbenchling -
Benchling
@benchling
Why are large and small #biopharma investing in different technologies â and how will this change in the coming year?
đ Get the report: www.benchling.com/state-of-tech -
Benchling
@benchling
How do you build an #llm-powered Slackbot? Learn how Benchling uses #ai to power an internal knowledge base that can answer common developer questions via a familiar Slack interface. benchling.engineering/building-an-llm-powered-slackbot-55âŚ
-
Benchling
@benchling
"We can use structured data to train the #ai algorithms, primarily on optimizing the food we feed to the cells." See how @hoxtonfarms is cultivating sustainable fats at scale â and why Benchling is embedded in everything they do: diginomica.com/tackling-worlds-food-scarcity-and-insecuri⌠#builtonbenchling
-
Benchling
@benchling
.@UmojaBiopharma is at the forefront of cancer immunotherapies. See how theyâre using Benchling to bring promising candidates to the clinic faster: www.benchling.com/customer-stories/umoja-biopharma-transf⌠#builtonbenchling
-
Benchling reposted
a16z Bio + Health
@a16zBioHealth
The 21st century is often called the century of biology, and @benchling is helping to realize that vision. Co-founder Saji Wickramasekara reflects on the company's evolution from a simple ideaâbetter tools for scientistsâto a platform serving over 200,000 researchers across 1,200 organizations globally.
Recently, Saji joined a16z partners @JorgeCondeBio and @JayRughani to discuss Benchling's evolution from idea to a transformative platform, reshaping life sciences through modern software and data-driven innovation.
Watch on Raising Health: youtu.be/gXWdWUvDECA -
Benchling
@benchling
How is @arbortx accelerating development of curative genomic medicines?
đ See why a centralized data foundation for next-generation sequencing is such a game changer. www.benchling.com/customer-stories/arbor-biotech-creating⌠#builtonbenchling -
Benchling
@benchling
Exciting to see our friends at @UmojaBiopharma on @BiotechTVHQ!
BiotechTV
@BiotechTV
đ đŤđ¨đŚ đđđđđđĽđ: @UmojaBiopharma is a pioneer of in vivo CAR-T cell engineering. CEO @andyscharenberg describes the technical innovations they have come up with to help make it succeed.
Full video: www.biotechtv.com/post/umoja-biopharma-december-11-2024This media couldn't be displayed. See it on the original post. -
Benchling
@benchling
It all starts with your data. See how @hoxtonfarms streamlined data capture & analysis to accelerate their #bioprocessing and improve their #ml models.
Weâre proud to support their mission, as they develop better, more sustainable fats! www.benchling.com/customer-stories/hoxton-farms-creating-⌠#builtonbenchling -
Benchling
@benchling
Most #biopharma report gaps in #ai readiness â even at the foundational level. Why?
đ Download the report: www.benchling.com/state-of-tech -
Benchling
@benchling
Results are in: the biggest gap with AI readiness for large biopharma is a unified wet and dry lab, with just 41% citing preparedness.The industry may agree that #ai will transform R&D, but they're still grappling with how to get there.
đ Get the data and hear their tech strategies. www.benchling.com/state-of-tech -
Benchling
@benchling
How do you move drug candidates through the pipeline faster? @sniprbiome is pioneering discovery and development of #crispr-based microbiome drugs â with all their R&D data on Benchling.
See how theyâre accelerating time to milestone: www.benchling.com/customer-stories/snipr-biome-pioneering⌠#builtonbenchling -
Benchling
@benchling
I got 96 problems, but a map ainât one. Plate maps are here!
đ Find out how to visualize and annotate wells in Benchling, using an easy, intuitive interface: help.benchling.com/hc/en-us/articles/30627806994061-Getti⌠#featurefriday -
Benchling
@benchling
Discover how @BioConstructiv is pioneering next-generation therapeutics. Using synthetic genomes and non-canonical amino acids, they can enhance drug properties â much like how Ozempicâs semaglutide uses a ncAA to â drug stability. www.benchling.com/blog/constructive-bio-building-beyond-n⌠#builtonbenchling
-
Benchling
@benchling
As a #biopharma, which technology would you invest in first?
-
Benchling
@benchling
Large #biopharma is adopting #ai/#ml at nearly 3x the rate of small biopharma â but smaller companies are investing in other technologies instead.
Find out how their tech strategies differ, and why: www.benchling.com/state-of-tech -
Benchling
@benchling
67% of large #biopharma companies have already adopted #ai â nearly 3x more than small companies. We asked hundreds of industry leaders about their tech strategy â and where theyâre lagging, when it comes to AI readiness.
Find out what we learned: www.benchling.com/blog/2024-state-of-tech-report -
Benchling
@benchling
Congrats to our #changemaker Award winners, announced at #benchtalk London!
đ Benchling Champions: Anne-Francoise Rorive at @Sanofi and Stefani Giacopazzi at @scDiscoveries
đ¤ AI/ML Pioneer: @cambrium_bio
đ¤ Human Impact Award: @orchard_tx
đ Changemakers of the Year: @novonesis
đŹ Top Community Contributor: Beata Dunne at @labgeni_us
Learn about our Changemakers: www.benchling.com/blog/changemaker-awards-london-2024 -
Benchling reposted
matthew_aujla
@matthew_aujla
Sajith Wickramasekara @benchling unpacks the evolution of Benchling from idea to transformative software platform. Saji discusses his journey from software engineer to building Benchling and digitizing biotech workflows for industry giants like Sanofi
open.spotify.com/episode/1mToTelvVxGzU8H9MhGTtz?t=1580 -
Benchling
@benchling
Whatâs the secret to better collaboration, faster decisions, and quicker IND filings? See how @UmojaBiopharma is speeding up delivery of next-generation cancer immunotherapies with Benchling. www.benchling.com/customer-stories/umoja-biopharma-transf⌠#builtonbenchling
-
Benchling reposted
Jay Rughani
@JayRughani
Benchling is a masterclass for any entrepreneur building software for complex industries (life sciences, healthcare, financial services, etc.). On our latest pod, Founder/CEO @sajithw shares how they grew from a free application for scientists in academic research labs to an enterprise workflow platform relied on by 200,000+ users across 1,200+ companies globally.
Saji joins @JorgeCondeBio & me to highlight how @benchling is empowering the life sciences industry with modern data infrastructure and AI tools, while revealing some lessons-learned from scaling the company from $0 to $200M+ in annualized revenue:
âśď¸ [1:35] Why biology offers solutions to humanityâs greatest challenges đ§Ź
âśď¸ [3:29] The âmovie trailerâ for Benchling Part I đŹ
âśď¸ [8:08] The AI opportunity in the life sciences, and biggest gap in the industry today đ¤
âśď¸ [13:10] Finding their first 100 daily active users đŠđ˝âđŹ
âśď¸ [15:29] Signing their first enterprise customer đŤąđźâđŤ˛đž
âśď¸ [18:58] Going from $0 to $1M ARR, then from $1M to $10M ARR đ
âśď¸ [20:25] Scaling from $10M to $100M+ ARR, and the challenges of âgrowing upâ đ
âśď¸ [24:52] Benchling Part II đŹâŚ
@a16z @a16zBioHealth -
Benchling reposted
a16z Bio + Health
@a16zBioHealth
What does it mean for the 21st century to be the âcentury of biologyâ? đ
In a recent conversation, @benchling's CEO and Co-founder, Sajith Wickramasekara, joins a16zâs @JorgeCondeBio and @JayRughani to explore how biotech is set to tackle humanityâs biggest challengesâand why data organization is crucial.
đđź Biotech companies are producing massive amounts of complex data, but much of it remains âdarkâ and underutilized.
đđź Structured data is essential to enable AI-driven insights and speed up drug discovery and development.
đđź Platforms like Benchling are helping scientists digitize workflows, bringing transformative therapies to market faster.
Listen on Raising Health: a16z.com/podcast/mastering-data-with-sajith-wickramasekara/ -
Benchling
@benchling
âI think the life science industry has got to get its data organized,â says Benchling CEO @sajithw. âBiotech companies are generating extremely high volume, multidimensional data â itâs not just a scale problem, itâs a complexity problem.â
Saji joined @a16zBioHealth's @JorgeCondeBio @JayRughani to talk about the increasing complexity of biology â and the powerful opportunity that comes with structured data. a16z.com/podcast/mastering-data-with-sajith-wickramasekara/ -
Benchling
@benchling
Congratulations to our #changemaker Award winners, announced at #benchtalk!
đ Benchling Champions: @SamivelEvans at @AeraTx & Peter Hillier at @EliLillyandCo
đ¤ AI/ML Pioneer: @ShapeTx
đ¤ Human Impact Award: @UmojaBiopharma
đŹ Top Community Contributor: Ken Robbins at Go2Software
Learn about our Changemakers: www.benchling.com/blog/changemaker-awards-boston-2024 -
Benchling
@benchling
How are the most cutting-edge #geneediting companies using Benchling to scale up?
đ See how @arbortx increased R&D throughput, accelerating development of next-generation genomic medicines. www.benchling.com/customer-stories/arbor-biotech-creating⌠#builtonbenchling -
Benchling reposted
Asimov Press
@AsimovPress
The first "modern" micropipette was made by a German postdoc, named Heinrich Schnitger, in just 2 days in 1957.
Schnitger's pipette had a spring-loaded piston, a second spring to dispense residual liquid, and a plastic tip. Eppendorf quickly licensed his invention.
Read more đť -
Benchling
@benchling
đ No tricks, just treats! Check out some of our new product capabilities added this month:
⨠Automate your data analysis & visualization with reusable templates
⨠Visualize & annotate plates in Benchling
⨠Find potential errors in notebook entries using our AI-assisted tool
⨠Design thousands of constructs at a time w/ high-throughput plasmid assembly
See what else is new: www.benchling.com/whats-new -
Benchling
@benchling
âWhen data is generated, there is a current value and a potential value.â
Explore how industry leaders are using #datascience to drive new efficiencies in process development. www.benchling.com/blog/keys-to-successful-process-develop⌠-
Benchling
@benchling
At @sanofi, a strong digital foundation is the first step towards #ai-driven R&D. Hear directly from their #datascience team to find out why a digital data platform is essential for delivering on #ml insights. www.benchling.com/customer-stories/benchling-builds-digit⌠#poweredbyai #builtonbenchling
-
Benchling
@benchling
đ Itâs a wrap! At #benchtalk, we announced some of this year's most anticipated updates, including new functionalities for #ai, analysis, and more.
Get the recap â and see you next year! đ www.benchling.com/blog/benchtalk-2024-highlights -
Benchling
@benchling
Itâs Times Square official! This week, we announced our acquisition of @pipe_bio. đ
Together, we will offer a complete software stack for end-to-end antibody discovery and development. www.benchling.com/blog/pipebio-joins-benchling
Thanks @Nasdaq for helping us celebrate! -
Benchling reposted
Christopher Frank @chrisfrank662
Finally, out in @ScienceMagazine today, our work on de novo protein design. Together with @HattoriLab , @sokrypton & @hendrik_dietz we showed how we can drastically improve AF2 based hallucination, surpassing, or reaching SOTA diffusion models
doi.org/10.1126/science.adq1741 -
Benchling
@benchling
We're kicking off #benchtalk London đŹđ§ in style! Over 200 R&D scientists & IT leaders gathered to dive into today's biggest biotech trends, from #automation to AI/ML.
Thanks everyone for bringing your insights and energy to our global community! đđ -
Benchling
@benchling
What sets @Terray_Tx apart? Their hardware innovation. With the ability to screen 32M molecules on a single microarray chip, their experimental dataset for training #ai models is now 50x larger than publicly available data. endpts.com/terray-therapeutics-raises-120m-series-b-for-i⌠#poweredbyai #builtonbenchling
-
Benchling reposted
Malay Gandhi @malaygandhi
Excited to welcome @jannickbendtsen, @obodley, and the entire @pipe_bio team to Benchling and to work together on the future of computationally-driven biologics discovery.
Benchling
@benchling
đ Weâre excited to share that Benchling has acquired @pipe_bio! This expands our capabilities in #biologics to accelerate #ai and computational science in antibody discovery.
Letâs shape the future of biologics, together. www.benchling.com/blog/pipebio-joins-benchling -
Benchling reposted
PipeBio (now Benchling) @pipe_bio
đ Weâre excited to announce that @benchling has acquired PipeBio!
Together with Benchling, weâll continue delivering innovation in bioinformatics for biologics discovery and more â on an open digital platform thatâs connected to the rest of your R&D.
pipebio.com/blog/pipebio-joins-benchling -
Benchling
@benchling
đ Weâre excited to share that Benchling has acquired @pipe_bio! This expands our capabilities in #biologics to accelerate #ai and computational science in antibody discovery.
Letâs shape the future of biologics, together. www.benchling.com/blog/pipebio-joins-benchling -
Benchling
@benchling
You asked, we delivered.
âŞâŞâŞâŞâŞâŞâŞâŞâŞâŞâŞâŞ
âŞâŞâŞ PLATE MAPS âŞâŞâŞ
âŞâŞâŞâŞâŞâŞâŞâŞâŞâŞâŞâŞ
âŞâŞâŞâŞ ARE âŞâŞâŞâŞâŞ
âŞâŞâŞâŞâŞâŞâŞâŞâŞâŞâŞâŞ
âŞâŞâŞâŞ HERE ! âŞâŞâŞâŞâŞ
âŞâŞâŞâŞâŞâŞâŞâŞâŞâŞâŞâŞ
âŞâŞâŞâŞâŞâŞâŞâŞâŞâŞâŞâŞ
Now you can visualize and annotate plates directly in Benchling â all while capturing metadata for analysis. help.benchling.com/hc/en-us/articles/30627806994061-Getti⌠#featurefriday -
Benchling reposted
SynBioBeta
@SynBioBeta
@Novonesis integrates @Benchling to automate R&D, ensuring faster, smarter biosolutions for industries from food to carbon capture.
#biosolutions #rdcollaboration #biotechinnovation #lifesciences
www.synbiobeta.com/read/novonesis-teams-up-with-benchling⌠-
Benchling
@benchling
What makes a strong leader? For industry icon @mmammen, itâs the confidence to stick to your convictions, even when they're contrarian.
At #benchtalk, the FogPharma CEO shared lessons from his own career, including the importance of curiosity. Thanks Mathai for your insights! -
Benchling
@benchling
New product capabilities announced at #benchtalk!
⨠Automated data analysis capabilities, including regression and interpolation statistics
⨠#ai-powered tools to boost productivity (and reduce mistakes)
www.benchling.com/whats-new -
Benchling
@benchling
Following the merger of Novozymes & Chr. Hansen to form @novonesis, a unified data model is more important than ever.
"Weâre able to automate key aspects of R&D and create a unified foundation for advanced data tooling." www.benchling.com/news/novonesis-and-benchling-long-term-⌠#builtonbenchling -
Benchling
@benchling
Global biosolutions leader @novonesis is building the foundation for a new era of smarter, faster, and more connected R&D â with Benchling as their digital R&D platform.
We're proud to support their mission. www.benchling.com/news/novonesis-and-benchling-long-term-⌠#builtonbenchling -
Benchling reposted
Randall Wilson @RW2Designs
Thought I'd share my latest commissioned piece for @benchling - a double helix build for their Benchtalk conference in Boston, this one was daunting but I got it to go! đĽ
-
Benchling reposted
Neil C. Hughes
@NeilCHughes
In this episode of The Tech Talks Daily Podcast, we explore the intersection of AI and cloud technology in the biotech industry with Stephen Deasy, CTO of @Benchling.
techblogwriter.co.uk/stephen-deasy-cto-of-benchling/ -
Benchling
@benchling
How are todayâs biotechs bridging the gap between wet & dry labs? And what else do they need to leverage #ai/#ml? These were the biggest topics at #benchtalk 2024.
To all the scientists & R&D IT leaders who joined the conversation â thanks for making it our best Benchtalk yet! -
Benchling reposted
Aera Therapeutics @AeraTx
It was a pleasure to be @ Benchtalk 2024 this week where our own Samivel Evans received the inaugural @benchling Champion award. Additional thanks to @bradloncar & @BiotechTVHQ for a great discussion w/ our VP, Computation and Lab Technology, Bob Gantzer.
www.biotechtv.com/post/bob-gantzer-ocotober-1-2024 -
Benchling reposted
Dyno Therapeutics, Inc.
@Dyno_Tx
Tune into @biotechtv at #benchtalk to hear Dynoâs Head of Gene Therapy Adrian Veres and Head of Stewardship Tyson Bertmaring discuss how Dyno solves the gene delivery challenge for our partners through our partner-centric business model and AI-driven capsid design expertise!
BiotechTV
@BiotechTV
Benchtalk: @Dyno_Tx is using AI to develop next generation AAV vectors for gene therapies. #benchtalk
Full video: www.biotechtv.com/post/dyno-therapeutics-october-1-2024This media couldn't be displayed. See it on the original post. -
Benchling
@benchling
Whatâs the difference between incremental work and profoundly impactful change? @mmammen shares his approach to advancing R&D.
Big thanks to @BiotechTVHQ and @bradloncar for highlighting #benchtalk! đş
BiotechTV
@BiotechTV
Benchtalk: @mmammen provides an update on the latest at FogPharma, and his philosophy of following the cadence of science, not the calendar. #benchtalk
Full video: www.biotechtv.com/post/fogpharma-october-1-2024This media couldn't be displayed. See it on the original post. -
Benchling
@benchling
âAs an industry, weâve realized weâre not going to be able to take advantage of this next generation of analysis capabilities, of #ai, without digitized recorded data."
Hear @gantzer16 @bradloncar talk about the evolution of lab work â and where it's headed next. #benchtalk
BiotechTV
@BiotechTV
Benchtalk: Biotech lab technologies expert @gantzer16 talks about the digital lab book, rovers, and future technologies still to come in biotech. #benchtalk
Full video: www.biotechtv.com/post/bob-gantzer-ocotober-1-2024This media couldn't be displayed. See it on the original post. -
Benchling reposted
Alfredo Andere
@AlfredoAndere
Attending Benchtalk this week, itâs pretty incredible to see the fan base that @benchling has built around their product.
Iâve met users organizing meet-ups in their cities, creating guides to âmake users into championsâ, and lots of other self-directed things. Very inspiring. -
Benchling
@benchling
What are three bottlenecks with RNA therapeutics, and how is @ShapeTx solving them? Hear from @RonHause about their approach and how they're accelerating their R&D with #ai.
Thanks @BiotechTVHQ and @bradloncar for coming to #benchtalk! đş
BiotechTV
@BiotechTV
Benchtalk: Seattle based @ShapeTx is aiming to reprogram cells by delivering guide RNAs via AAV - it has partnerships with Otsuka and Roche. #benchtalk
Full video: www.biotechtv.com/post/shape-therapeutics-october-1-2024This media couldn't be displayed. See it on the original post. -
Benchling
@benchling
"In the space of #genetherapy, we're really poised for huge impact." Find out why solving the gene delivery challenge is so critical â and how @Dyno_Tx is doing it.
Thanks @BiotechTVHQ and @bradloncar for joining us at #benchtalk! đş
BiotechTV
@BiotechTV
Benchtalk: @Dyno_Tx is using AI to develop next generation AAV vectors for gene therapies. #benchtalk
Full video: www.biotechtv.com/post/dyno-therapeutics-october-1-2024This media couldn't be displayed. See it on the original post. -
Benchling
@benchling
"I can tell just walking around here, that your customers love Benchling."
Thanks @bradloncar for visiting us at #benchtalk! We're thrilled to be on @BiotechTVHQ. đ
BiotechTV
@BiotechTV
Benchtalk: @benchling Co-Founder and CEO @sajithw kicks off #benchtalk 2024 and highlights new feature announcements for this software platform that powers the biotech sector.
Link: www.biotechtv.com/post/benchling-benchtalk-2024
#sponsoredThis media couldn't be displayed. See it on the original post. -
Benchling reposted
Brad Loncar
@bradloncar
Benchtalk is packed this morning. Great to be here.đ§Ź@benchling
-
Benchling reposted
Drug Discovery World
@DDWJournal
In Focus eReport - AI and ML: How technology is improving drug discovery
Download the e-report
info.edifydigitalmedia.com/in-focus-ereport-ai-and-ml-howâŚ
Sponsored by @benchling
#drugdiscovery -
Benchling reposted
Brad Loncar
@bradloncar
Tomorrow and Wednesday, @benchling is having its Benchtalk event in Boston. BiotechTV will be there tomorrow and have interviews (thanks to Benchling for sponsoring the coverage).
Registration is still open if youâd like to attend in person. Link: benchtalk.benchling.com/boston24/ -
Benchling
@benchling
đ Exciting news! We just opened a new office in #belfast, home to the team behind Benchling In Vivo for streamlined #invivo study management.
Currently, we have 11 Benchlings in Belfast â and weâre hiring a 12th! Check out our open roles across Europe: www.benchling.com/careers -
Benchling reposted
Brad Loncar
@bradloncar
I'll be in Boston all next week. BiotechTV will be broadcasting from @benchling's Benchtalk on Tuesday, and a capital markets event hosted by @NYSE @HSBC and @Orrick on Wednesday.
Plus, helping others to record video podcasts from the BiotechTV/@MassBio studio Kendall Square! -
Benchling
@benchling
Just one week away... join us at #benchtalk Boston!
Thereâs still time to register: benchtalk.benchling.com/boston24 #jeffyp -
Benchling
@benchling
âAs scientists, you want to know what you did and know how to fix it quickly.â
đ Find out how @arbortx is using Benchling to revolutionize their NGS processes â and troubleshoot faster than before. www.benchling.com/customer-stories/arbor-biotech-creating⌠#builtonbenchling -
Benchling
@benchling
See how @sanofi uses #ai/#ml to speed up the design of next-generation mRNA therapeutics. www.benchling.com/customer-stories/benchling-builds-digit⌠#poweredbyai #builtonbenchling
-
Benchling
@benchling
See how @Dyno_Tx is solving the challenge of in vivo gene delivery by engineering better AAV capsids.
With Benchling, theyâve scaled up their #ai/#ml by
âď¸ Standardizing data across teams
âď¸ Centralizing experimental data and metadata
âď¸ Increasing automation and instrument connectivity
www.benchling.com/customer-stories/dyno-tx-unlocking-the-⌠#poweredbyai #builtonbenchling -
Benchling
@benchling
#benchtalk is coming. Are you ready?
đ Thereâs still time to register! benchtalk.benchling.com/boston24 #jeffyp #packingtips -
Benchling
@benchling
âThis is the best tool. Weâve done our homework, and this is the best tool,â says @Neoplants co-founder Patrick Torbey.
See how theyâre using Benchling to scale their R&D and engineer air-purifying plants for a greener future. www.benchling.com/customer-stories/neoplants-scaling-sust⌠#builtonbenchling -
Benchling reposted
Joshua Meier
@joshim5
Weâre excited to introduce @ChaiDiscovery and release Chai-1, a foundation model for molecular structure prediction that performs at the state-of-the-art across a variety of drug discovery tasks
We're releasing inference code, weights & a web interface: www.chaidiscovery.com/blog/introducting-chai-1 -
Benchling
@benchling
When your entire thesis committee is available on the same day, at the same time
-
Benchling reposted
Saren H. Seeley, Ph.D.
@sarenseeley
-
Benchling
@benchling
"There are waves of FOMO coursing through the industry.â Fomo about what? Yep, #ai. Everyone's jumping on the bandwagon â for a good reason.
đ Check out this long read on AI and the hunt for new antibiotics. www.newyorker.com/magazine/2024/09/09/how-machines-learne⌠-
Benchling
@benchling
How do you precisely control the timing and location of therapeutic protein expression? @StrandTx develops first-in-class programmable #mrna therapeutics.
See how they use Benchling to speed up their process dev: www.benchling.com/customer-stories/strand-therapeutics-sh⌠#builtonbenchling -
Benchling
@benchling
#jeffyp is going. Are you?
Register for #benchtalk today: benchtalk.benchling.com/boston24 -
Benchling
@benchling
Yes, this. đ âHere's a crucial point that often gets lost in the #ai hype: For now, these systems aren't replacing human scientists. They're empowering them.â
www.inc.com/micha-breakstone/ai-in-pharma-hype-hope-or-re⌠-
Benchling
@benchling
âItâs impossible now to keep this information in spreadsheets â and software is the only way youâre going to be able to do that at scale.â
See how @arbortx is using Benchling to revolutionize their NGS processes â and speed up development of genetic medicines for #geneticdiseases. www.benchling.com/customer-stories/arbor-biotech-creating⌠#builtonbenchling -
Benchling reposted
Patrick Hsu
@pdhsu
Interested in protein design? Build on ESM3-98B!
Global hackathon starting Oct 10EvolutionaryScale @EvoscaleAI
EvolutionaryScale is partnering with @Lux_Capital & @envedabio to bring you a Bio x ML Hackathon from Oct 10-20.
Build on ESM3 *98 billion* and proprietary datasets of protein activity to develop next-gen bio applications.
Open globally. Get started: hackathon.bio -
Benchling
@benchling
Curious how top #biotech companies speed up #processdevelopment?
Weâve got insights from 3 industry leaders on:
âď¸ Key external factors
âď¸ Prioritizing digital initiatives
âď¸ Role of tech & #datascience
đ Check out the full story: www.benchling.com/resources/driving-transformation-across⌠-
Benchling
@benchling
How are the most cutting-edge #biotech and #biopharma companies shaping the future of tech-driven R&D?
Hear directly from @EliLillyandCo @Merck @sanofi @bmsnews at #benchtalk, where theyâll share insights and digital strategies. ⨠www.benchling.com/news/benchtalk-convenes-r-and-d-scienti⌠-
Benchling
@benchling
How do you show the complexity of proteins without it being visually overwhelming? Before 1981, there was no uniform way of illustrating and comparing protein structures. Then came structural biologist Jane Richardson...
Check out this fun read đ
Quanta Magazine
@QuantaMagazine
Jane Richardsonâs protein ribbon diagrams have been so successful that it can be hard to remember that our cells are not, in fact, filled with colorful ribbons and broad arrows. www.quantamagazine.org/how-colorful-ribbon-diagrams-becamâŚ
-
Benchling
@benchling
How do you achieve a scalable, cost-effective #bioprocess?
@hoxtonfarms is combining cell biology and mathematical modeling, as they develop sustainable cultivated fats for better, tastier meat alternatives. www.benchling.com/customer-stories/hoxton-farms-creating-⌠#builtonbenchling -
Benchling
@benchling
𤍠Whatâs the secret to successful IT change management in #biotech?
After completing thousands of software rollouts, our implementation team shares core principles for successful adoption of new tech. www.benchling.com/blog/it-change-management-in-biotech -
Benchling
@benchling
âEveryone is starting to truly understand how important their work is beyond just getting the results you were hoping for in your experiment.â In this new age of #ai/#ml, every bit of data counts.
See how @Sanofi is accelerating their AI-driven R&D: www.benchling.com/customer-stories/benchling-builds-digit⌠#poweredbyai #builtonbenchling -
Benchling
@benchling
84% of #biopharma companies rely on custom-built software. But these ad hoc software solutions can hold R&D teams back when it comes to applying #ai.
Read the full @theNASEM proceedings, which includes commentary from Benchling CEO @sajithw. nap.nationalacademies.org/read/27469/chapter/1 -
Benchling
@benchling
đ Happy 1st birthday to #benchlingcommunity!
In the last year, over 300 of our customers have taken part in our online community:
âď¸ 1600+ members
âď¸ 3500+ posts published
âď¸ 395 product ideas submitted
đť Cheers to another inspiring year! Join us: community.benchling.com -
Benchling
@benchling
Benchling is on the Forbes #cloud100 âď¸ for the 5th year in a row!
The union of software and biology is where the future unfolds â and we are honored to be part of it! đ§ŹâĄđ§Ş
A heartfelt thank you to the 200,000+ scientists and 1,200+ #biotech companies worldwide who rely on Benchling to accelerate their breakthroughs.
Explore the full list: www.forbes.com/lists/cloud100 -
Benchling
@benchling
Why copy and paste data when you can automatically import and aggregate your data for analysis and visualization â all in Benchling?
Check out our no-code data transformation and charting tools. đ www.benchling.com/blog/no-code-data-transformations-charting -
Benchling
@benchling
"#ai-driven drug discovery is already putting new and different pressures on lab-based experimentation," say Benchling co-founders @sajithw and @daashu.
See why #biopharma needs to scale operations across the entire R&D lifecycle to keep up. www.ddw-online.com/rethinking-the-pharma-rd-lifecycle-wit⌠-
Benchling
@benchling
Thrilled to announce Benchling on the @Forbes #cloud100 list, celebrating the worldâs top private cloud companies âď¸
Software + biology is how our future unfolds đ§ŹâĄ We're proud to partner with 1,200 biotech companies â including over half of the top 50 global biopharma and pioneering biotech startups alike â harnessing the power of data and technology to move science forward faster.
Special thanks to @BessemerVP, @Forbes, and @salesforce for this incredible recognition.
www.forbes.com/lists/cloud100/ -
Benchling
@benchling
Every day, @Neoplantsâ team works on over 1000 different plasmids and plants â relying on Benchling to provide real-time visibility into their data.
See how this Paris-based biotech is designing air-purifying plants for a greener future: www.benchling.com/customer-stories/neoplants-scaling-sust⌠#builtonbenchling -
Benchling
@benchling
Find out how @ShapeTx is revolutionizing the field of #genetherapy through the power of generative #ai â and how AI-ready data is getting them there. www.benchling.com/customer-stories/shapetx-revolutionizin⌠#builtonbenchling
-
Benchling
@benchling
How are the most cutting-edge biotechs scaling up their #ai/#ml? See how @Dyno_Tx centralized and standardized their data to accelerate their R&D, as they design new AAV capsids for better #genetherapy. www.benchling.com/customer-stories/dyno-tx-unlocking-the-⌠#poweredbyai #builtonbenchling
-
Benchling
@benchling
How is @sniprbiome bringing microbial gene therapies to the clinic faster with Benchling?
⥠Better data standardization
⥠Reduced manual data entry
⥠Improved traceability and handoffs betweens teams
www.benchling.com/customer-stories/snipr-biome-pioneering⌠-
Benchling
@benchling
Happy #nationalinternday to our amazing interns across software and security engineering!
This talented group is working on everything from developing new Notebook features, to helping audit our AWS infrastructure, and improving our configuration migration tool. Thanks for being part #teamscience! đwww.benchling.com/university-recruiting -
Benchling
@benchling
Reduce the time you spend on manual tasks like data wrangling, copying-and-pasting, or confirming data quality â see how Benchlingâs native analysis features make your work easier.
đ See them in action! Join our July 30 webinar: www.benchling.com/whats-new -
Benchling reposted
TechInformed
@TechInformed
#pharma and Life Sciences have been slow to move to the #cloud, in part due to security concerns đŹ
@benchling CISO Zach Powers looks at four myths around CloudSecurity in these industries. techinformed.co/4bUnDC1 -
Benchling
@benchling
The wait is over â our #benchtalk agenda is live! See what's planned for Boston:
đĄ Smarter, faster research in an #ai world
đĄ How to reduce time to milestone with efficient process development
đĄ Lessons on achieving end-to-end automation
Register now: benchtalk.benchling.com/boston24 -
Benchling
@benchling
How do you selectively engage T cells directly in a patientâs body? @CueBiopharma is developing targeted immunotherapies that modulate specific T cell populations to treat cancer and more.
See how they're speeding up process development: www.benchling.com/customer-stories/cue-biopharma-improvin⌠#builtonbenchling -
Benchling
@benchling
đ Heatmaps, line charts, scatter plots, and more! Increase the efficiency of your analyses with our latest no-code tools for data transformations and charting.
đ See them in action! Join our July 30 webinar: www.benchling.com/whats-new -
Benchling
@benchling
.@cambrium_bio is at the cutting-edge of using #ai to design new biomaterials. Theyâve already commercialized precision fermented collagen for cosmetics.
See how theyâre using Benchling to shorten AI / ML feedback cycles by
âď¸ Ensuring structured data capture
âď¸ Centralizing all their data on Benchling
âď¸ Seamlessly plugging AI-ready data into their models
www.benchling.com/customer-stories/cambrium-harnessing-ai⌠#builtonbenchling -
Benchling reposted
Enveda
@enveda
On July 25, our SVP of Business Strategy and Development Bigyan Bista will join the @decodingbio  team to host a panel discussion at the @NYSE. He'll be speaking with @nabsicle of @CellinoBio ,
@mike_nally of @generate_biomed, and Sajith Wickramasekara of @benchling about "Building an AI-Driven Biotech in 2024." Stay tuned for more info! -
Benchling
@benchling
Discover how @neoplants is pioneering the future of plants. Theyâre genetically engineering plants to metabolize air pollutants.
See how this innovative French biotech is using Benchling to scale their R&D and build a sustainable future. www.benchling.com/blog/neoplants-scaling-sustainability #builtonbenchling -
Benchling
@benchling
What happens when over 1,500 scientists at @Sanofi transition from legacy systems to Benchling? Real-time visibility into standardized data across teams is a critical starting point for their #ml models. www.benchling.com/customer-stories/benchling-builds-digit⌠#poweredbyai #builtonbenchling
-
Benchling reposted
Generate:Biomedicines
@generate_biomed
What does it take to build an AI-driven biotech in 2024? Our CEO @mike_nally will share his insight at @Decodingbioâs AI x Bio Summit at the @NYSE on July 25 alongside @nabsicle of @CellinoBio & Sajith Wickramasekara of @Benchling, with Bigyan Bista of @EnvedaBio moderating.
-
Benchling
@benchling
How do you build an #ai-driven biotech? Our CEO @sajithw joins @nabsicle of @CellinoBio and @mike_nally of @generate_biomed to share insights with @decodingbio.
Ahead of the event, check out Sajiâs op-ed in @statnews on the pitfalls and potential of AI in biotech: -
Benchling reposted
Cellino
@CellinoBio
đ We're excited to share that @nabsicle, our CEO & Co-Founder, will speak at @decodingbioâs AI x Bio Summit on 7/25 at @NYSE. She'll join a panel with @generate_biomed's @mike_nally & @benchling's Sajith Wickramasekara to discuss #growth, #innovation & the evolving #techstack.
-
Benchling
@benchling
What are the 4 biggest cloud computing myths in #pharma? Our CISO debunks them in @TechInformed:
đŤ It's less safe
đŤ Security is solely the vendor's job
đŤ Security incidents will rise
đŤ You canât verify what's happening with your data
Read more đ techinformed.com/busting-four-myths-around-secure-cloud/ -
Benchling
@benchling
âThe focus for #ai can't just be on discovery.â
Find out why the rest of the R&D system â developing, testing, approving, and manufacturing drugs â will need to accommodate the imminent increase in speed and scale. www.benchling.com/blog/what-if-billions-in-ai-funding-led⌠-
Benchling
@benchling
Billions of dollars in funding may not be enough. What happens when #ai fuels more drug candidates than our current R&D system can handle?
ICYMI: Benchling CEO @sajithw joined industry experts at #ftpharma to weigh in â how will #biopharma need to adapt R&D processes and teams to make the most of AI/ML? www.benchling.com/blog/insights-from-pharma-leaders-on-fu⌠-
Benchling reposted
Miles Grimshaw
@milesgrimshaw
Breakthrough models are remarkable AND we need innovation to make sure we can test, develop and bring to market. @benchling is working tirelessly to help teams work smarter and more efficiently for all of us to benefit.
Kelly Sims
@kellylsims
AI-driven drug discovery is enormously exciting. But it will also put entirely new pressures on the lab-based experimentation required to bring real drugs to trial.
AI can generate millions of new drug candidates, and new data-hungry models mean that labs need to run experiments at a vastly greater scale. Yet wet labs and the knowledge work outside/adjacent to the lab are still largely manual or quasi-manual. Imagine a supercomputer spitting out blueprints for millions of possible cures per second, and burying the scientists trying to catch them.
Saji Wickramasekara from @benchling points out that while generative AI is extremely exciting, there is fundamental work that needs to be done to modernize the entire drug discovery chain, or a treasure trove may be left on the cutting room floor. www.statnews.com/2024/06/25/ai-drug-discovery-pharma-rese⌠-
Benchling
@benchling
With over 1,600 drug candidates in development, RNA therapeutics are on the rise. But modeling siRNA and oligonucleotide conjugates can be challenging â until now.
See how you can design and visualize siRNA and ASO conjugates in Benchling. www.benchling.com/blog/oligonucleotide-conjugates -
Benchling reposted
David Bikard
@dbikard
1/ đ§ľ Thrilled to share work of @EligoBio just published in @Nature ! We show proof of principle results of efficient base editing performed on E. coli directly in the mouse gut đŚ đĄ #microbiome #syntheticbiology www.nature.com/articles/s41586-024-07681-w
-
Benchling reposted
Kelly Sims
@kellylsims
AI-driven drug discovery is enormously exciting. But it will also put entirely new pressures on the lab-based experimentation required to bring real drugs to trial.
AI can generate millions of new drug candidates, and new data-hungry models mean that labs need to run experiments at a vastly greater scale. Yet wet labs and the knowledge work outside/adjacent to the lab are still largely manual or quasi-manual. Imagine a supercomputer spitting out blueprints for millions of possible cures per second, and burying the scientists trying to catch them.
Saji Wickramasekara from @benchling points out that while generative AI is extremely exciting, there is fundamental work that needs to be done to modernize the entire drug discovery chain, or a treasure trove may be left on the cutting room floor. www.statnews.com/2024/06/25/ai-drug-discovery-pharma-rese⌠-
Benchling reposted
Greg Tucker-Kellogg (gtuckerkellogg.bsky.social)
@gtuckerkellogg
This is a super-cool paper
Benchling
@benchling
What is this... a chip for ants? Very cool work from @MIT's @MEBirnbaum @ltuckerkellogg and team, developing a microfluidic chip for producing CAR T cells.
Miniaturization is how we ramp automation and get to more affordable #celltherapy manufacturing. đ news.mit.edu/2024/new-way-miniaturize-cell-production-for⌠-
Benchling
@benchling
What is this... a chip for ants? Very cool work from @MIT's @MEBirnbaum @ltuckerkellogg and team, developing a microfluidic chip for producing CAR T cells.
Miniaturization is how we ramp automation and get to more affordable #celltherapy manufacturing. đ news.mit.edu/2024/new-way-miniaturize-cell-production-for⌠-
Benchling reposted
Lux Capital
@Lux_Capital
Great piece from @sajithw & @daashu of Lux fam co @benchling on why we need to apply AI beyond drug discovery and use it to improve every part of the R&D lifecycle
STAT
@statnews
We're entering an era of AI-driven drug discovery, which promises to be AI's greatest contribution by finding treatments for the thousands of currently untreatable diseases. www.statnews.com/2024/06/25/ai-drug-discovery-pharma-reseâŚ
-
Benchling
@benchling
Pharma R&D has a known efficiency challenge. Todayâs companies spend upwards of $6 billion in R&D per drug approval. So how do we turn it around?
Benchling co-founders @sajithw and @daashu discuss how the industry can speed and scale up with #ai â but only if we apply it across the R&D lifecycle. www.benchling.com/blog/what-if-billions-in-ai-funding-led⌠-
Benchling
@benchling
See how Zealand Pharma ensures real-time access to data and secure information exchange with multiple CMO partners â all on a GxP-compliant platform. www.benchling.com/customer-stories/zealand-pharma-advanci⌠#builtonbenchling
-
Benchling
@benchling
Thereâs no question that #ai will speed up drug discovery. But are we ready to handle a massive influx of drug candidates?
In @statnews, Benchling co-founders @sajithw and @daashu explain why the existing R&D system is no longer enough. www.statnews.com/2024/06/25/ai-drug-discovery-pharma-rese⌠-
Benchling
@benchling
Focus more on your studies and less on data entry. Record consistent, accurate dosing for groups of animals with a single action!
đ See what else is new: www.benchling.com/whats-new -
Benchling reposted
Niko McCarty.
@NikoMcCarty
There were an insane number of "big" biotechnology papers published this week.
The Bridge RNA gene-editing papers are important. But here are 7 more advances.
Many new CRISPR tools, epigenetic editing for prion disease, gene drives for plants & more...đ§ľ -
Benchling
@benchling
đ Get a behind-the-scenes look at how we built our native analysis features, including no-code data transformations and charting.
Our engineers describe the architecture behind these new tools and their decision journey along the way. benchling.engineering/a-behind-the-scenes-look-at-buildin⌠-
Benchling
@benchling
Itâs here! Now you can design and visualize siRNAs and antisense oligonucleotide conjugates directly in Benchling. đ§Ź
See what else is new: www.benchling.com/whats-new -
Benchling
@benchling
This is huge. Congrats @pdhsu @mgdurrant @ntperry13 @SKonermann @HNisimasu and team! đđ§Ź
Patrick Hsu
@pdhsu
What if we could universally recombine, insert, delete, or invert any two pieces of DNA?
In back-to-back @Nature papers, we report the discovery of bridge RNAs and 3 atomic structures of the first natural RNA-guided recombinase - a new mechanism for programmable genome designThis media couldn't be displayed. See it on the original post. -
Benchling
@benchling
So GPT-5 will take 5 years to answer your question. Maybe 6. Or 7.
Just don't ask how much longer it's going to take... -
Benchling reposted
Patrick Hsu
@pdhsu
Great article on AI drug discovery from the discerning duo of @benchling founders, @sajithw and @daashu
STAT
@statnews
We're entering an era of AI-driven drug discovery, which promises to be AI's greatest contribution by finding treatments for the thousands of currently untreatable diseases. www.statnews.com/2024/06/25/ai-drug-discovery-pharma-reseâŚ
-
Benchling
@benchling
Check out this op-ed by @sajithw and @daashu!
STAT
@statnews
We're entering an era of AI-driven drug discovery, which promises to be AI's greatest contribution by finding treatments for the thousands of currently untreatable diseases. www.statnews.com/2024/06/25/ai-drug-discovery-pharma-reseâŚ
-
Benchling
@benchling
What if billions of dollars in #ai funding leads to the same number of new drugs?
Today in @statnews, Benchling co-founders @sajithw and @daashu weigh in on how to avoid over-promising and under-delivering on AI-driven drug discovery. www.statnews.com/2024/06/25/ai-drug-discovery-pharma-rese⌠-
Benchling
@benchling
No code? No problem. With our native analysis features, you can get to insights faster with no-code data transformation and charting tools â right in Benchling.
See what else is new: www.benchling.com/whats-new -
Benchling
@benchling
âAs far as we know, this is the most compute that has gone into training a language model for biology.â
ESM3 has whopping 98 billion parameters and was trained on one trillion teraflops of compute â and a (pared back) version will be free for academics! đ
Andrew Dunn
@AndrewE_Dunn
NEW: A team of former Meta scientists have raised a $142 million seed round to advance their AI protein model research
@RLCscienceboss and I talked with EvolutionaryScale's co-founder and chief scientist @alexrives on progress w/ ESM3 & long-term vision: endpts.com/ex-meta-scientists-launch-evolutionaryscale-wi⌠-
Benchling
@benchling
What happens when you can:
âď¸ Capture 50 TB of experimental data / day
âď¸ Screen 2M molecules against a target in 4 mins
âď¸ Use generative #ai
See how @Terray_Tx is transforming small molecule drug discovery: www.nytimes.com/2024/06/17/business/ai-drugs-development-⌠#poweredbyai
#builtonbenchling -
Benchling
@benchling
Where does #ai miss the mark? Our CEO @sajithw gets real with @AndrewE_Dunn, sharing his đĽ take on the realities of AI in #biotech.
Read the full @endpts interview. endpts.com/the-endpoints-slack-interview-saji-wickramasek⌠-
Benchling
@benchling
How do you bridge the gap between lab scientists and data scientists? @RonHause, Head of AI at @ShapeTX, shares their tactics for #ai success: www.benchling.com/blog/lessons-from-shape-therapeutics-ha⌠#builtonbenchling
-
Benchling
@benchling
How is #ai like self-driving cars? Our CEO @sajithw shares his predictions on the future of AI in #biotech.
Read the full @endpts interview with @AndrewE_Dunn: endpts.com/the-endpoints-slack-interview-saji-wickramasek⌠-
Benchling reposted
Andrew Dunn
@AndrewE_Dunn
NEW: Benchling CEO Saji Wickramasekara joined our secret Slack channel
We talked about Y Combinator's "bio-curiosity," đĽ AI takes, Q's on Benchling's revenue (>$200m) and thoughts on testing the IPO window:
endpts.com/the-endpoints-slack-interview-saji-wickramasek⌠-
Benchling
@benchling
Which are the best public sources of large-scale RNA biology data?
đ Check out this review on how to design and train deep learning models for RNA biology, including successful examples.
www.nature.com/articles/s12276-024-01243-w -
Benchling reposted
Max Planck Society
@maxplanckpress
Good morning, everyone! Wishing you all a lovely day today ... with many inspirational squirrels!đđżď¸đżď¸đżď¸Cartoon by @errantscience @MCeeP
-
Benchling
@benchling
See how @CueBiopharma uses Benchling to accelerate novel immunotherapies to the clinic:
âď¸ Decreased time to process dev milestones
âď¸ Seamless handoffs between research & development
âď¸ Ready for innovation w/ adaptable data structures
www.benchling.com/customer-stories/cue-biopharma-improvin⌠#builtonbenchling -
Benchling
@benchling
Over 1,500 scientists across 30 global teams at @sanofi are using Benchling to enable their AI-powered R&D.
By transitioning from legacy systems, they can scale and accelerate processes in just hours instead of weeks â all with #ai-ready data. www.benchling.com/news/benchling-builds-data-foundation-p⌠#poweredbyai #builtonbenchling -
Benchling reposted
Girl Geek X Community
@GirlGeekX
#4 - 5 Practical Tips to be an Effective Staff Engineer - Swathi Sundar, Benchling Head of System of Record Engineering, shares pragmatic tips for aspiring staff engineers on how to be successful on the job. girlgeek.io/best-of-elevate-2024
-
Benchling
@benchling
What does #ai think #crispr looks like?
Our text-to-video prompt was "cinematic animation of CRISPR gene editing in action."
Not quite, #dreammachine. But definitely still incredibly cool đ -
Benchling reposted
Dyno Therapeutics, Inc.
@Dyno_Tx
It was a pleasure sharing with @benchling how efficient lab software supports us in our mission of using AI to engineer effective delivery of gene therapies to every cell, for every patient! Check out the video:
Benchling
@benchling
Hear from @ekelsic how @Dyno_Tx is solving the challenge of in vivo gene delivery.
With their experimental data & metadata centralized on Benchling, they can innovate faster with #ml, as they design better AAV capsids for #genetherapy.
Weâre proud to support their mission! www.benchling.com/customer-stories/dyno-tx-unlocking-the-⌠#poweredbyai #builtonbenchling -
Benchling
@benchling
Hear from @ekelsic how @Dyno_Tx is solving the challenge of in vivo gene delivery.
With their experimental data & metadata centralized on Benchling, they can innovate faster with #ml, as they design better AAV capsids for #genetherapy.
Weâre proud to support their mission! www.benchling.com/customer-stories/dyno-tx-unlocking-the-⌠#poweredbyai #builtonbenchling -
Benchling
@benchling
How is @sanofi accelerating development of mRNA-based therapeutics? Real-time visibility into standardized data gives their R&D teams the #ai-ready data they need to get new insights faster.
Weâre proud to support their mission! www.benchling.com/customer-stories/benchling-builds-digit⌠#poweredbyai #builtonbenchling -
Benchling
@benchling
When reviewer #2 asks for more experiments
Justine Moore
@venturetwins
When you ask where the training data comes from
-
Benchling
@benchling
Global #pharma leader @sanofi is paving the way for a new era of #biotechnology, where every stage of R&D is faster, smarter, and more automated.
Benchling is proud to support 1,500+ scientists across 30 teams with a digital data foundation that enables Sanofi's #ai-powered R&D. www.benchling.com/news/benchling-builds-data-foundation-pâŚ
#poweredbyai #builtonbenchling -
Benchling
@benchling
Most R&D and IT execs will agree â #ai is here to stay. Find out what theyâre saying about the impact on #biopharma , and what other technologies theyâre investing in today.
đ Read the full report:
www.benchling.com/state-of-tech -
Benchling
@benchling
What if you could structure and compress the world's known DNA, RNA, and protein sequences, making it more easily accessible for today's #bioinformatics tools? Thanks to @akkah21 @m_karasikov & team, we're 10% there. đ
Science Magazine
@ScienceMagazine
A tool that functions like a Google for DNA has demonstrated its promise for making all of the worldâs biological sequence data cheaply and easily searchable. scim.ag/7eI @NewsfromScience
-
Benchling
@benchling
The weather is heating up and so is our online Community! Stay cool in our limited edition Benchling summer Hawaiian shirt. âď¸đđ§Źđ
âĄď¸ Join our fast-growing #benchlingcommunity to enter the contest by June 13! community.benchling.com/general-announcements-48/win-a-be⌠-
Benchling
@benchling
How do you generate nearly 1M new antibiotic candidates? #ai.
See how @delafuenteupenn @luispedrocoelho & team used #ml to predict new antibiotics. An astounding 79/100 were experimentally validated. They're also making the data and code freely available. đ #poweredbyai
CĂŠsar de la Fuente
@delafuentelab
(1/7)Antimicrobial resistance is one of the greatest threats facing humanity and novel antibiotics are urgently needed. Today @CellCellPress we report the discovery of nearly 1 million new antibiotics by mining the global microbiome. đ§Ťď¸đŹ. www.cell.com/cell/fulltext/S0092-8674(24)00522-1
-
Benchling
@benchling
Would you eat pink đ? Yeah, us too. đ
đ âMaybe the pink pineapple is frivolous. But maybe itâs just the kind of product that can help prepare consumers for the food system of the future, which will likely involve more #bioengineering.â www.wired.com/story/pink-pineapples-grocery-store-pinkglo⌠-
Benchling
@benchling
What are the biggest challenges of implementing #ai in #biotech?
See top learnings and tactics from @RonHause, Head of AI @ShapeTX, where generative AI is critical to their process of developing programmable RNA therapeutics. www.benchling.com/blog/lessons-from-shape-therapeutics-ha⌠#builtonbenchling -
Benchling
@benchling
How are the most cutting-edge #biotech companies using #ai to supercharge R&D? Learn from @ShapeTx, where theyâre using AI to generate hundreds of billions of therapeutic possibilities.
See how theyâre:
âď¸ Developing breakthroughs in programmable RNA
âď¸ Paving the way for AI-enabled scientists and AI-ready data
âď¸ Powering scale, #automation, and last mile capabilities
www.benchling.com/customer-stories/shapetx-revolutionizin⌠#builtonbenchling -
Benchling
@benchling
See how @cambrium_bio uses Benchling to centralize all their data â and accelerate their #ai-enabled protein design.
⥠More effective AI models
⥠More experiments performed each month, with faster AI / ML feedback loops
⥠10x improvement in protein synthesis capabilities within a year
www.benchling.com/customer-stories/cambrium-harnessing-ai⌠#builtonbenchling -
Benchling
@benchling
Thank you #teamscience â and thank you to all the scientists delivering breakthrough innovations for a better world! #benchlingturns12 đ
-
Benchling
@benchling
Two Benchling product designers share a behind-the-scenes look at how #benchlingbioprocess was made.
đ See how we built an end-to-end solution for modern process development. www.builtinsf.com/articles/research-scientists-best-frien⌠#teamscience -
Benchling
@benchling
Whatâs the major limiting factor for #ai/#ml today? And whatâs the solution?
At #ftpharma, our CEO @sajithw joined industry experts from @Regeneron @EikonTX @iambic_ai to share predictions for the future of AI â and insights on how #pharma will get there. www.benchling.com/blog/insights-from-pharma-leaders-on-fu⌠-
Benchling
@benchling
With all their data centralized on Benchling, the team at @cambrium_bio can build more effective #ai models for the design of new, sustainable biomaterials. đ
We are proud to support their mission! www.benchling.com/customer-stories/cambrium-harnessing-ai⌠#builtonbenchling -
Benchling
@benchling
â˛ď¸ Most process development scientists spend an inordinate amount of time assembling data for tech transfer. But thereâs an easier way.
With #benchlingbioprocess, teams can simplify their tech transfer with a structured, ISA88-compatible recipe data model: www.benchling.com/bioprocess -
Benchling
@benchling
What are #biopharma execs considering when they think about top technology investments, like #ai? Find out how theyâre modernizing their R&D â and the impact they expect to see.
đ Get the full report:
www.benchling.com/state-of-tech -
Benchling
@benchling
âIt would be a great shame if the billions and billions of dollars of funding going towards #ai for designing new molecules leads to a ton of new good ideas that the rest of the R&D system can't prosecute â because it's not set up to handle 10x the scale.â
Together with experts from @Regeneron @iambic_ai @EikonTX, our CEO @sajithw spoke at #ftpharma on diverging schools of thought with AI in #pharma.
ICYMI, video from the event coming soon! đ˝ď¸ -
Benchling reposted
Menlo Ventures
@MenloVentures
The team at @MenloVentures extends a big welcome to the two world-class new hires for @Benchling! Welcome Ron Gill, Benchlingâs new CFO and Parm Uppal, who joins as CRO! Excited to see them propel this incredible company forward.
Find out what they have to say about joining #teamscience, and unlocking the power of #biotechnology:
www.benchling.com/news/benchling-welcomes-CFO-ron-gill-CR⌠-
Benchling
@benchling
A warm welcome to new leaders joining Benchling: Ron Gill as CFO and Parm Uppal as CRO! đ
Find out what they have to say about joining #teamscience, and unlocking the power of #biotechnology. www.benchling.com/news/benchling-welcomes-CFO-ron-gill-CR⌠-
Benchling
@benchling
Manual data transfers happen more often than they should â especially when many lab instruments still arenât connected to any software. So whatâs a R&D team to do? Find out how to standardize your data w/ our open source data converters: www.benchling.com/resources/connect-product-brief #benchlingconnect
-
Benchling
@benchling
Registration for #benchtalk 2024 is open! This year will be our biggest and best yet:
â Two central locations
â 30+ sessions & workshops with industry leaders
â 400+ other #biotech innovators
â And so much more â including cool swag
Register now:
đ Boston: benchtalk.benchling.com/boston24
đ London: benchtalk.benchling.com/london24 -
Benchling
@benchling
So you want structured data thatâs traceable and reusable across your R&D teams, but also secure?
See the framework that we use to help hundreds of companies â both big and small â to fit new data models to their science and roll it out to their teams: www.benchling.com/blog/data-model-in-life-sciences -
Benchling
@benchling
The FDA expects that "by 2025, 10 to 20 [gene therapy] products will be approved a year.â #genetherapy is on the rise, and so is @elevatebio!
đ Congrats to the team at Elevate for being named #8 on @CNBCâs #disruptor50 list. www.cnbc.com/2024/05/14/elevatebio-cnbc-disruptor-50.html #builtonbenchling -
Benchling
@benchling
đŠđ° Danish #biotech @Zealand Pharma is on a mission to change lives with next-generation peptide medicines, focusing on metabolic diseases such as obesity.
See how their development teams are using Benchling to
âď¸ Increase control and visibility of data
âď¸ Reduce data transfer steps in process development
âď¸ Ensure secure, compliant information exchange with CMOs
www.benchling.com/customer-stories/zealand-pharma-advanciâŚ
#builtonbenchling -
Benchling
@benchling
No one should have to redo experiments because they couldnât find the data they need. Eliminate siloed data by standardizing and centralizing your data at every stage of your process development cycle.
See how #benchlingbioprocess can help: www.benchling.com/bioprocess -
Benchling reposted
Genetic Engineering & Biotechnology News
@GENbio
New webinar! On 5/28, Stef van Grieken and Prem Mohanty will discuss how the success of AI / ML technologies is tied to data quality. REGISTER: www.workcast.com/register?cpak=7276151124048456&referrer=400 @benchling #artificialintelligence #drugdiscovery
-
Benchling
@benchling
.@StrandTx is at the forefront of #mrna therapeutics. See how they use Benchling to shorten process dev cycles by
âď¸ Improving data integrity
âď¸ Harnessing data at scale
âď¸ Running high-throughput experiments on a centralized platform
www.benchling.com/customer-stories/strand-therapeutics-sh⌠#builtonbenchling -
Benchling
@benchling
Decades in the making, a huge breakthrough in #genetherapy. đ Read about the toddler who can now hear for the first time â thanks to @Regeneron's groundbreaking new treatment. www.theguardian.com/science/article/2024/may/09/uk-toddleâŚ
-
Benchling
@benchling
Thereâs no doubt that #ai has catapulted into the spotlight â the only open question is how #pharma will use it for R&D and where the biggest impact will be.
Together with experts from @Regeneron @iambic_ai @EikonTX, our CEO @sajithw will discuss AI trends in #biotech with @ftlive and @endpts' @AndrewE_Dunn.
Join us at #ftpharma: uspharma.live.ft.com/home -
Benchling
@benchling
âWhile the fundamentals of process development have not changed so much, the technology that we have now to track and aid our process development has.â
Find out how @CueBiopharma is using Benchling to advance more drug candidates through process development faster. www.benchling.com/customer-stories/cue-biopharma-improvin⌠#builtonbenchling -
Benchling
@benchling
From the official launch of #benchlingbioprocess to our newly unveiled #ai-assisted search, get the scoop on Benchlingâs latest product innovations!
đĽ Watch the video to find out whatâs new in two(ish) minutes!
Find out more: www.benchling.com/whats-newThis media couldn't be displayed. See it on the original post. -
Benchling
@benchling
Join us for Community Day, a jam-packed day of learning, networking, and Benchling best practices:
⨠Find out how #biotech is gearing up for #ai
⨠Learn about our new product innovations
⨠Get hands-on training
đ Register now: events.benchling.com/benchlingcommunityday #benchlingcommunity -
Benchling
@benchling
đĄ Did you know? #benchlingbioprocess will dynamically populate information from your recipes and experiments right into a guided interface for batch execution.
See it in action! Join tomorrowâs webinar to find out what else is new: www.benchling.com/whats-new -
Benchling
@benchling
Weâre in a new era defined by biology, data, and #ai â and #biopharmaâs tech strategy has never been more important.
See how R&D execs are prioritizing tech, and what that means for their science: www.benchling.com/state-of-tech -
Benchling
@benchling
âThe new tech stack for #ai in bio is going to be built ground-up for scale, security, privacy, and interoperability." Listen to @pharmaphorum's podcast to hear what our CISO has to say about AI-ready data, #automation, and cloud #security in Europe. pharmaphorum.com/digital/pace-acceleration-and-precision-âŚ
-
Benchling
@benchling
đĄ Did you know? You can connect Chromeleon⢠to Benchling, automatically bringing your HPLC data â from chromatograms to calibration curves â into a single, centralized platform.
Learn how weâre powering a connected lab: www.benchling.com/connect -
Benchling
@benchling
.@ElevateBio improved sample throughput by 10X. Learn how theyâre accelerating cell and gene therapy development by bringing massive efficiencies to processes and data management. www.benchling.com/customer-stories/elevatebio-going-digitâŚ
-
Benchling
@benchling
⨠Plasmid alignment is here! Now scientists can align multiple reads to a plasmid template in Benchling, without having to reindex sequences beforehand.
đ Join our May 7 webinar to see what else is new: www.benchling.com/whats-new -
Benchling
@benchling
Thanks @ycombinator for featuring us on Top Companies of 2024! đ
Cheers to our incredible team, who always keep our customers at the forefront of what we do â helping scientists deliver world-changing breakthroughs, faster. www.ycombinator.com/blog/yc-top-companies-2024 #teamscience #teambenchling -
Benchling
@benchling
#ai-driven drug discovery may be on everyoneâs minds, but AIâs potential extends far beyond that.
@JanetMatsen @alangpierce discuss how ML models are being used for clinical trials, filing, manufacturing, and more:
www.benchling.com/blog/biotech-intro-GenAI-LLMs -
Benchling
@benchling
Did you know? In #benchlingbioprocess, recipe design is as simple as drag-and-drop.
And each recipe is backed by a unified data model, aligned with ISA88 standards for process control, and ready for advanced analysis and #ai. đ
See what else is new: www.benchling.com/whats-new -
Benchling
@benchling
đ Centralize your data in Benchling â without manual data entry. Introducing new data connectors for your instruments, including Chromeleonâ˘, QuantStudioâ˘, and more.
Join our May 7 webinar to learn more đ www.benchling.com/whats-new -
Benchling reposted
Relation
@RelationRx
Thank you @benchling great to partner with you đ§Źđ§Ťđ§ŞđŹ
#cause2cure #thepatientiswaiting
Benchling
@benchling
âThis is the future of what drug discovery will look like: This tight coupling of real-world experimentation with these emerging techniques in #ml.â
Benchling customer @RelationRx is truly at the forefront of the #biotech + #ai revolution. #labintheloop endpts.com/relation-raises-35m-with-nvidia-and-deerfield-⌠-
Benchling
@benchling
âThis is the future of what drug discovery will look like: This tight coupling of real-world experimentation with these emerging techniques in #ml.â
Benchling customer @RelationRx is truly at the forefront of the #biotech + #ai revolution. #labintheloop endpts.com/relation-raises-35m-with-nvidia-and-deerfield-⌠-
Benchling
@benchling
Nothing says commitment to being an end-to-end solution like our team in head-to-toe Benchling gear! #teamscience
Seriously though, weâre excited to launch #benchlingbioprocess, an end-to-end solution to accelerate every step of your process development. www.benchling.com/bioprocess -
Benchling
@benchling
What if you could use #ai to design a new gene editor? In an exciting proof-of-concept, @ProfluentBio has done exactly that. đđ˝đđ˝
Find out how they used generative #ai to create #opencrispr, the world's first AI-generated (and open source) gene editor. www.nytimes.com/2024/04/22/technology/generative-ai-gene-⌠-
Benchling
@benchling
đŠđ° Danish #biotech Zealand Pharma knows that a strong digital strategy is key to success. That's why they chose to partner with Benchling.
By standardizing and centralizing their data, Zealand can streamline partnerships with CMOs and ultimately accelerate development â all on a GxP-compliant platform. www.benchling.com/news/zealand-pharma-partners-with-bench⌠#builtonbenchling -
Benchling
@benchling
đđ˝ Say goodbye to manual copy-pasting⌠and hello to easy bulk cloning with our new combinatorial cloning tool! See how weâve improved in silico cloning:
âď¸ Visualize fragments and constructs as theyâre being created
âď¸ Clone using multiple methods, including Gibson, Golden Gate, and homology
âď¸ Use API endpoints for assemblies
Join our webinar to see what else is new: www.benchling.com/whats-new -
Benchling
@benchling
The #ai revolution is coming for #biotech... but are R&D orgs ready?
Next week, @ShapeTXâs Head of AI @RonHause will discuss their AI-based approach to discovery â along with advice for companies looking to set up AI-driven processes.
Register now đ www.bio.org/webinars/scientific/resetting-rd-ai-biotechs-⌠-
Benchling
@benchling
Did you know? With #benchlingbioprocess, you can:
⥠Create recipes with a drag-and-drop visual designer
⥠Design experiments across process parameters
⥠Improve efficiency with guided batch execution
⥠Structure your data for #ai
Find out how to accelerate your process development with an end-to-end solution: www.benchling.com/bioprocess -
Benchling
@benchling
Introducing: #ai-assisted search in Benchling! đâ¨
Just type in what youâre looking for â using natural language queries â and the #llm will configure nearly 100 search filters and parameters for you.
đ See it in action! Join our May 7 webinar: www.benchling.com/whats-new -
Benchling
@benchling
A typical #biotech lab uses dozens to hundreds of instruments on a regular basis. So itâs easy to see how data can become disconnected and error-prone, especially if youâre relying on manual data entry.
Thatâs why we built #benchlingconnect, a flexible platform for end-to-end data management â now with connectivity to even more instruments, including for:
âď¸ HPLC
âď¸ qPCR
âď¸ xMAP
âď¸ Spectrophotometry
âď¸ And more
Find out more about our newest product capabilities: www.benchling.com/whats-new -
Benchling
@benchling
đ #benchlingbioprocess is officially here! Today weâre excited to deliver an end-to-end solution for modern, high-throughput process development.
Now with Bioprocess, scientists can:
⥠Shorten development cycles
⥠Simplify tech transfer
⥠Enable #ai-ready data
Find out how weâre accelerating R&D with additional product updates â from connecting more lab instruments to transforming your lab work with AI. www.benchling.com/whats-new -
Benchling reposted
Jake Becraft
@DrSynbio
A great video highlighting not only the incredible innovation at @StrandTx across the entire mRNA value chain, but also our amazingly talented workforce with a fantastic interview by Mae Kingsbury!
Benchling
@benchling
âAs a PD scientist, if we have a more holistic view of our historical data, we can create more efficient plans for optimization strategies.â
Find out how @StrandTx is using Benchling to shorten process development cycles â and build curative #mrna therapeutics â by harnessing data at scale. www.benchling.com/customer-stories/strand-therapeutics-sh⌠#builtonbenchling -
Benchling
@benchling
âAs a PD scientist, if we have a more holistic view of our historical data, we can create more efficient plans for optimization strategies.â
Find out how @StrandTx is using Benchling to shorten process development cycles â and build curative #mrna therapeutics â by harnessing data at scale. www.benchling.com/customer-stories/strand-therapeutics-sh⌠#builtonbenchling -
Benchling reposted
Dan Stanton @Dan5tanton
Large crowd at #bpieurope attending the LiveLabs tour... currentluly hearing about @benchling process management software offerings
-
Benchling
@benchling
You no longer need to be a machine learning shop to join the #ai party. #llms are ready for #biotech today.
@JanetMatsen @alangpierce explain how generative AI and LLMs can be used for more than drug discovery, throughout the entire R&D lifecycle: www.benchling.com/blog/biotech-intro-GenAI-LLMs -
Benchling
@benchling
For all the hype around #ai and #ml, there's already real progress, esp for antibody drug discovery.
See @dr_alphalyrae's review of the innovators applying AI/ML to target identification, antibody design, and high-throughput screening and optimization. www.benchling.com/blog/antibody-discovery -
Benchling
@benchling
Every industry is rushing to apply #ai â but why is this so critical for #biotech and why now? Today, our CEO @sajithw and other industry experts joined @theNASEMâs workshop on AI and #automation to explain why.
âśď¸ Watch the recording: www.youtube.com/live/mRmjKZVkYgw?t=22208 -
Benchling
@benchling
What do you lose if you donât invest in #ai and #labautomation? @theNASEM is bringing together industry experts, including our CEO @sajithw, to discuss the strategic imperatives of investing in these technologies.
đď¸ Tune in on Wednesday: www.nationalacademies.org/event/41736_04-2024_artificial-⌠-
Benchling
@benchling
âLarge and small companies alike are adopting computational experiments at rapid clips.â Benchling's @malaygandhi joined @jacobeffron @nikillinit on the Vital Signs podcast, to talk about the future of #biotech.
Hereâs what heâs seeing:
âď¸ There's a high willingness to experiment and adopt #ai
âď¸ Companies are rushing to invest in their data infrastructure first â only then can they apply AI/ML effectively
Listen to the podcast:
đđ˝ Spotify: spoti.fi/3ITnrqA
đđ˝ Apple: podcasts.apple.com/us/podcast/ep-41-benchling-head-of-str⌠-
Benchling
@benchling
#ai and automated labs are already transforming #biotech â but what does that mean for your R&D? Join us for @theNASEM panel, where our CEO @sajithw will discuss the strategic implications of these technologies.
Join virtually on April 3 at 2:45pm ET đđ˝ www.nationalacademies.org/event/41736_04-2024_artificial-⌠-
Benchling reposted
Jacob Effron
@jacobeffron
đď¸New Vital Signs with @malaygandhi and @nikillinit on:
- Revisiting Malay's early digital health pieces
- Future of life sciences & RWE
- Lessons from @benchling
- Opportunities for AI in healthcare
Spotify: spoti.fi/3ITnrqA
Apple: podcasts.apple.com/us/podcast/ep-41-benchling-head-of-str⌠-
Benchling
@benchling
What's #biotechâs software system of choice? Biodevelopers â thatâs scientists who code â overwhelmingly choose Benchling as their #lims.
#techbio is evolving everyday, and scientists need tools that can keep up. See what @bitsinbio discovered: www.stateoftechbio.com -
Benchling
@benchling
âEveryone in the operating room burst into applause. It was truly the most beautiful kidney I have ever seen.â @eGenesisBio's pig kidney has 69 DNA edits so it's more compatible with humans. Amazing to see how #crispr could solve the organ shortage crisis! www.statnews.com/2024/03/21/first-xenotransplantation-criâŚ
-
Benchling
@benchling
The majority of âbiodevelopersâ are integrating #ml into their work. For some scientists, thatâs #alphafold or GPT-4. Most use cases involve target identification, in silico screening, and hit generation.
See what else @bitsinbio found: www.stateoftechbio.com -
Benchling
@benchling
#immunotherapy has been a gamechanger â but only for some patients. How can we better predict which patients will benefit?
See how #ml is being used with multi-omics cancer data to identify biomarkers and predict patient response: www.nature.com/articles/s41746-024-01043-6 -
Benchling
@benchling
It may be the first day of spring, but we're not ready to pack away our Benchling hoodies yet! From đşđ˛ to đ¨đ, Benchlings suited up to show their #teamscience pride.
Want to help scientists bring life-changing products to market faster? Join us: www.benchling.com/careers #hiring -
Benchling
@benchling
đŠđ° Denmark-based @sniprbiome is tackling the global antimicrobial resistance crisis â with #crispr-based therapeutics. Find out how theyâre moving drug candidates through the pipeline faster with Benchling: www.benchling.com/customer-stories/snipr-biome-pioneering⌠#builtonbenchling
-
Benchling
@benchling
đź Springtime fact: Did you know that a common #alzheimers drug uses an active ingredient from daffodils?
See how @UTAustin researchers are using #ai to engineer bacteria to produce the target molecule: cns.utexas.edu/news/research/alzheimers-drug-fermented-he⌠-
Benchling
@benchling
Using #ai for drug discovery is not exactly a new trend â so why are we having a breakthrough moment? It comes down to these 3 ingredients:
⥠Mass of training data now available
⥠Explosion of computing resources
⥠Advancements in AI algorithms
www.forbes.com/sites/richardnieva/2024/03/13/why-nvidia-g⌠-
Benchling
@benchling
Without the right infrastructure, therapeutic development is difficult. Thatâs why @ElevateBio exists, to eliminate these challenges and power cell and gene therapy development.
Read how Benchling is helping them improve sample throughput, scientist efficiency, and probability of success. www.benchling.com/customer-stories/elevatebio-going-digit⌠-
Benchling
@benchling
âAI or ML means nothing if you donât have a database that is large enough and smart enough and clean enough to run complex and expensive models on it.â See how @Immunaitech is using #machinelearning to unlock the next-generation of immunomodulatory drugs. www.labiotech.eu/podcast/ai-immune-system-map/
-
Benchling
@benchling
More and more biologists are learning to code â and #python is the overwhelming favorite. Scientists are turning to Python for everything from data analysis to #machinelearning.
See what @bitsinbio found out about the state of techbio: bitsinbio.substack.com/p/the-state-of-techbio-2023 -
Benchling
@benchling
Data quality is the most important driver of success with #machinelearning. Thatâs why @hoxtonfarms is using Benchling to standardize data capture and analysis â to accelerate development of cultivated fats for tastier meat alternatives. www.benchling.com/customer-stories/hoxton-farms-creating-⌠#builtonbenchling
-
Benchling
@benchling
With enough data and computing power, can #ai models make breakthroughs that scientists wouldnât be able to reach otherwise?
Experts weigh in on how AI is poised to expand the limits of scientific discovery â and share the incredible progress made so far. www.nytimes.com/2024/03/10/science/ai-learning-biology.html -
Benchling reposted
Proby Shandilya @ProbyShandilya
best founders are learning machines (h/t @ericvishria)
this photo has two of the greats at that precisely. legendary
Benchling
@benchling
âPeople often assume thereâs a tradeoff between reliability, quality, and speed. I donât think thatâs necessarily true.â
@patrickc (CEO of @stripe) joined Benchling co-founder @sajithw to chat about speed, #innovation, and the infrastructure needed to move fast.
đ The key to success? Be thoughtful, eliminate inefficiencies, and create streamlined mechanisms to increase speed and reliability. -
Benchling
@benchling
There is no cookie-cutter female scientist. đŠđžâđŹđŠđťâđŹđŠđ˝âđŹđŠđżâđŹ âTeach, move to industry, be a manager. Success in science takes many forms beyond academia.â
We could not agree more! Women at Benchling come from all backgrounds & we're proud to lift each other up! www.nature.com/articles/d41586-024-00703-7 -
Benchling
@benchling
đď¸On #internationalwomensday, listen to stories about women who made significant contributions to science, but never got the recognition they deserved. This resonates deeply with us: www.lostwomenofscience.org
To all the women at Benchling and beyond, in science, tech, or pioneering in another field altogether: We see you, we celebrate you. đđ˝ââđđ˝
#iwd #womenshistorymonth #womeninstem -
Benchling
@benchling
We welcomed our customer #revolutionmedicines to talk about the biggest challenges in #biotech today.
Their answer? âData sprawl and data silos; data are everywhere.â
Being able to centralize and search across in-house generated data, along data from CROs and numerous external collaborators, via a scientifically intuitive interface, is a huge win. -
Benchling
@benchling
đŹđ§ London-based @hoxtonfarms is growing real animal fat â without the animals. Find out how theyâre applying #machinelearning to #bioprocessing â and why Benchling has been essential as the central source of truth for their R&D: www.benchling.com/customer-stories/hoxton-farms-creating-⌠#builtonbenchling
-
Benchling
@benchling
đ Mark your calendars â our global community of R&D scientists and tech leaders will come together at #benchtalk 2024 for networking, best practice sharing, product innovation, and fun.
đ Boston: benchtalk.benchling.com/boston24
đ London: benchtalk.benchling.com/london24
Stay tuned for more updates! #benchlingcommunity -
Benchling
@benchling
"R&D data is expected to double in the next year."
đď¸ Listen to find out why data standardization and instrument connectivity is more important than ever before.
SLAS
@SLAS_Org
New Matter is back with a new episode featuring Glenwood Barbee, M.B.A., Product Marketer at @Benchling. Glenwood discusses Benchling Connect â a platform designed to accelerate connectivity and automation in laboratory settings. Listen now⌠www.slas.org/education/new-matter-podcast/.
-
Benchling
@benchling
What are the #privacy and #security risks of using #ai, and how can #biotech companies protect themselves? Visit our detailed guide to vetting AI tools:
đ Consumer vs enterprise tools
đ Due diligence framework
đ Security and privacy requirements
www.benchling.com/blog/security-privacy-ai-tools -
Benchling
@benchling
âPeople often assume thereâs a tradeoff between reliability, quality, and speed. I donât think thatâs necessarily true.â
@patrickc (CEO of @stripe) joined Benchling co-founder @sajithw to chat about speed, #innovation, and the infrastructure needed to move fast.
đ The key to success? Be thoughtful, eliminate inefficiencies, and create streamlined mechanisms to increase speed and reliability. -
Benchling
@benchling
#teamscience gives back! We volunteered at @GLIDEsf, serving meals to those in need.
While weâre focused on serving our customers and the #biotech community, itâs also important to remember the larger community that weâre a part of.
Thank you Benchlings for donating to or volunteering at over 200 nonprofits last year! #benchlingforgood -
Benchling
@benchling
#teamscience at the @exploratorium! Thereâs nothing like bringing the entire team together to connect, learn, and have fun. Itâs a reminder of why weâre here â to solve big problems with other awesome, intellectually curious people.
Join us: www.benchling.com/careers -
Benchling
@benchling
Our entire team gathered in SF to kick off the new year â to celebrate all that #biotech will achieve in 2024, and how we plan to help our customers get there.
With over 750 Benchlings in one room, it's impossible not to feel inspired about the future of R&D. Go #teamscience! -
Benchling
@benchling
Happy Valentineâs Day from #teamscience! Share a Benchling Valentine with the scientists in your life. đ
Much love to our customers who came up with Benchling-inspired pick-up lines. Join the community to see more! community.benchling.com -
Benchling
@benchling
Whatâs your love language? Share a Benchling Valentine with the scientists in your life! đ
Happy Valentineâs Day from the Benchling Community: community.benchling.com -
Benchling
@benchling
We â¤ď¸ our customers. And our customers love their jobs.
Join the folks at @cambrium_bio @UmojaBiopharma @OriBiotech @StrandTx @elevatebio @Dyno_Tx â tell us why you love working in #biotech.
Happy Valentineâs Day from #teamscience! đ -
Benchling
@benchling
Science + puns are a match made in heaven! Happy Valentineâs Day from #teamscience. đ
Want more Benchling pick-up lines? Join our community to see what else our users came up with: community.benchling.com -
Benchling
@benchling
A biotechâs tech strategy is now its competitive edge. Find out how to get ahead with the biggest technological shifts of the year. thejournalofmhealth.com/2024-tech-biotech-outlook/
-
Benchling
@benchling
Weâre in a new era of #biotech â at the intersection of biology, data and AI. How will #ai and #llms, along with communities like @bitsinbio @bios_community @NucleateHQ, drive innovation?
Our experts @dr_alphalyrae @JanetMatsen share predictions for 2024: www.benchling.com/blog/2024-biotech-tech -
Benchling reposted
Nicholas Larus-Stone
@nlarusstone
This is a great article â I love this heading: âLLMs will boost productivity and creativity for scientists, just as they have for engineers.â
Something that we constantly discuss in @bitsinbio and need more bright technical minds working on!
Benchling
@benchling
How will scientists use #llms? Why will #ai move slower in #biotech than tech?
Our experts @JanetMatsen & @dr_alphalyrae weigh in on the upcoming year â and the tech (and communities) that will help drive innovation. www.benchling.com/blog/2024-biotech-tech @bitsinbio @bios_community @NucleateHQ -
Benchling reposted
Vega Shah
@dr_alphalyrae
How will technology shape biotech in 2024?
@JanetMatsen, an ML engineer, and I co-authored a @benchling blog. We looked at the changes in biotech last year and shared our thoughts on what might grow in 2024:
â commercial progress with AI in biotech will be slower than tech, but more transformational
â LLMs will boost productivity for scientists, just as they have for engineers
â the tipping point is here for novel drug modalities, and it will drive an R&D IT reset
â techbio community will grow in force and be a catalyst for change with players like @bitsinbio and @NucleateHQ
link in thread đ§ľđ -
Benchling
@benchling
How will scientists use #llms? Why will #ai move slower in #biotech than tech?
Our experts @JanetMatsen & @dr_alphalyrae weigh in on the upcoming year â and the tech (and communities) that will help drive innovation. www.benchling.com/blog/2024-biotech-tech @bitsinbio @bios_community @NucleateHQ -
Benchling
@benchling
.@ElevateBio is helping accelerate access to the cutting-edge technologies and expertise that will change the future of medicine. Learn how they use Benchling to establish a high-throughput #cellandgenetherapy research pipeline: www.benchling.com/customer-stories/elevatebio-going-digitâŚ
#builtonbenchling -
Benchling
@benchling
âThe user experience is seamless and it feels like one solution. It helps us integrate equipment reservations in our workflows.â
Manage and schedule equipment directly in Benchling using our new integration with @clustermarket. www.benchling.com/blog/clustermarket-integration -
Benchling
@benchling
What are key privacy and security concerns when using #ai in #biotech? This #dataprivacyweek, weâre sharing a detailed guide to vetting AI tools:
đ Consumer vs enterprise tools
đ Security and privacy due diligence
đ Security and privacy requirements
www.benchling.com/blog/security-privacy-ai-tools -
Benchling
@benchling
Biologics and other advanced modalities are upending the way we work in the lab â and biotechs need an updated tech strategy to match. @dr_alphalyrae shares some of the biggest changes in R&D IT. pharmaphorum.com/rd/5-changes-underway-rd-it-shifting-advâŚ
-
Benchling reposted
Calira (formerly Clustermarket) @calirasoftware
We are excited to announce our integration with @benchling, the R&D Cloud powering the #biotechnology industry đ
The Clustermarket & Benchling integration brings equipment mgmt and scheduling functionality to usersâ workstreams.
đ clustermarket.com/press/clustermarkets-equipment-scheduli⌠#labops -
Benchling
@benchling
Today, weâre excited to launch a new integration with @clustermarket! Now scientists can seamlessly access Clustermarketâs booking calendar within the Benchling R&D Cloud:
âď¸ Book equipment directly from Benchling
âď¸ Automatically register equipment information
âď¸ Record dynamic equipment data
đ Find out how weâre streamlining your R&D with a more integrated lab ecosystem: www.benchling.com/blog/clustermarket-integration -
Benchling
@benchling
We all knew that #ai would be a đĽ topic this week, and #jpm2024 did not disappoint. Hereâs what we heard again and again:
⥠AI is here to stay â and now itâs time to start investing in the possibilities.
⥠Use cases exist at every stage of the R&D lifecycle, whether youâre modeling new molecules or generating reports for regulatory submission.
⥠AI cannot deliver results unless a proper data architecture is in place.
Hereâs how biotechs can get started with AI and LLMs:
www.benchling.com/blog/biotech-intro-GenAI-LLMs -
Benchling
@benchling
Set the foundation for #fair data practices â and standardize it across different Benchling solutions and tenants within your company. See how to move configurations between tenants in an automated, streamlined way. www.benchling.com/blog/configuration-migration #featurefriday
-
Benchling
@benchling
We are rolling into #jpm2024! đ With all the pharma and healthcare leaders converging on San Francisco, itâs hard not to feel energized for the year ahead.
Benchling
@benchling
One recurring theme from the past few days? The convergence of science and technology.
#jpm2024 agrees that tech is the ânew competitive frontierâ â and a key driver of future success. Thatâs why weâre proud to help #biotech and #pharma lead with high quality data. -
Benchling
@benchling
Being on #teamscience means working on meaningful problems with inspiring people. Weâre proud to be listed again in @BuiltIn's 2024 Best Places to Work: builtin.com/awards/san-francisco/2024/best-places-to-work
-
Benchling
@benchling
What's the state of tech in #biopharma? Here's what we, and other European biotech leaders, have to say about new approaches in tech â from real use cases of #ai/#ml, to other tools that reduce timelines and labor. pharmaphorum.com/digital/look-back-2023-benchling-biotechâŚ
-
Benchling
@benchling
Even the smallest details matter. That's why we're constantly innovating to optimize your Benchling experience.
Which little improvements were among scientists' favorites in 2023?
⨠Flexible notebook sections
⨠Bulk nucleotide modifications
⨠Improved search
Find out which product updates most impacted daily life in the lab: www.benchling.com/blog/benchling-experience-updates -
Benchling
@benchling
#benchlingconnect is better than ever â better tooling for scientists to generate better data from instruments. đĽ
âł Problem: Transforming raw equipment or instrument data into a structured dataset is tedious, time-consuming, and error-prone.
đ ď¸ Solution: See how transformations affect an output file in real time, as you configure data ingested in Benchling. You can also delete or sort transform steps and see their effect in a preview window.
đ§âđŹ Impact for scientists: Get more accurate, usable data faster to drive better decisions.
Learn more about this new feature at our upcoming webinar: www.benchling.com/whats-new -
Benchling
@benchling
Did you know that most R&D organizations use >100 lab instruments?
Thatâs why we launched â¨Benchling Connectâ¨, to bring all your data from lab instruments into one platform for end-to-end data management and analysis.
See what else we built in 2023: www.benchling.com/blog/2023-year-in-review -
Benchling
@benchling
What did we build in 2023? Our biggest moments centered around key themes that came up again and again:
⥠No more siloed data
⥠Make #fair happen
⥠#ai. #ml.
See how these phrases guided some of our most exciting advancements yet. www.benchling.com/blog/2023-year-in-review -
Benchling
@benchling
Now you can assemble multiple protein sequences in Benchling using the amino acid combinatorial concatenation feature!
Watch how a user assembles an antibody IgG heavy chain using a variable region and 3 constant regions.
Latest updates include:
đ§Ź Pull sequences from previously prepared worklists
đ§Ź Preview fragments before adding them to bins
đ§Ź Visualize constructs before concatenation
Learn about all the product updates in our Whatâs New webinar, January 9th. Sign up here: www.benchling.com/whats-new -
Benchling
@benchling
Introducing our new In Vivo task management features! đ Create in vivo studies faster, track tasks, and easily visualize study data.
Now available:
âď¸ Defined task start and end dates to ensure greater flexibility of protocol design
âď¸ Study timeline view to easily track progress
âď¸ Combined calendar view for increased visibility across multiple studies
đĄLearn about all of our product updates at www.benchling.com/whats-new -
Benchling reposted
Vega Shah
@dr_alphalyrae
Approximately 2 decades ago, the FDA approved only 6 biologics versus 27 new molecular entities in 2022. New modalities such as antibodyâdrug conjugates, bispecific proteins, and cell and gene therapies accounted for about a third of the approvals. In this @benchling blog post, we talk about the ways in which IT and data teams are evolving to catch up with complex modalities. www.benchling.com/blog/changes-underway-it-shifting-to-biâŚ
-
Benchling
@benchling
Your science is what matters most, so weâre continuously launching updates that make Benchling efficient and easy to use, that accelerate science âď¸đ§ŹâĄ
To kick off the new year, weâre hosting a special edition #whatsnew webinar, with all the details on this yearâs top new products and the Benchling improvements, small and large, that make a big difference!
âĄď¸ Sign up now for the January 9th webinar: www.benchling.com/webinars/whats-new-webinar-jan-2024-ame⌠-
Benchling
@benchling
The recent CRISPR/Cas9 milestone with sickle cell disease is yet another indicator -- biologics are on the rise!
Biologics create unprecedented opportunity for patients and the biopharma that pursue them. They also require a big shift in R&D IT.
How is IT adapting to the complexity of biologics, what are the major hurdles? We share the top 5 changes with #biotech #it here with @dr_alphalyrae
www.benchling.com/blog/changes-underway-it-shifting-to-bi⌠-
Benchling
@benchling
Weâre sharing advice from process development experts navigating today's fast-evolving industry changes.
In our latest whitepaper, PD experts from leading biopharma discuss the 5ď¸âŁ key themes theyâre working through:
â Handling the scale-up of data with better traceability
â Being ready for innovation with adaptable data structures
â Creating a culture of data sharing and transparency across the company
â Selecting the right moments for PD transformations, especially when they impact established workflows and data collection
â Guardrails for data access with a cross-functional PD team
⥠Check out the whitepaper here: www.benchling.com/resources/the-rapidly-changing-expectat⌠-
Benchling
@benchling
Did you know? Benchling allows you to visualize features on amino acid alignments. Easily turn on and off:
𪟠CDR annotations
𪟠Liability sites
𪟠Antibody numbering
#featurefriday #teamscience -
Benchling
@benchling
Q: What's the sharpest look for the lab this holiday season?
A: Definitely the limited edition Benchling holiday ugly sweater! âď¸đđ§Ź đ
⥠Join our fast-growing Benchling Community to participate in our contest by Dec 15th, and win one of your own! community.benchling.com/general-announcements-48/win-a-li⌠-
Benchling
@benchling
First draft of a report in minutes as opposed to hours/days? It is indeed possible, thanks to #llms.
đŠ Problem: While 60% of biopharma execs are using AI/ML, they also cite the lack of off-the-shelf tools built for scientific AI as the top limiting factor to greater adoption, according to our 2023 State of Tech in Biopharma report.
đĄ Solution: Report Generation with LLMs from Benchling is purpose-built for scientists. It easily integrates, understands scientific inputs, and most importantly, cuts down on labor-intensive, time-consuming work.
đ Check out #ai at Benchling, and sign up to be part of our beta program today: www.benchling.com/ai -
Benchling
@benchling
Work smarter đ¤ not harder đĽľ
AstraZeneca revolutionized its #dna construct development by integrating their FRAGLER software into Benchling. The result:
â Costs cut by 50-90%
â Reduced DNA synthesis time by 1-4 weeks
Their innovative solution not only streamlines the construct generation process, but also opens doors to unprecedented scale and efficiency in early #drugdiscovery. đđ§Ź
đ Learn more about how AstraZeneca unleashes the scale-up potential of a fully automated de-novo fragment pipeline with Benchling: www.benchling.com/how-astrazeneca-created-automated-dna-a⌠-
Benchling
@benchling
Announcing the public preview of Chart Generation with #llms, Report Generation with LLMs, and ML-driven Bioprocess & Strain Optimization from Benchling.
These capabilities use #ai to predict the best parameters for your experiment, optimize analysis, and speed-up reporting âĄď¸ ultimately saving time, costs, and resources. Less grunt work = more time for science âĄ
đ Sign-up to be part of our beta program, get on the waitlist today: www.benchling.com/ai -
Benchling
@benchling
What new functionality can you expect from Benchling R&D Cloud in the coming year? đ¤ âď¸Â đ§Ź
Get access to a special roadmap overview, available on-demand between November 13 - December 15.
⥠Join #benchlingcommunity to check it out:community.benchling.com -
Benchling
@benchling
Want to learn how to scale instrument connectivity? Or how to simplify tech transfer in process design?
Get your questions answered in our #europe-focused #whatsnew webinar. You'll hear directly from the leaders and developers behind new Benchling products, #connect and #bioprocess.
đđ˝ Takes place 21st of November, 10am GMT, sign-up here: www.benchling.com/webinars/whats-new-webinar-nov-2023-europe -
Benchling
@benchling
#benchtalk23 was all about moving science forward, together đ We're still buzzing from the energy, ideas, and insights from this inspiring community.
đđť ICYMI: Read the full recap on our blog: www.benchling.com/blog/benchtalk-2023This media couldn't be displayed. See it on the original post. -
Benchling
@benchling
How do R&D and IT differ when it comes to tech priorities in the lab?
đ The 2023 State of Tech in Biopharma investigates. The aim: data can foster an honest dialogue between IT and R&D on the real disconnect, such as organizational culture and change management.
300 R&D and IT #biopharma experts revealed:
â R&D rates organizational culture and change management as a significant barrier to tech adoption, while for IT lack of built-for-science tech and skills are larger barriers.
â For connected lab instruments, R&D is 4x more likely than IT to identify change management as a barrier to adoption.
â IT indicates a strong bias towards SaaS applications, while R&D is more focused on robotics and automation and connected instruments.
đ Learn more in our 2023 State of Tech in Biopharma report: www.benchling.com/state-of-tech -
Benchling
@benchling
Imagine a world where data is siloed and scientists canât collaborate effectively and quickly to bring life-changing products to market. Now thatâs scary! đť Happy Halloween, from Jeffy P(umpkin) to you! đ
-
Benchling reposted
LabGenius Therapeutics
@labgeni_us
Our CEO @jejfield had the pleasure of sitting down with Sajith Wickramasekara, CEO of @benchling, @uzma_choudry Investor at @OctopusVentures, Emmanouil Metzakopian VP of RD at @bitbio, and Pierre Salvy Head of Engineering at Cambrium.
đ§Ź đ¤ đ§Ť Great discussion centred around AI/ML tools for biology, including the opportunities for drug discovery and how such tools permeate across all steps of the scientific process.  Thank you to Benchling and Patty Tredway for the invitation, and to the panellists for an insightful conversation!
www.clinicaltrialsarena.com/features/ai-biotech-talent-re⌠-
Benchling
@benchling
Day 2 at #benchtalk23 Europe in London: From start-up biotechs to leading biopharma, customers shared how they're blending the best of tech with science to move faster and more accurately đ§ŹâĄđ§Ş
đĄ The 5R framework and collaboration breakthroughs with @AstraZeneca
đĄ Building an AI-first approach with @cambrium_bio, @OriBiotech, @hoxtonfarms
đĄ Winning data strategies from @sanofi, @OctapharmaGroup, and @DTUBiosustain
đĄ Women leadership in biotech @bitbio, @OctopusVentures, Evox Therapuetics
đĄ Change management for tech adoption with @HookipaPharma
đĄ Structured data approach from @MeiraGTx
Follow this space for recaps! -
Benchling
@benchling
"While much of the focus with AI + bio has been about drug discovery, its potential is underappreciated if we limit our scope here."
Biotech can use #generativeai and #llms today, in both scientific and operational use cases, and throughout the entire R&D lifecycle.
⥠Check out our Biotech's Intro to #generativeai to learn: which tools to use and where, including RFdiffusion, MegaMolBART, DNABERT, etc.; build vs. buy vs. open source with LLMs; how to build out your internal team and resources
www.benchling.com/blog/biotech-intro-GenAI-LLMs -
Benchling
@benchling
âąď¸ Process development scientists spend 23% of their time on avg searching for and structuring data for analysis.
đĄ #benchlingbioprocess helps reduce this by providing a structured, traceable process development solution built on an ISA-88 compatible data model. Teams simplify analysis and reporting with experimental context, process, and analytical data in a central place.
đđ˝ Sign up for the #whatsnew webinar tomorrow, Oct 17th at 10am PT/1pm ET, to learn more: www.benchling.com/webinars/whats-new-webinar-oct-2023-ame⌠-
Benchling
@benchling
Got questions about Benchling's latest products #connect and #bioprocess?
Get answers in our upcoming #whatsnew webinar. With a live product Q&A, hear directly from the leaders and developers behind these products, Shawna Wolverton, Derek Halliday, and more. Learn best practices and see these products in actionâ¨
đDon't miss the livestream on Oct 17th, 10am PT/1pm ET: www.benchling.com/webinars/whats-new-webinar-oct-2023-ame⌠-
Benchling
@benchling
This is a fireside chat that's not to be missed! đĽ
Hear from @MenePangalos @AstraZeneca Executive Vice President of BioPharmaceuticals R&D (retiring) on his lessons in leadership and the 5Rs framework for championing quality over quantity.
⥠Secure your spot at #benchtalk23 Europe, 24-25 October in London benchtalk.benchling.com/emea -
Benchling
@benchling
Q: "What makes your product 10x better for scientists?" đ§ŹâĄđ§Ş
A: đ§ Listen to @Inc Founders Project interview with Benchling CEO Sajith Wickramasekara and @alexavontobel to hear the answer.
Learn how Benchling builds product with scientists at the center -
Benchling
@benchling
Cell and gene therapies revolutionize the way we treat disease â but bottlenecks in process development limit widespread patient access.
đŤ Thatâs where @OriBiotech comes in, empowering therapeutics developers to scale from pre-clinical process development to commercial-scale manufacturing.
@OriBiotech uses Benchling to power a new generation of personalized, lifesaving treatments. Learn how their flexible platform:
⏠Reduces planning time between process runs
⏠Reduces data entry errors
⏠Reduces experimental workload
đđ˝ Get the full story here! www.benchling.com/customer-stories/ori-biotech -
Benchling reposted
Jag Singh @JagveerLLC
Thank you to everyone who came out to @bitsinbio #seattle - Generative #ai in Biology tonight đ¤đ§Źđť We had phenomenal engagement: the enthusiasm was palpable and the conversations insightful.
Special thanks to everyone who helped make this event possible.
@Sagebio @benchling @union_ai @UWproteindesign @ArzedaCo -
Benchling
@benchling
Get ready Benchling Europe community, we're coming for you! #benchtalk23 is in London, 24 - 25 October.
â New product announcements
â Hands-on workshops to become an expert in Benchling
â Instructional sessions on AI/ML, FAIR data, and more
â Inspiring keynote speakers (watch this space for announcements!)
đđź Register today! benchtalk.benchling.com/emea/3737621
đ Convene Centre, 22 Bishopsgate, London -
Benchling reposted
Genetic Engineering & Biotechnology News
@GENbio
Join us Thursday--Malay Gandhi at @Benchling and DeAnna Zacherl at @EliLillyandCo, to discuss hurdles biopharma needs to overcome to deploy a solid tech strategy and the key technologies companies are investing in. Register now: www.workcast.com/register?cpak=3358688371282128&referrer=400
-
Benchling
@benchling
Just shipped: updated #workflows in Benchling đŤ đŠđťâđť
⥠Now, with intelligent, easy-to-use Workflows and structured forms, automating and streamlining lab processes is A LOT easier:
âď¸ Faster and more consistent study execution with structured forms
âď¸ Improve data integrity and user compliance with automated conditional routing and looping
âď¸ Restart failed experiments automatically with workflow looping
đđź Learn more at our #whatsnew product webinar on October 17 - register now! www.benchling.com/webinars/whats-new-webinar-july-2026 -
Benchling
@benchling
đŁ #boston Benchling users unite! We're kicking off our Boston Benchling User Group in your backyard.
đ Mark your calendars: October 18th, 4-6pm ET
â Deep dive on new products, beginning with #benchlingconnect
â Share ideas with other Benchling end-users, admins, and developers
â Have fun, make friends, eat đ
đđź Sign up here: www.meetup.com/benchling-user-group-boston/events/296110850/
đLocation: 20 Acorn Park Dr., Suite 300 -
Benchling
@benchling
Introducing #benchlingbioprocess đ§ŹâĄđ§Ş
âĄď¸ Because process development needs an end-to-end solution for modern, high-throughput process science.
With #benchlingbioprocess, customers can:
â Accelerate process development cycles by harnessing data at scale
â Simplify tech transfer for cutting-edge products with structured, traceable process design
â Enable #data science with a centralized and open data platform
đ Learn more here: www.benchling.com/news/announcing-benchling-bioprocess-fo⌠-
Benchling
@benchling
âBiopharma is an industry that hasnât really seen the benefits of digital transformation yet. But itâs the industry that needs it the most.â đ§ŹâĄđ§Ş
Benchling CEO and co-founder Sajith Wickramasekara goes on @BloombergTV to discuss the state of tech adoption in #biopharma, new products from the company, and the latest with #ai/ML.
đđ˝ Watch the show here:Â www.youtube.com/watch?v=pnyBzFdssRg -
Benchling
@benchling
Donât miss Benchlingâs session at @Informaâs upcoming Antibody Engineering & Therapeutics Digital Week, hosted by @dr_alphalyrae and @svsaraf on September 28 at 10 am EST. Register now:
ms.informaengage.com/AntibodyEngineeringandTherapeuticsDi⌠-
Benchling
@benchling
Want to know how #biopharma is using technology to get ahead? The data has been a bit of a black box. Until now...
Introducing the inaugural 2023 State of Tech in Biopharma đ đ đ
We looked at how 300 biopharma R&D and IT execs are adopting enabling tech. What did we discover? Adoption of enabling tech is high, but the environment is complex:
đ 84% of respondents use some custom-built software
đ 40% of IT at larger orgs manage 20+ unique scientific software applications
đ 59% regularly use #ai/ML, despite it being relatively new tech
đ FAIR adoption lags, less than 1/3 achieve org-wide interoperability or reusability
đ IT broadly rates investment in enabling tech as more important, compared to R&D counterparts
đđź Get the full story: www.benchling.com/state-of-tech -
Benchling
@benchling
What you want âĄď¸ Seamless, connected, standardized lab instrument data
How youâll get it âĄď¸ #benchlingconnect, launching today ⨠â¨
Lab instrument connectivity and data management is hard. Hereâs how weâre making it easierđđ˝
âď¸ With a rapidly expanding library of out-of-the-box instrument connectors + generic file converters for edge cases
âď¸ With open source data converters posted in #github
âď¸ By mapping all instrument output data to the Allotrope Simple Model (ASM) industry standard
âď¸ď¸ By automatically linking Instrument data with experimental metadata
đđ˝ Learn more about #benchlingconnect here: shorturl.at/cgiv7
âđ˝ Visit our GitHub repository of open source data converters: shorturl.at/ehGM6 -
Benchling
@benchling
Day 1 of #benchtalk23 was a hit â hands-on workshops, demos, R&D speed-networking, a Boston community meet-up, and more. The fun has just begun!
âĄď¸ Day 2: get ready for product launches and đĽ speakers -
Benchling
@benchling
Who else is excited for #benchtalk23? đđ˝ Get ready to see the launch of new products, learn tech strategies with industry leaders, and connect with #biotech peers â all while enjoying great food, drinks, and swag. đˇ Check out the full schedule here: benchtalk.benchling.com/boston
-
Benchling
@benchling
đ Countdown to #benchtalk is on! Get a sneak peek of the amazing things coming your way. đĽ Check out our sizzle video for a taste of what's in store this Fall.
www.youtube.com/watch?v=QWwvihv9S8k -
Benchling
@benchling
UK biotech @etcembly has developed the first #ai-generated #immunotherapy candidate, which targets PRAME, a protein found in various cancers. Benchling is proud to serve Etcembly as they make groundbreaking strides in cancer research. #builtonbenchling
www.insideprecisionmedicine.com/topics/oncology/generativ⌠-
Benchling
@benchling
#biotech can capture its opportunity with #llms and #chatgpt today. In our made-for-science guide to #generativeai learn how to incorporate LLMs throughout the R&D lifecycle; pros and cons of build vs buy vs open-source LLMs; and more.
www.benchling.com/blog/biotech-intro-GenAI-LLMs -
Benchling reposted
Vega Shah
@dr_alphalyrae
Identifying targets is the backbone of drug discovery. @svsaraf and I wrote an article about the current state and future opportunities in target id+validation for the @bitsinbio blog! Link in bio âŹď¸
-
Benchling
@benchling
What do R&D teams need to do to truly have #fairdata? Read more on our blog about why âprogrammatic ownershipâ is so critical. www.benchling.com/blog/fair-data-strategy
-
Benchling
@benchling
Check out our new blog to learn how innovative software-led approaches are revolutionizing antibody drug discovery, from smart design and optimization to accelerated screening with #ai.
www.benchling.com/blog/antibody-discovery -
Benchling
@benchling
Celebrating science is central to our everyday work at Benchling. We are #teamscience, down to the last detail â even how we name our conference rooms. đ
-
Benchling
@benchling
Researchers have developed a yogurt drink as an alternative to colonoscopies using bacteria engineered with #crispr that detect and may treat colorectal issues. This cutting-edge tech shows potential for less invasive diagnostics and targeted therapies.
www.statnews.com/2023/08/10/colon-cancer-test-engineered-⌠-
Benchling
@benchling
Seeing the collaboration, learning, and sharing that happens when our community gets together at #benchtalk inspired us to launch Benchlingâs new, online community. Hear more about why we launched it from our CEO @sajithw in his blog post: www.benchling.com/blog/introducing-benchling-online-commuâŚ
-
Benchling
@benchling
Todayâs the day â the Benchlingâs online community is here! Sign up today to connect with other Benchling customers, ask questions to your peers, jump into best practices and share product ideas. Visit community.benchling.com to create your login and join the conversation.
-
Benchling
@benchling
We're just one sleep away from the launch of Benchlingâs online community. Follow along as we count down at benchling.com/community and check back tomorrow to get signed up!
-
Benchling
@benchling
#bioprocessing is embracing sustainability to meet the ambitious green goals of biomanufacturers. Have you considered the impact of sustainable bioprocessing on data management? Learn more by downloading our guide: www.benchling.com/resources/why-bioprocess-needs-a-digitaâŚ
-
Benchling reposted
Xtalks Webinars
@Xtalks
Sign up today! This webinar from @benchling will provide an overview of the antibody discovery process highlighting the critical steps involved in developing effective antibody-based therapeutics.
xtalks.com/webinars/antibody-drug-discovery-from-target-vâŚ
#antibodies #drugdiscovery #drugtargetidentification -
Benchling
@benchling
FAIR data â every R&D company needs it. But an explosion of data makes it hard to achieve. Read the top data challenges companies are facing, plus key considerations for building a FAIR strategy. www.benchling.com/resources/how-to-make-rd-data-your-compâŚ
-
Benchling
@benchling
Process analytical technologies (PAT) are changing the game for #bioprocessing. A combination of in-line, on-line, at-line, and off-line analytical technologies now provide control and visibility into process runs. Learn more by downloading our guide: www.benchling.com/resources/why-bioprocess-needs-a-digitaâŚ
-
Benchling
@benchling
At Benchling, inclusion and belonging are baked into our DNA. Dive into the inspiring journey of how our employee resource groups foster growth, learning, and togetherness for our team:
builtin.com/brand-studio/benchlings-ergs-offer-passport-câŚ
#teamscience #dei -
Benchling reposted
Morgan Cheatham, MD
@morgancheatham
the Cloud 100 is here!
this year's list features top AI companies and embraces our most efficient cloud leaders.
two healthcare/bio companies made the list: @KomodoHealth + @benchling
check out the report for more insights đ
Bessemer
@BessemerVP
2023 was one of the most competitive years in history to make the #cloud100.
This yearâs list:
âş $654B of equity value
âş $6.6B average valuation
Dive in for more insights, brought to you by @mcadonofrio, @NextBigTeng, @gracejhma, @ayuditz, & @aschmitt111.
www.bvp.com/atlas/the-cloud-100-benchmarks-report -
Benchling reposted
Menlo Ventures
@MenloVentures
Cheers to @Benchling on making the #cloud100âyet again! Benchling will deliver a healthier future by unlocking the power of biotechnology to accelerate CRISPR gene engineering, cell therapies, synthetic biology, and more. A well-deserved honor mnlo.vc/BenchlingCloud100 via @Forbes
-
Benchling
@benchling
Benchling ranks #20 on the Forbes #cloud100 list, standing out as the only modern software purpose-built for biotech R&D đ . We honor this award alongside the scientists and biotechs globally that rely on us to get breakthrough products to market faster.
www.forbes.com/lists/cloud100/ -
Benchling
@benchling
#bioprocessing is at the cusp of unprecedented digitization due to Bioprocessing 4.0. A wave of smart technologies like automation, IoT, and AI/ML are making this possible. Learn more by downloading our guide: www.benchling.com/resources/why-bioprocess-needs-a-digitaâŚ
-
Benchling
@benchling
Happy #nationalinternday! This year, weâre lucky to have 8 amazing interns across engineering and product design, working on everything from improving the user experience of our product to enhancing and implementing new features. Thanks for being part of #teamscience! đŤ
-
Benchling
@benchling
Bioprocess intensification promises to boost #bioprocessing productivity dramatically. How are you incorporating bioprocess intensification in your work? Learn more by downloading our guide: www.benchling.com/resources/why-bioprocess-needs-a-digitaâŚ
-
Benchling
@benchling
A 14-year-old legally blind teen has regained his sight after a groundbreaking #genetherapy. This breakthrough brings hope for treating millions with other eye diseases. #biopharma
www.washingtonpost.com/health/2023/07/24/gene-therapy-bli⌠-
Benchling
@benchling
San Francisco, Boston, or ZĂźrich? Guess the office: itâs not a Benchling office without jellyfish decor. 𪟠#teamscience
-
Benchling
@benchling
Tired of waiting ages for your code changes to take effect? In our latest Benching #engineering blog post, Raymond Lu shares a game-changing solution to speed up the feedback and testing process. Learn more about their handy #coding hack on our blog:
benchling.engineering/10x-faster-python-test-iteration-vi⌠-
Benchling
@benchling
When the number of samples its strain engineering team needed to run increased from hundreds to thousands, @Novozymes needed to modernize their digital infrastructure. See why they chose Benchling as their central source of truth: www.benchling.com/customer-stories/novozymes-building-mor⌠#builtonbenchling
-
Benchling
@benchling
Wish you could wave a wand and visualize your R&D data? Well, now you can get pretty close. Simple point-and-click integrations let you connect @JMP_software, @tryplutobio, and @watershedai to Benchling.
www.benchling.com/blog/analytics-integrations -
Benchling
@benchling
What does it mean to be on #teamscience? Find out what Benchlings have to say about our mission and culture â and above all, why weâre so passionate about helping scientists power new possibilities for humanity. youtu.be/KiBmXAGoMgU
-
Benchling
@benchling
We're thrilled to receive @DeloitteUS's Technology #fast500 Award! It's an honor to be included among the most innovative, fastest-growing technology companies of the year. đ fast500.com
-
Benchling
@benchling
Want a crash course on how to start and scale a biotech company? Join us on Oct 21 to hear from VCs, incubators, startup founders, and more. Donât miss out on this exclusive eventâregister now: events.benchling.com/buildyourbench/orgtw #buildyourbench @awscloud @cartainc @deepdyve @Quartzy @cmsymp
-
Benchling
@benchling
Just found the #fluorescencefriday hashtag - our mascot, JeffyP, is inspired by jellyfish-derived GFP! Can't believe that million year old fossils still fluoresce!
@cenmag
Andres Tretiakov
@Andrestrujado
Left & right handed ammonites glowing green under UV light for #fluorescencefriday. My favourite, the hyaline layer in the exoskeleton of a scorpion preserved in ethanol glowing blue-green. Even fossils millions of years old still fluoresce! #cenchempics @cenmag #glowingnature












































































































































































































































































































































